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Helicobacter pylori is a major etiological agent which is strongly 
associated with the risk of developing peptic ulcer disease and gastric cancer. 
The interactions between various host and microbial proteins result in chronic 
infection, where enhanced inflammation and proliferation were reported as 
major risk factors. Galectin-3 (Gal-3) is a multifunctional ß-galactoside lectin 
and changes in its expression are observed commonly in cancers and in 
microbial infections. It is widely expressed in gastric epithelial cells where it is 
upregulated and rapidly secreted as a host response to H. pylori infection.   
However, the role of Gal-3 expression and its significance in H. pylori 
infection remains unestablished. 
 
 The current study aims to characterize the cellular dynamics; 
expression as well as functional roles of Gal-3 in modulating crucial host 
responses in H. pylori infected gastric epithelial cells. In this study, Gal-3 was 
found to be upregulated and exported from the nucleus to the cytoplasm in H. 
pylori-infected gastric epithelial cells. The upregulation in Gal-3 expression 
was found to be dependent on extracellular signal related kinases (ERK) 
activation, where the H. pylori Cytotoxin associated gene A (CagA) 
oncoprotein plays a contributory role during early hours of infection. 
Intriguingly, Gal-3 was found to be an enhancer of IL-8 secretion in H. pylori-
infected cells, through the direct activation of NFκB promoter activity. The 
data suggests an active role of Gal-3 in mediating the pro-inflammatory 
response in H. pylori-infected cells. Moreover, a cross talk event of signal 
transduction was shown to exist between ERK and Gal-3. Gal-3 played a 
mediatory role in the enhancement of Ras protein expression. This had a direct 
effect on PI3K activation, as Ras contributes to phosphorylated PI3K 
expression. Interestingly, this led to an activation of ERK phosphorylation, in 
an MEK independent manner. The results imply a MEK independent but Gal-
3 sensitive feedback loop of signal transduction which enhances ERK 
phosphorylation through the Ras-PI3K signalling cascade.  
 
Summary                                                                                                  
xiv 
 
Gal-3 was also shown to enhance the proliferation in H. pylori-infected 
cells, through its association with certain key components of the Wnt pathway. 
In this study, Gal-3 was found to be co-expressed with GSK3β in H. pylori 
infected cells, resulting in enhanced GSK3β phosphorylation, thereby 
contributing to the nuclear translocation of β-catenin. Nucler translocation of 
β-catenin is a critical event in Wnt signalling as it leads to the upregulation of 
cyclin D1, a key regulator of cell cycle progression. Gal-3 expression resulted 
in an enhanced expression of cyclin D1, therby suggesting a major role of Gal-
3 in the enhancement of Wnt signalling. These findings provide a deeper 
insignt into the Wnt mediated transcriptional regulation of genes engaged in 
cell cycle regulation and proliferation. 
 
Apart from the intracellular roles, the present study also investigates 
the extracellular Gal-3 expression, as Gal-3 was found to be secreted out of the 
cells as a rapid response to H. pylori infection. Extracellular Gal-3 showed 
inhibitory effects on adhesion of H. pylori to gastric epithelial cells and was 
also found to be a negative regulator of apoptosis. Furthermore, the 
extracellular Gal-3 was shown to induce migration of THP-1 monocytes 
towards infected cells. This suggests a possible chemo attractant role of Gal-3 
that could further stimulate the host response during H. pylori infection.  
 
Taken together, our study identifies Gal-3 as an important endogenous 
protein which would interfere with various host response events in H. pylori 
infection. The elevated Gal-3 expression demonstrated pro–inflammatory, 
proliferative and anti-apoptotic roles that may contribute to prolonged 
persistence of the infected cells, a characteristic in carcinogenesis. The data 
provide preliminary strong and convincing evidence suggesting Gal-3 as a 
potential diagnostic and/or therapeutic target, wherein its expression may 
serve as an indicator of altered host response in H. pylori-associated severe 
gastroduodenal diseases.   
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VBNC Viable but non-culturable 
WCL Whole cell lysate 
 WT Wild type 
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1.1 Helicobacter pylori and gastroduodenal diseases  
Helicobacter pylori infect the human gastric mucosa and plays an 
important role in the pathogenesis of chronic gastritis and peptic ulcer disease 
(Kuipers et al., 1995; Blaser, 1998). Studies have reported a strong association 
between H. pylori infection and the development of gastric adenocarcinoma 
and mucosa associated gastric lymphoma (Parsonnet et al., 1991; Uemura et 
al., 2001). Although WHO has considered H. pylori as a class I carcinogen 
(IARC, 1994), the consequences of its persistence in gastroduodenal diseases 
including gastric cancer, are determined by the interaction between various 
environmental, host, genetic and microbial factors (Peek and Blaser, 2002; 
Chang et al., 2006).  
 
1.2 Characteristics of H. pylori infection 
H. pylori infection of the gastric epithelium is associated with a 
concomitant increase in various host responses including an enhanced 
inflammation and proliferation of the gastric epithelium. Development of a 
chronic inflammation is an hallmark event in H. pylori infection and is 
initiated by a number of inflammatory mediators including cytokines and 
chemokines (Bodger and Crabtree, 1998). The infection is marked by NFκB 
activation, resulting in an active pro-inflammatory response through the 
secretion of IL-8 (Maeda et al., 2000; Meyer et al., 2000). Of interest, the role 
of H. pylori cytotoxin-associated gene A (CagA) protein in inflammation has 
been well established (Odenbreit et al., 2000). The functional significance of 
CagA is attributed to its translocation into the host cell through a type IV 
secretion system (Guruge et al., 1998; Backert and Selbach, 2008) that triggers 
a cascade of events leading to enhanced IL-8 secretion (Lai et al., 2011). 
 
Another characteristic feature in H. pylori-induced gastric 
malignancies arises from its effect in cell proliferation. A failure to regulate 
proliferation along with the suppression of apoptosis are the minimal 




requirements for a cell to become cancerous (Green and Evan, 2002; Hipfner 
and Cohen, 2004). In this respect H. pylori infection of the gastric mucosa has 
been associated with an increase in gastric epithelial cell proliferation (Peek et 
al., 1999; Schneider et al., 2011). The infection induces an upregulation of 
several key cell cycle regulators (e.g Cyclin D1, C-myc etc), which would lead 
to an acceleration of cell cycle progression, thus contributing to malignant 
transformation (Hirata et al., 2001). Furthermore, infection with CagA positive 
strains elicited a stronger proliferative response when compared with CagA 
negative strains, suggesting that the proliferative activity could well be the 
epithelial regenerative response to cell damage caused by inflammatory 
mediators (Wroblewski et al., 2010) . Hence, inflammation and proliferation 
act as major risk factors in H. pylori infection in promoting cancer 
development through sustained cell proliferation in an environment rich in 
inflammatory cells (De Luca and Iaquinto, 2004; Suzuki et al., 2009).  
 
1.3 Galectin-3  
Recently, a growing amount of literature suggests the role of lectins in 
microbial infections. Among the major group of mammalian lectins are the 
Galectins, that exhibit regulatory roles in various intracellular processes (Yang 
et al., 2008) and act as inflammatory mediators in infections (Almkvist and 
Karlsson, 2004). Of these, Galectin 3 (Gal-3), a 31-KD β-galactoside binding 
lectin, is one of the most studied galectin and is found upregulated during 
inflammation and infection (Vray et al., 2004; Bernardes et al., 2006). 
Increased expression of Gal-3 was reported in Trypanosoma cruzi and 
Streptococcus pneumoniae infections (Silva-Monteiro et al., 2007b; Farnworth 
et al., 2008). Also, studies have reported a strong correlation between Gal-3 
expression and neoplastic transformation. An upregulation in Gal-3 expression 
was demonstrated in several carcinomas including carcinomas of the stomach, 
colon, liver, pancreas, thyroid, ovary, bladder and breast cancer (Miyazaki et 
al., 2002; van den Brule et al., 2004). Many studies have demonstrated a 
critical role of Gal-3 in cell cycle regulation and inflammation (Yoshii et al., 




2002; Henderson and Sethi, 2009). These findings were in accordance with in 
vivo studies, which demonstrated a downregulation of inflammation and 
proliferation in Gal 3-deficient mice (Nieminen et al., 2008; Fermino et al., 
2011). 
  
1.4 Gal-3 in H. pylori infection 
Gal-3 is widely expressed in gastric epithelial cells and increase in its 
expression is linked to increased malignancy in gastric adenocarcinomas and 
in a number of tumors (Baldus et al., 2000; Miyazaki et al., 2002). 
Interestingly, Gal-3 is upregulated and rapidly secreted as a host response to 
H. pylori infection (Fowler et al., 2006). It is therefore not surprising to have 
implied that, Gal-3 would potentially play a role in contributing to H. pylori-
induced gastric malignancies. Although the protein reportedly has various 
intracellular roles in various cancers, no prior work has been done to identify 
its functional significance in H. pylori-induced gastric infections. Given its 
diverse functions, it is possible that Gal-3 could play a regulatory role in H. 
pylori infection by interfering with various associated host response events. 
The current study aims to identify the intracellular dynamics of Gal-3 and its 
significance in H. pylori-infected gastric epithelial cells. 
 
1.5 Objectives of the study 
Being a multifunctional protein, Gal-3 is shown to have diverse roles 
where it interferes with several intracellular signalling pathways. However, 
little is known regarding its role in H. pylori infections. The current study 
discusses the role of Gal-3 in host response to H. pylori infection by 
addressing the following key objectives. 
 
 






(I) Intracellular Roles 
(1) Expression and sub cellular localization of Gal-3 in H. pylori-infected 
gastric epithelial cells. 
(2) Significance of Gal-3 expression in H. pylori infection. 
(a) Inflammatory response-Role of Gal-3 in IL-8 secretion. 
            Gal-3 in NFκB activation. 
            ERK signal transduction and Gal-3 expression.  
(b) Cell proliferation- Role of Gal-3 in Wnt signalling pathway. 
      Gal-3 in β- catenin nuclear translocation. 
Gal-3 and cyclin D1 expression.     
                           
(II) Extracellular roles 
(i) Gal-3 secretion in H. pylori-infected gastric epithelial cells. 
(ii) Role of extracellular Gal-3 in adhesion of H. pylori  































2.1 Helicobacter pylori 
2.1.1 Historical perspective 
For centuries, human stomach had been generally considered as an 
inhospitable environment for bacteria because of its acidic pH. The first 
observation concerning the presence of bacteria in animal/human stomachs 
dates from the dawn of medical microbiology, when the bacterial etiology of 
some other diseases (tuberculosis, cholera, dysentery, syphilis) was 
ascertained. The first observation regarding bacteria living in the human 
stomach was reported in 1899 by Warley Jaworski (Konturek, 2003). Soon 
after, spiral micro-organisms in the stomachs of patients with gastric and 
duodenal ulceration were reported (Krienitz, 1906). It was felt, however, that 
these organisms were contaminants from the oral cavity. Sixty years later, 
bacteria were reported to be in association with gastritis in 80% of gastric 
resection specimens from patients with gastric ulceration (Steer, 1975). 
Interest in the role of gastric bacteria in the pathogenesis of 'peptic' conditions 
was rekindled in 1979 when spiral bacteria were described on the luminal 
surface of epithelial cells of gastric ulcer patients (Fung et al., 1979). 
 
 A modern era in the history of gastroenterology began in 1981, when 
Warren and Marshall successfully isolated a Campylobacter-like organism 
(CLO) from human gastric biopsy specimens (Warren and Marshall, 1983). 
The association of these CLO’s with peptic ulceration, and possibly with 
gastric adenocarcinoma was initially suggested by Marshall and Warren 
(1984). Later, the acute effects of the infection were illustrated after deliberate 
ingestion of a suspension of the organism by Marshall and Morris on separate 
occasions (Marshall et al., 1985; Morris and Nicholson, 1987). The 
'Campylobacter-like organisms' when first isolated were named 
Campylobacter pyloridis, since they resembled other campylobacter’s both 
morphologically and in guanine/cytosine DNA content (Marshall, 1984), but 
was later changed to Campylobacter pylori (Marshall and Goodwin, 1987). 
However due to taxonomic differences such as ultra structure features 




(Goodwin et al., 1985) and ribonucleic sequences (Romaniuk et al., 1987) 
with Campylobacter genus, coupled with its helical morphology, the genus 
Helicobacter was created and the organism was then renamed as Helicobacter 
pylori (Goodwin et al., 1989). H. pylori has been classified as a Group I 
carcinogen by the International Agency for Research on Cancer since 1994 
(IARC, 1994). The bacterium is now considered as the most common 
etiological agent of various gastro duodenal diseases including chronic 
gastritis, peptic ulcer disease, gastric lymphoma and gastric adenocarcinoma 
(Ernest and Gold 2000; Atherton 2006). The discovery of H. pylori and the 
gradual realisation of its importance in peptic ulcer and upper gastrointestinal 
diseases is one of the greatest achievements in the modern history of 
gastroenterology for which Warren and Marshall were awarded with the Nobel 
Prize in Physiology or Medicine in 2005.  
 
2.1.2 Characterisation of H. pylori 
H. pylori is a gram negative, micro-aerophilic bacterium that 
selectively colonises the human gastric mucosa. The spiral shaped 
microorganism measures about 2-4 µm in length with approximately 0.5-
0.8µm in width and possesses 4-6 polar sheathed flagella. On culture plates, H. 
pylori form small translucent colonies of about 0.5- 2mm in diameter after 2-3 
days.  
 
2.1.2.1 Morphological forms 
H. pylori exhibits a characteristic spiral morphology, but can undergo 
morphological transformation from the spiral bacillary form to a coccoid form 
under adverse conditions such as nutrient deprivation, accumulation of waste 
products etc. The transformation from spiral to coccoid takes place in in vitro 
cultures after prolonged incubation of 3 days and more at 37
0
C (Hua and Ho, 
1996; Owen et al., 2001).  It is suggested that the coccoid form may represent 
a viable but non-culturable (VBNC) state of H. pylori, which ensures the 
survival of the bacterium under unfavourable conditions (Cellini et al., 1998; 




Azevedo et al., 2007).  There are conflicting evidences suggesting the 
infectivity of coccoid forms as some studies suggest it as a degenerative form 
which poses no infectious risk (Kusters et al., 1997; Bumann et al., 2004) 
whereas others indicate it as potentially infectious, playing a role in the 
transmission of H. pylori (Nillson et al., 2002; Ng et al., 2003). 
 
2.1.2.2 Growth requirements 
H. pylori is micro-aerophilic with optimal growth at O2 levels of 2% to 
5% and the additional need of 5 to 10% CO2 and high humidity. The standard 
growth condition in a laboratory involves 85% N2, 10% CO2, and 5% O2 for 
H. pylori culture. Growth occurs at 34°C to 40°C, with an optimum 
temperature of 37°C (Kusters et al., 1997; Kusters et al., 2006).  
 
2.2 Epidemiology of H. pylori infection 
2.2.1 Prevalence 
About half of the world’s population is reported to be infected by H. 
pylori. However, the prevalence of infection exhibits large geographical 
variations (Covacci et al., 1999) and is often associated with low socio-
economic status (Malaty et al., 1992; Malaty and Graham, 1994; Bardhan, 
1997). High acquisition rate of H. pylori has been reported in early childhood 
(Malaty et al., 2002). In developing countries, more than 80% of the 
population is H. pylori positive whereas the prevalence generally remains 
under 40% in developed countries (Pounder and Ng 1995; Perez-Perez et al., 
2004).  Other factors which have statistically been associated to H. pylori 
infections include ethnicity (Graham et al., 1991; Malaty et al., 1992) and 
increasing age (Dube et al., 2009; Jackson et al., 2009). 
 
2.2.2 Transmission  
The transmission route of H. pylori infection remains poorly 
understood.  The bacterium has a narrow host range and is found exclusively 




in humans (Megraud and Broutet, 2000) and in some non-human primates 
(Dubois et al., 1994). Transmission is thought to occur via person to person 
contact which could be either through gastro-oral (Leung et al., 1999), oral-
oral (Allaker et al., 2002) or fecal-oral routes (Parsonnet et al., 1999). H. 
pylori has been cultured from gastric reflux, diarrhoeal stools and saliva 
(Ferguson et al., 1993; Megraud 1995; Kabir 2004), but none of these studies 
has provided conclusive evidence suggesting these as predominant routes of 
transmission.  H. pylori was reportedly cultured from waste water (Lu et al., 
2002), but as such may well represent faecal contamination of water source 
(Kusters et al., 2006). Other possible transmission source may include 
contaminated food, as H. pylori was reported to survive briefly on refrigerated 
food (Poms et al., 2001). However, considering the sensitivity of the 
bacterium to atmospheric oxygen coupled with nutrient availability and 
external temperature, it could very well be assumed that direct person to 
person transmission remains the most likely route of transmission (Ng et al., 
2003).  
 
2.3 Clinical aspects of H. pylori-associated diseases 
H. pylori colonises the gastric mucosal lining and causes chronic 
inflammation of the stomach and duodenum (Bodger and Crabtree, 1998; 
Dixon, 2000). Although colonisation with H. pylori occurs in a vast majority 
of population, only a minority develops clinical manifestations of the 
infection. Thus acquisition does not directly mean infection but is a condition 
that would enhance the relative risk of developing various clinical disorders of 
the upper gastro- intestinal tract. For instance, the life time risk of developing 
peptic ulcer disease in H. pylori positive subjects is estimated to be 10-20% 
(Kuipers et al., 1995) which is 3-4 folds higher than in non-infected 
individuals (Nomura et al., 1994). The severity of infection is strongly 
associated with the virulence of the infecting strain and is also dependent on 
various host and environmental factors (Wroblewski et al., 2010).  
 




2.4 Pathogenesis of infection 
H. pylori manifests many mechanisms of pathogenicity which includes 
changes in host gene expression, infection induced inflammation and cell 
proliferation, loss of epithelial cell polarity and cell elongation and disruption 
of tight junctions (Yamaoka 2010). The primary disorder which accompanies 
H. pylori colonisation is chronic acute gastritis. The intra-gastric severity of 
this chronic inflammatory process depends on a variety of factors, such as 
characteristics of the colonizing strain, host genetics and immune response, 
diet, and the level of acid production (Kusters et al., 1997). Hence, 
understanding these factors is important in characterising the role of H. pylori 
in the etiology of upper gastrointestinal pathology. 
 
2.5 Virulence factors of H. pylori 
Studies on the differential pathogenic properties of H. pylori indicated 
that, the increased pathogenesity correlates with the ability of the strain to 
induce morphological changes, infection-associated inflammation, vacuole 
formation and successive degeneration of in vitro cultured cells. Some of the 
established virulence factors which are likely to play a crucial role in 
determining the outcome of H. pylori infection are described as follows. 
 
2.5.1 cag pathogenicity island (cag PAI) 
The cag PAI is a 40-kb DNA insertion element which contains 27 to 
31genes flanked by 31-bp direct repeats. It encodes for one of the most 
intensely investigated H. pylori protein, CagA and its expression is strongly 
associated with peptic ulceration (Crabtree et al., 1991; Censini et al., 1996). 
Eighteen of the cag PAI-encoded proteins serve as building blocks of a type 
IV secretary system (T4SS) which functions to export bacterial proteins across 
the bacterial membrane  into host gastric epithelial cells (Christei and Vogel 
2000). Due to its association with gastroduodenal diseases, the cag PAI is now 
a well characterized H. pylori virulence determinant, and CagA is frequently 




used as an indicator of the presence of the entire cag PAI (Wroblewski et al., 
2010). 
 
2.5.2 Cytotoxin associated gene A (CagA) 
The oncoprotein CagA is encoded by the gene cagA and is present in 
approximately 50- 70% of the H. pylori strains (Owen et al., 2001; Truong et 
al., 2009). It is translocated into the host cell through the T4SS and is tyrosine 
phosphorylated at glutamate-proline-isoleucine-tyrosine-alanine (EPIYA) 
motifs (Noto and Peek, 2012).  Once translocated into the host cells, CagA 
induces actin cytoskeleton and cell morphological changes, termed as “the 
hummingbirds” (Hatakeyama 2008). This virulence factor has been studied 
extensively, especially its role in H. pylori-induced inflammation. Phospho-
CagA activates a eukaryotic tyrosine phosphatase (SHP-2), leading to 
sustained activation of extracellular signal-regulated kinases1 and 2 (ERK1/2). 
Also, ectopic expression of CagA in gastric epithelial cells induces NFkB 
nuclear translocation and IL-8 production, and was shown to be mediated 
through the ERK1/2 pathway (Backert and Naumann, 2010). 
 
2.5.3 Vacuolating cytotoxin A (VacA) 
VacA is a highly immunogenic 95-kDa protein that is secreted by 
approximately 50% of all H. pylori strains (Atherton et al., 1995; van Doorn et 
al., 1998a). The protein induces massive vacuolization in epithelial cells in 
vitro (Cover and Blaser 1992) and is reported to play a role in gastric 
colonization of H. pylori (Oertli et al., 2013). Many of the VacA mediated 
effects arise either directly or indirectly from its membrane binding and pore 
formation. However, VacA also enters the cytosol of host cell and interferes 
with cytoskeleton-dependent cell functions, induction of apoptosis, and 
immune modulation (Cover et al., 2003; Cover and Blanke 2005; Hellmig et 
al., 2005).  
 
 




2.5.4 Outer membrane proteins (OMPs) 
Adhesion of the bacteria to the gastric epithelium is critical for the 
establishment of a stable infection. At least 32 OMPs have been identified in 
H. pylori, of which majority are involved in the adhesion of the bacteria to the 
gastric epithelial cell surface (Tomb et al., 1997). Some of the widely studied 
OMP’s of H. pylori include AlpA, OipA, SabA, SabB, BabB, and HopZ  for 
which the fucosylated ABO blood group antigens and the related sialyl-Lewis 
x and sialyl-Lewis a antigens (sLe x and sLe a) have been identified as 
functional receptors (Yamaoka et al., 2006; Yamaoka, 2008). The presence of 
some of these OMPs is associated with enhanced mucosal inflammation and 
colonisation ability of H. pylori (Yamaoka et al., 2002b) resulting in mucosal 
injury and increased risk to gastro duodenal diseases (Sugimoto et al., 2011). 
 
2.5.5 Lipopolysacharide (LPS)  
H. pylori LPS, like that of other gram negative bacteria, is composed of 
three parts- lipid A, the core oligosaccharide and the O-antigen side chain. 
However, unlike other gram negative bacteria H. pylori lipid A shows low 
endotoxic and immunological activity (Nilsson et al., 2006). The O-antigen 
region of the H. pylori LPS shows structural similarity to Lewis X and Y, a 
mechanism called molecular mimicry and thus contributes in many respects to 
the virulence of the microbe. H. pylori profits from this molecular mimicry, as 
LeX and LeY interact with the C-type lectin DC-SIGN on dendritic cells, 
which signals the immune system to down-regulate an inflammatory response 
(Bergman et al, 2004). 
 
2.6 Characteristics of H. pylori infection 
The development of chronic gastritis associated with H. pylori is a 
multifactorial process and is characterized by gastric epithelial cell injury and 
infiltration of the mucosa with both acute and chronic inflammatory cells 
(Smoot et al, 1999; Yang et al., 2012). The virulence factors produced by H. 




pylori inflict a direct damage on the gastric epithelial cells together with 
significant increases in inflammatory cytokine production, epithelial cell 
proliferation and apoptosis. In H. pylori-infected patients gastric abnormalities 
is likely due to a combination of direct mucosal injury from bacterial toxins 
and indirect injury from the strong inflammatory response stimulated by the 
infection. Interestingly, inflammation and proliferation showed an invariable 
correlation in vivo and the increase in inflammation-induced epithelial cell 
injury was shown to be associated with a reflex increase in proliferation of 
uninjured cells (Tao et al., 2007). This appears to be a characteristic feature of 
H. pylori infection as gastric mucosal cell proliferation is increased in H pylori 
associated chronic gastritis but not in chronic gastritis where the organism is 
absent (Lynch et al., 1995). Study by Munoz et al. (2007) also suggested 
proliferative activity as the epithelial regenerative response to cell damage 
caused by inflammatory mediators. The initiation of an active inflammatory 
response concomitant with the failure to regulate proliferation and suppression 
of apoptosis are the minimal requirements for a cell to become cancerous 
(Green and Evan 2002; Hipfner and Cohen, 2004). Among the H. pylori 
virulence factors, especially the role of CagA has been well defined in 
contributing to disease severity and was shown to stimulate proliferation, 
apoptosis induction and inflammation in infected cells (Smooth et al., 1999; 
Backert and Selbach, 2008; Boonyanugomol et al., 2011).  
 
2.7 Inflammatory response 
A key pathophysiological event in H. pylori infection is the initiation 
and continuance of an inflammatory response. Gastric inflammation is a 
charactersistic outcome in patients infected with H. pylori and represents the 
host immune response to the organism. Histologically, H. pylori-associated 
chronic gastritis is characterised by surface epithelial degeneration and 
infiltration of the gastric mucosa by neutrophils, macrophages, T and B 
lymphocytes. Infiltration by these chronic inflammatory cells results in the 
mucosal upregulation of numerous pro-inflammatory cytokines including IL-




1β, IL6, IL-8 and the tumor necrosis factor alpha (TNF-α) (Crabtree et al., 
1991a; Noach et al., 1994). However, this immune and inflammatory response 
cannot clear the infection, but leaves the host prone to complications resulting 
from chronic inflammation (Naito and Yoshikawa 2002). Qualitative or 
quantitative differences in H. pylori-induced gastric mucosal inflammation 
may play a pivotal role in determining the varied clinical outcomes of 
infection (Bodger and Crabtree, 1998). 
 
2.7.1 Mechanism of inflammation  
Gastric inflammation in H. pylori infection may occur through two 
ways. Firstly, the organism may interact with the surface epithelial cells, 
producing either direct cell damage or may cause the liberation of epithelial 
derived pro -inflammatory mediators (Chemokines) (Watanabe et al., 1997). 
Secondly, H. pylori virulence factors (e.g CagA, VacA) may gain access to the 
gastric mucosa, thereby stimulating specific and non- specific immune 
response involving the liberation of a variety of cytokine messengers as 
illustrated in Table 1(Bodger and Crabtree, 1998). 
 
2.7.2 Chemokines as mediators of gastric inflammation 
The role of chemokines as mediators of gastric inflammation is well 
established (Table. 1). Many studies have shown that the gastric epithelium is 
an important source of chemokines. Interestingly, a contributory role of H. 
pylori virulence factors, especially CagA protein has previously been reported 
in chemokine activation, especially IL-8 (Crabtree et al., 1995; Watanabe et 
al., 1997; Eck et al., 2000).  
 





Tumor Necrosis Factor α (TNFα) Pro-inflammatory (activation of leukocytes) 




Interleulin- 1 α/β (IL-1 α/β) Pro-inflammatory (activation of leukocytes) 
Interleukin- 6 (IL-6) 
Pro-inflammatory. B- and T- cell 
activation/differentiation) 
Interleukin- 7 (IL-7) T-and B-cell regulation 
Interleukin- 10 (IL-10) Immune down-regulation 
Interleukin- 12 (IL-12) Stimulation of TH1 response 
Interferon- γ  (IFN-γ) Pro-inflammatory, especially cellular immunity) 
Granuocyte Macrophage- 
Colony Stimulating Factor 
(GM-CSF) Pro-inflammatory, maturation factor 
Chemokines 
Interleukin- 8 (IL-8) Neutrophil recruitment and activation 
Growth-regulated oncogene α 
GRO-α Neutrophil recruitment and activation 
Regulated on Activation, Normal 
T cell Expressed and Secreted 
(RANTES) Mononuclear cell recruitment and activation 
Macrophage Inflammatory 
Proteins α (MIP-1α) Mononuclear cell recruitment and activation 
   
2.7.3 IL-8 generation 
H. pylori infection induces the secretion of several pro-inflammatory 
mediators, especially IL-8, a potent neutrophil-activating chemotactic cytokine 
or chemokine. Histological severity of H. pylori-induced gastritis (Ando et al., 
1996) and gastric ulcers (Shimizu et al., 2000) correlate well with increased 
IL-8 levels in patient’s gastric mucosa. Similary, in vitro co-culturing of H. 
pylori with gastric epithelial cells showed an increase in IL-8 secretion 
(Crabtree et al., 1995; Sharma et al., 1995). It was therefore no surprise that 
the whole genome profiling of H. pylori-infected gastric epithelial cells 
revealed IL-8 to be the most significantly upregulated gene (Eftang et al., 
2012). 
 
IL-8 release by infected gastric epithelial cells is instrumental in 
regulating neutrophil infiltration of the gastric mucosa in H. pylori-associated 
gastritis (Yamaoka et al., 1996, Nozawa et al., 2002). It induces the 
production of reactive oxygen species and is also known to be a chemotactic 
and an activating peptide for T lymphocytes (Naito and Yoshikawa et al., 




2002). If defence mechanisms fail and chronic infection results, continued 
upregulation of IL-8 coupled with activation of neutrophils and lymphocytes 
could lead to mucosal damage and increased free radical formation thereby 
generating IL-8 to play a pivotal role in the immunopathogensis of H. pylori 
infection. 
 
2. 7.4 Intracellular signalling in gastric inflammation 
The adherence of H. pylori to the gastric epithelial cells induces 
tyrosine phosphorylation of CagA by host src-Kinases. This would lead to 
cytoskeletal re-organization and activation of several intracellular signalling 
events which will further have a downstream effect in the activation of 
transcription factor, Nuclear Factor-KappaB (NFκB). NFκB in gastric and 
intestinal epithelial cells has a central role in regulating genes that govern the 
onset of mucosal inflammatory responses following microbial infections 
(Orlowski and Baldwin, 2002; Lamb and Chen, 2010; Yang et al., 2012a) . 
NFκB activation is effected through a series of phosphorylation and 
transactivation events (Malinin et al., 1997; Nemoto et al., 1998) triggering a 
down steam signalling pathway which contributes to the gastric inflammation 
in H. pylori-infected individuals (Bhattacharyya et al., 2002).  
 
 2.7.5 NFκB activation in gastric inflammation 
 Activation of NFκB leads to the upregulated expression of a variety of 
inflammatory mediators including IL-8 (Keates et al., 1999; Naito and 
Yoshokawa, 2002; De Luca and Iaquinto, 2004). This event is essential for the 
activation of innate and adaptive immune responses against pathogens (Lamb 
and Chen, 2013). Stimulation and activation of NFkB does not require protein 
synthesis, and therefore its effect is particularly important in immune, 
inflammatory and acute phase responses where rapid initiation of host 
response following exposure to pathogens is critical in facilitating survival 
(Naito and Yoshikawa 2002).  However, sustained and constitutive NFκB 
activation results in the progression of diseases including rheumatoid arthritis, 




atherosclerosis, asthma, inflammatory bowel disease, and cancer (Lu et al., 
2006; Hayden and Ghosh, 2008). H. pylori strains harbouring the cag-PAI 
(cag PAI
+
) can direct signalling in gastric epithelial cells to activate NFκB, 
leading to the release of  IL-8 (Naumann, 2005). The role of bacterial 
virulence factors, especially CagA in NFκB induction has also been identified 
previously (Papadakos et al., 2013). 
 
 In resting cells, NFκB activity is inhibited by its association with the 
IκB (IkBα, IkBβ) proteins in the cytoplasm (Verma et al., 1995). Activation of 
NFκB requires phosphorylation of two conserved serine residues within the N-
terminal domain of IκBα (Karin and Neriah, 2000; Takeshima et al., 2009). H. 
pylori infection results in the activation of specific intracellular signalling 
pathways with subsequent activation of the IκB kinase (IKK) complex. This 
complex comprises two catalytic subunits (IKKα and IKKβ) and a regulatory 
subunit (IKKγ), and can phosphorylate IκBα. Phosphorylation of IkBα is 
followed by its ubiquitination and proteosomal degradation, thereby resulting 
in the NFkB nuclear translocation (Karin and Neriah, 2000, Maeda et al., 
2000). Nuclear translocation of NFκB is followed by increased IL-8 
messenger RNA and protein levels (Sharma et al., 1998) which when secreted 
out is critical in the initiation of a inflammatory response.  Protein kinases are 
also required for optimal NFκB activation by targeting functional domains of 
NFκB protein itself.  More importantly, phosphorylation and activation of 
these key subunits plays an important role in determining both the strength and 
duration of the NFκB mediated transcriptional response (Takeshima et al., 
2009).  
 
2.7.6 Signalling pathways in NFκB activation  
2.7.6.1 Activation of Mitogen Activated Protein Kinases (MAPKs) 
The MAPKs comprise an important group of serine and threonine 
signalling kinases that transduce a variety of extracellular stimuli through a 
cascade of protein phosphorylations that lead to the activation of transcription 




factors. The MAP kinase signal transduction pathway plays a crucial role in 
many aspects of immune-mediated inflammatory responses. The involvement 
of MAPK pathways in NFκB activation has been well documented (Malinin et 
al., 1997; Nemoto et al., 1998). There are three principal MAPK family 
members: (i) p46 and p54 c-Jun N-terminal kinase (JNK), or stress-activated 
protein kinase,with multiple subisoforms, (ii) p38 MAPK, with a, b, c, and d 
isoforms, and (iii) p42 and p44 extracellular signal-regulated kinase (ERK) 
(Bhattacharyya et al., 2002). Previous studies have shown that exposure of 
gastric epithelial cell lines to H. pylori strains induced the production of IL-8 
through the activation of MAP kinase signalling pathways. Keates et al (1999) 
and  Meyer-ter-Vehn et al (2000) identified marked stimulation of p38, ERK 
and JNK pathways in the event of H. pylori infection. Inhibition of these 
pathways showed differential attenuation of H. pylori-induced IL-8 secretion. 
Among the MAPKs, ERK was shown to play a prominent role in signal 
transduction for the efficient activation of H. pylori-induced NFκB activation, 
resulting in the production of IL-8 (Nozawa et al., 2002). 
 
2.7.7 ERK signalling in NFKB activation 
ERK exerts its multiple biological effects by phosphorylating 
membrane or cytoskeletal proteins and is activated upon phosphorylation by 
dual specificity kinases MEK1 and MEK2 (Roberts and Der, 2007).A study by 
Nozawa et al. (2002) indicates that the stimulation of ERK signalling pathway 
by H. pylori may be directly responsible for the NFkB activation and 
subsequent synthesis of IL-8. Moreover, when phosphorylated ERK (pERK) 
translocates to the nucleus, it can result in the activation of  other transcription 
factors, including activator protein-1 (AP-1) which when bound to IL-8 
promoter region would lead to maximal gene expression (Hoffmann et al., 
2002; Asim et al., 2010)  
 
The role of CagA in ERK activation has been studied previously (Zhao 
et al., 2010). As shown in Figure 1, CagA contributes to ERK phosphorylation 
and thereby IL-8 secretion in a phosphorylation dependent and independent 




pathway (Nguyen et al., 2008). Once translocated into the host cell, CagA gets 
phosphorylated by several Src family kinases (SFKs) on the tyrosine residues 
of all the EPIYA motifs albeit with much weaker affectivity at EPIYA-A and 
EPIYA-B than at EPIYA-C and EPIYA-D (Naito and Yoshikawa, 2002). This 
is a very important process since nearly 80 % of host cell transcriptional 
changes elicited by CagA are phosphorylation dependent Moreover, the 
number of EPIYA motifs is proportional to the phosphorylation level and 
biological activity of CagA protein, and accordingly is associated with gastric 
cancer (El-Etr et al., 2004). After phosphorylation, the phosphorylated CagA 
binds to SHP-2 via the EPIYA-C or EPIYA-D motif and activates the SHP-2 
protein which in turn activates the ERK signalling cascade (Higashi et al., 
2002; Higashi et al., 2004). Furthermore, gene expression analysis of in vitro 
H. pylori-infected cells revealed a dominant role of ERK/NFκB signalling 
cascade in regulating the host response as it mediates the regulation of a wide 
majority of the genes having crucial implications in carcinogenesis (Shibata et 
al., 2005; Keates et al., 2007). 
 
 
2.7.8 Alternative pathways in ERK activation 
2.7.8.1 Ras- Raf signalling pathway in ERK activation 
The components of this pathway, Ras and Raf, are proto oncogenes 
which contributes to the ERK activation through complex protein-protein 
interactions(Kolch, 2000). This pathway is shown to be activated by H. pylori 
cagA in a phosphorylation independent manner (Nguyen et al, 2008). Once 
translocated into the host cell, CagA binds to growth factor receptor-bound 
protein 2 (Grb-2) and activates the Ras/Erk pathway via son of sevenless 
(SOS) leading to cell scattering and proliferation. The interaction between 
CagA and Grb-2 relies strictly on the presence of EPIYA motifs but does not 
require tyrosine phosphorylation (Mimuro et al., 2002). During the process the 
archetypal Ras exchange factor, SOS, is towed to the membrane by the GRB-2 
adapter protein, which recognizes tyrosine phosphate docking sites located on 




the receptors themselves or on receptor substrate proteins. This activates Ras 
proteins by inducing the exchange of GDP with GTP, which converts Ras into 
its active conformation (Nguyen et al, 2008). Activated Ras bind with high 
affinity to Raf and induces its phosphorylation (Moodie and Wolfman, 1994). 
Phosphorylayted Ras activates MEK 1/2 which then lead to the activation of 
downstream ERK kinases (Kolch, 2000). H. pylori CagA was found to 
potentiate the activation NF-kB via the Ras→Raf→Mek→Erk pathway 
(Brandt et al., 2005).  




                                                      
 
 
Figure 1.  Intracellular events in H. pylori induced IL-8 secretion: H. 
pylori virulence factors are translocated into the host cells through a type IV 
secretion system. Among others, CagA is shown to play a key role in IL-8 
secretion, through the activation of ERK signalling kinases. Both 
phosphorylated (CagA-P) and unphosphorylated CagA contributes to IL-8 
secretion in a SHP-2 mediated and Ras-Raf mediated pathways respectively. 
(Adapted and modified from Nguyen et al., 2008) 




2.7.8.2 EGFR in ERK activation 
Epidermal growth factor receptors (EGFRs) are receptor linked 
tyrosine kinases and its over expression is prevalent in gastric cancer 
(Normanno et al., 2006).  H. pylori infection triggers the ectodomain shedding 
of the EGFR ligand HB-EGF, which are required for EGFR activation through 
its phosphorylation at tyrosine residues (Figure 2). Tyrosine kinase activity of 
the cytoplasmic domain of the EGFR also leads to its over expression through 
an autocrine loop of EGFR transactivation (Keates et al., 2007).  P-EGFR 
residues binds to the GRB-2 docking protein and forms a complex with the 
guanine nucleotide exchange factor SOS (Zarich et al., 2006). This assembly 
promotes Ras activation. Activated Ras directly interacts with and activates 
Raf which phosphorylates and activates MEK, that in turn phosphorylates and 
activates ERKs leading to downstream activation of NFκB and IL-8 secretion 
(Avruch et al., 2001) 
 
Figure 2. Schematic representation of the mechanism involved in EGFR 









2.8 Cell proliferation 
Another characteristic feature of H. pylori-induced gastric 
malignancies arises from its effect in cell proliferation. An aberrant regulation 
of proliferation together with the suppression of apoptosis are the minimal 
requirements for a cell to become cancerous (Green and Evan 2002; Hipfner 
and Cohen, 2004). H. pylori infection of the gastric mucosa has been 
associated with an increase in gastric epithelial cell proliferation (Peek et al., 
1999; Schneider et al., 2011), both in vitro and in vivo (Brenes et al., 1993; 
Bechi et al., 1996; Fan et al., 1996). This effect in proliferation has an 
important pathogenic significance because increased cell proliferation may 
elevate gastric mutation rate and could well be a predisposing factor for gastric 
neoplasia.  
 
 A study by Smoot et al (1999) have suggested that, direct contact by 
H. pylori could inhibit gastric cell proliferation, supporting the theory that the 
increased cell proliferation seen in vivo with H. pylori-associated gastritis is a 
reflex response to cell injury, not directly caused by bacterial contact. 
Successful treatment of H. pylori infection was shown to reduce the hyper 
proliferation rates of gastric epithelial cells to normal (Cahill et al., 1995; 
Lynch et al., 1995). Intriguingly, in vitro studies with cagA positive strains 
exhibited a pro-proliferative effect compared with the cagA negative strains 
(Smoot et al., 1999). This effect of cagA in cell proliferation, together with its 
contribution to inflammation may explain in part the stronger association of 
cagA-positive strains with gastric cancer (Cabral et al., 2007; Suzuki et al., 
2009).  
 
2.8.1 Signalling events in cell cycle regulation and proliferation 
Several pathways have been proposed to explain the mechanisms 
underlying the alteration of cell proliferation in H. pylori infection. In 
mammalian cells, cellular proliferation is regulated in a cell cycle governed by 
the sequential formation and degradation of cyclins and cyclin-dependent 




kinases (Hirata et al., 2001). Among various cyclins, cyclin D1 regulates 
passage through the restriction point and entry into the S phase (Sherr, 1996). 
It was also found that, over expression of cyclin D1 shortens the G1 phase and 
increases the rate of cellular proliferation (Resnitzky and Reed, 1995; Robles 
et al., 1996). Various factors, such as the MAPK cascade (Lavoie et al., 1996) 
and the Wnt signalling (Shtutman et al., 1999; Tetsu and McCormick, 1999) 
are known regulators of cyclin D1 expression (Hirata et al., 2001). Among 
these,  activation of Wnt pathway was shown to play a key role in cell 
proliferation (Zhang and Xue, 2008)  and alteration in its signalling 
components has been described in about 30% of the gastric cancer patients 
(Clements et al., 2002).  
 
2.8.2 Wnt pathway in cell proliferation 
 The canonical Wnt signalling pathway plays a crucial role in 
regulating the proliferation and homeostasis of gastrointestinal epithelia. In 
normal stomach and intestinal epithelia, Wnt signalling has been shown to be 
important for proliferation and tissue renewal (Byun et al., 2005). In order to 
ensure proper functioning, Wnt signalling is constantly regulated at several 
points along its signalling pathway (MacDonald et al., 2009). An aberrant 
activation of Wnt signalling was reported in H. pylori-induced gastritis  which 
would lead to enhanced proliferation thereby leading to carcinogenesis (Yang 
et al., 2012b). A critical event in this process involves the nuclear 
translocation of β-catenin that would lead to the transcriptional upregulation of 
certain key proteins which could act as  regulators of cell cycle (Gnad et al., 
2010).  
 
2.8.2.1 Wnt pathway in β-catenin activation 
β-catenin is a ubiquitously expressed protein with a dual role. On one 
hand, it is important in the establishment and maintenance of adherence 
junctions and, therefore, mediating cell-cell adhesion by connecting E-
cadherin via α-catenin to the actin cytoskeleton (Nelson, 2008). On the other 




hand, it acts as a transcription factor by forming heterodimers with 
lymphocyte enhancer factor (LEF) and T cell factor (TCF) (Korinek et al., 
1997). Asssociation of β-catenin with LEF/TEF proteins would result in the 
transcriptional upregulation of target genes such as  cyclin D1, c-myc, Axin2 
or MMP-7 etc., which are involved in cellular processes like cell cycle control 
and proliferation (He et al., 1998; Brabletz et al., 1999; Lustig et al., 2002). 
Detection of β-catenin nuclear translocation provides an estimate for the 
frequency of Wnt activation in a large number of gastric cancers. Previous 
studies have shown nuclear β-catenin expression in 27 and 31% of tumors, 
respectively (Woo et al., 2001; Tong et al., 2001). These findings are in 
tandem with the previous reports which showed Wnt activation in nearly one-
third of the patients with gastric cancers (Clements et al., 2002).  
 
2.8.2.1 β-catenin expression in H. pylori infection 
Recent studies demonstrated that infection of epithelial cells with H. 
pylori stimulates transcriptional activity of β-catenin (Murata-Kamiya et al., 
2007). Also, in vivo studies have shown activation and nuclear accumulation 
of β-catenin in gastric epithelium of patients infected with H. pylori (Franco et 
al., 2005), suggesting the aberrant activation of β-catenin as a preceding factor 
for the development of gastric cancer. Increased β-catenin expression was 
reported in up to 50% of H. pylori-infected gastric adenocarcinoma specimens 
when compared with non-transformed gastric mucosa
 
(Tsukashita et al., 
2003). However, mechanistic insight for the underlying intracellular signalling 
leading to β-catenin induced activation of target gene expression resulting in 
hyper proliferation and cell survival still remains unclear. 
 
2.8.2.2 Aberrant activation of β-catenin by H. pylori 
Mutations that constitutively activate β-catenin signalling can lead to 
the development of cancer (Logan and Nusse, 2004). In non-stimulated cells, 
the protein level of free β-catenin is kept low by a so-called destruction 
complex (Figure 3).  The complex consists mainly of the tumor suppressor 




adenomatous polyposis coli (APC) and Axin, which build a scaffold on which 
the serine/threonine kinases casein kinase 1α (CK1α) and glycogen synthase 
kinase 3β (GSK3β) function to phosphorylate β-catenin on N-terminal 
residues Ser-45 (CK1α) and Ser-33, Ser-37, and Thr-41 (GSK3β) (Liu et al., 
2002). This phosphorylation of β-catenin leads to polyubiquitinylation and 
subsequent degradation in the 26S proteasome (Kimelman and Xu, 2006). Wnt 
ligands binds to their Frizzled family of serpentine receptors and to their co-
receptors LDL-related protein (LRP) 5/6. This binding impairs β-catenin 
phosphorylation by a complex mechanism not fully understood yet (Gnad et 
al., 2010).Binding of Wnt ligands to LRP 6 activates the dishevelled homolog-
1 (Dv1) phosphoprotein. Dv1 activation leads to a sequence of events in which 
the C-terminus of LRP6 becomes phosphorylated by GSK3β and CK1γ-
following which axin together with Dvl translocates to the plasma membrane 
(Davidson et al., 2005; Zeng et al., 2005). As a consequence, the degradation 
complex is no longer functional and β-catenin translocates to and accumulates 
in the nucleus (Polk and Peek, 2010). Recently, it was shown that infection of 
epithelial cells with H. pylori suppresses GSK3β activity via the Phospho 
Insitol Kinsae 3 (PI3K) /AKT pathway, inhibiting proper β-catenin 
degradation, inducing LEF/TCF transactivation, and upregulation of the β-
catenin target gene cyclin D1 in a CagA- and T4SS-independent manner 

















Figure 3. Wnt pathway in activation of β- catenin.  
In the absence of Wnt , cytosolic β-catenin remains bound within a multi-
protein inhibitory complex comprised of GSK3β and APC tumour suppressor 
protein and axin where β-catenin is constitutively phosphorylated (P) by 
GSK3β, ubiquitylated and degraded. Binding of Wnt to its receptor, Frizzled 
activates Dvl and Wnt co-receptors, low density lipoprotein receptor-related 
protein 5 (LRP5) and LRP6, which then interact with axin and other members 
of the inhibitory complex, leading to GSK3β dephosphorylation. These events 
inhibit the degradation of β-catenin, leading to its nuclear accumulation 
resulting in the transcriptional activation of target genes that influence 











2.8.3 MAPK in cell proliferation  
Mitogen-activated protein kinase (MAPK) cascades have also been 
shown to play a role in regulation of cell proliferation in mammalian cells in a 
manner inextricable from other signal transduction system by sharing substrate 
and cross-cascade interaction (Chen et al., 2006). The activated ERKs 
translocate to the nucleus and transactivate various transcription factors 
changing gene expression to promote growth, differentiation or mitosis (Zhang 
and Liu, 2002).  The interaction among the MAPK members (ERK, P38 and 
JNK) that may be important in controlling different signal cascades during 
bacterial infection has not been determined in gastric epithelial cells. 
However, studies have demonstrated a cross-talk among MAPK members that 
may be important in modulating the downstream molecules, regulating cell 
cycle and proliferation (Cargnello and Roux, 2011). Thus the interactions 
between bacterial infection and MAPK activation is likely to contribute to the 
H. pylori-induced alterations in cell cycle control and proliferation of gastric 
epithelial cells (Ding et al., 2008). 
 
2.9 Regulation of host response in H. pylori infection 
Relatively little is known about host responses to H. pylori that occur 
during the very early stages of infection. Recently, there is a growing amount 
of literature suggesting the role of lectins (from the latin word legere meaning 
“to select”) in tumour progression and in microbial infections. Lectins have 
been reported as mediators of a variety of biological functions by modulating 
the physiologic and homeostatic balance in host cells. (Cash et al., 2006; 
Bishop et al., 2007; Vasta et al., 2009). Lectins are proteins which specifically 
bind or crosslink carbohydrates and initially consisted of the C-type family 
which binds carbohydrates in a calcium dependent manner and the S-type 
family (Lobsanov et al., 1993). The S-type family was so called because its 
first discovered member was dependent on sulfhydryl residues but it has now 
been designated a new name, the galectins as they show high affinity for β-




galactoside containing glycoconjugates and have conserved sequence elements 
in the carbohydrate-binding site (Barondes et al., 1994).  
 
2.10 Galectins  
Galectins are a major group of mammalian lectins, which are 
evolutionarily conserved and have pleiotropic functions with widespread 
distribution. They are ubiquitously expressed in most normal adult tissues and 
also in a variety of tumours (Menon et al., 2011). Galectins show regulatory 
roles in various intracellular processes (Yang et al., 2008) and acts as 
inflammatory mediators in infections (Almkvist and Karlsson, 2004).  
 
2.10.1 The Galectin family- Biochemistry and classification 
Thus far, 15 members of the mammalian galectin family have been 
identified. Hirabayashi and Kasai (1993) classified galectins based on their 
biochemical structure into three groups, the prototype galectins (galectins-1, -
2, -5, -7, -10, -11, -13, -14 and -15), which exists as monomers or non-
covalent homodimers; the tandem repeat group (galectin-4, -6, -8, -9, and -12), 
which is divalent ; and the chimera-type galectins (galectin-3), (Figure 4). 
Chimeric Gal-3 can exist in monomeric form or can associate via the non-
lectin domain into multivalent complexes up to a pentameric form (Liu and 
Rabinovich, 2010).  
 
 
 A) Prototype galectin       B) Tandem repeat galectin    C)   Chimeric galectin                  




Figure  4. Classification of mammalian Galectin family.  
Schematic representation of the structure of different members of the galectin 
family (adapted from Norling et al., 2009). A) Prototype galectins- contain 
one carbohydrate recognition domain (CRD) and a short N-terminal sequence. 
B) Tandem repeat galectins-consist of two non-identical CRD’s linked via a 
short peptide sequence. C) Chimeric galectins- (found in solution as 
monomers with an extended N-terminal tail containing a proline-, glycine-, 
tyrosine-rich domain fused onto the CRD. 
 
 
Through recognition of cell surface glycoproteins and glycolipids, 
these endogenous lectins can trigger a cascade of intracellular signalling 
pathways capable of modulating cell differentiation, proliferation, survival, 
and migration. These cellular events are critical in a variety of biological 
processes including embryogenesis, angiogenesis, neurogenesis, and immunity 
and are substantially altered during tumorigenesis, neurodegeneration, and 
inflammation. In addition, galectins can modulate intracellular functions and 
this effect involves direct interactions with distinct signalling pathways 
(Laderach et al., 2010). Among others, Galectin 3 is one of the most studied 
galectin which is found upregulated during inflammation and infection (Vray 
et al., 2004, Bernardes et al., 2006) 
 
2.11 Galectin 3 (Gal-3)  
Gal-3 is approximately 31 kDa and and contains a carbohydrate-
recognition-binding domain (CRD) of about 130 amino acids that enable the 
specific binding of β-galactosides (Dumic et al., 2006). It is encoded by a 
single gene, LGALS3, located on chromosome 14, locus q21–q22 (Raimond et 
al., 1997). Gal-3 is a multi functional lectin and changes in its expression are 
commonly seen in cancers and pre- cancerous conditions (Yang et al., 2008). 
Gal-3 was reported to have diverse roles in various infections as its expression 
is often associated with pathogen recognition, immune homeostasis and 
inflammation (Vasta, 2012). Gal-3 was shown to regulate a broad range of 




cancer cell activities involving cell growth, transformation, apoptosis, 
proliferation and survival (Laderach et al., 2010; Newlaczyl and Gaung Yu, 
2011). In vivo studies using Gal 3-deficient mice emphasized the critical role 
of this protein in regulating inflammation and cell proliferation (Nieminen et 
al., 2008, Fermino et al., 2011). Other studies have demonstrated the role of 
Gal-3 in cell cycle regulation and inflammation (Yoshii et al., 2002; 
Henderson and Sethi, 2009). The diverse influence of Gal-3 in cancer cell 
activities derives from its multiple inter and sub cellular localizations, where it 
interacts with a range of different binding partners (Newlaczyl and Yu, 2011). 
However, the ubiquitous sub cellular distribution and multiple biological 
effects of Gal-3 warrant an in-depth investigation. 
 
2.11.1 Expression and cellular localization 
Gal-3 is widely expressed in majority of cell lines and exists as both 
intracellular and extracellular forms. Its localization and sub-cellular 
expression is dependent on the tissue, cell type, proliferative state and level of 
differentiation (Okada et al., 2006). Intracellular Gal3 is seen localized in both 
the nucleus and cytoplasm. Depending on the cell type and specific 
experimental conditions, the protein has been reported to be  
exclusively/predominantly cytoplasmic (Gaudin et al., 2000; Openo et al., 
2000), predominantly nuclear (Moutsatsos et al., 1987; Gaudin et al., 2000; 
Haudek et al., 2010) or distributed between the two sub cellular compartments 
(Haudek et al., 2010). 
 
The cellular localization strongly correlates with its biological 
functions, for instance, Gal-3 can either protect cells from apoptosis when 
functioning intracellularly, or promote cell death when functioning 
extracellularly. For e.g. T and B cells over expressing Gal-3 are protected from 
apoptosis (Acosta-Rodriguez et al., 2004; Hsu et al., 2009), whereas 
extracellularly added Gal-3 was shown to induce T cell apoptosis (Stillman et 
al., 2006)  




2.11.1.1 Functions of intracellular Gal-3 
Intracellular Gal-3 has been identified as a component of heterogeneous 
nuclear ribonuclear protein (hnRNP) (Laing and Wang, 1988), a factor in pre-
mRNA splicing (Dagher et al., 1995). It interacts with Gemin 4, an important 
spliceosome component in pre-mRNA splicing and post transcriptional 
processes (Park et al., 2001). In addition, Gal-3 plays a role in regulation of 
apoptosis through its interactions with the Bcl-2 family of proteins.  (Kim et 
al., 1999). Gal-3 was shown to promote activation of Ras (Elad-Sfadia et al., 
2004; Shalom-Feuerstein et al., 2005; Levy et al., 2010) and AKT (Lee et al., 
2003; Oka et al., 2005) proteins, thereby interfering with the regulation of cell 
proliferation and differentiation in several carcinomas. Gal-3 is suggested to 
play a role in Wnt/β-catenin signalling, as studies have identified β- catenin as 
a novel binding partner of Gal-3 in human breast carcinoma (Shimura et al., 
2004). Previous studies have demonstrated a critical role of Gal-3 in cell cycle 
regulation and inflammation (Yoshii et al., 2002; Henderson and Sethi, 2009). 
These studies were consistent with in vivo studies where Gal 3-deficient mice 
exhibited subdued inflammatory and proliferative responses (Nieminen 
(Nieminen et al., 2008; Fermino et al., 2011). Specific functions have been 
attributed to Gal-3 which is expressed on the cell memberane as well. Because 
of its ability to multimerize via its N-terminal domain and bind specific 
carbohydrate branches by the C-terminal domain, Gal-3 is thought to cross-
link glycoproteins and form a cell surface molecular lattice that influences 
cellular function Gal-3 has been shown to interact with the Mgat5-modified N-
glycans of the EGF and TGF receptors in a carbohydratedependent manner 
and delay their constitutive endocytic removal from the plasma membrane 
(Markowska et al., 2011). 
 
2.11.1.2 Functions of extracellular Gal-3  
Studies have confirmed extracellular secretion of Gal-3 even though it 
lacks a recognizable secretion signal sequence (Hughes, 1999; Menon and 
Hughes, 1999; Menon et al., 2011). Gal-3 is secreted from epithelial cells and 




in response to infections (Fowler et al., 2006). In macrophages, secreted Gal-3 
was shown to be a negative regulator of inflammation (Li et al., 2008). 
Extracellular Gal-3 also manifests chemo attractant functions as shown for 
monocytes and macrophages (Sano et al., 2000). Furthermore,Gal-3 is known 
to activate various other cell types including mast cells (Frigeri et al., 1993), 
neutrophils (Yamaoka et al., 1995) and lymphocytes (Joo et al., 2001).   Apart 
from this, studies have also shown Gal-3 as a mediator of cell-cell and cell-
extracellular matrix interactions (Inohara et al., 1996; Kuwabara and Liu, 
1996), through its crosslinking with cell surface glycoproteins (Delacour et al., 
2007).  
 
2.11.2 Gal- 3 and Cancer 
To date, a series of experimental and clinical evidences have been 
reported to support a correlation between galectin expressions and neoplastic 
transformation. Lotan et al (1994) first demonstrated that Gal-3 expression 
was different in gastric carcinomas compared to normal tissue. These data 
were confirmed by Baldus et al. (2000) and Kim et al. (2010) who showed 
that Gal-3 expression was higher in primary gastric adenocarcinomas 
compared to the normal tissues. An up-regulation in Gal-3 expression was 
demonstrated in other carcinomas as well, including carcinomas of the 
stomach, colon,  liver,  pancreas, thryroid, ovary, bladder and breast cancer 
(Miyazaki et al., 2002; van den Brule et al., 2004). In breast epithelial cells, 
Gal-3 was shown to enhance the cyclin D1 promoter activity thereby 
regulating the gene expression and cell proliferation (Lin et al., 2002). 
Consequently, diagnostic and prognostic relevance of Gal-3 have been shown 
in specific cancer types (van den Brule et al., 2004), though there are still 
some conflicting data regarding some types of tumour tissues (Castronovo et 
al., 1996). In recent years, studies have shown that expression of Gal-3 is 
elevated with neoplastic progression in certain malignancies, and therefore is 
expected to serve as a reliable tumor marker (Honjo et al., 2000; Balan et al., 
2010; Cay, 2012). . In breast carcinoma, Gal-3 was found to favour MAPK 
(ERK and JNK ) activation, which  at least in part, resulted in suppression of 




apoptosis by inhibiting cytochrome c release and subsequent caspase 
activation (Takenaka et al., 2004). In thyroid carcinomas, over expression of 
Gal-3 resulted in activation in Ras signalling thereby contributing to 
tumorogensis, tumor invasion and progression (Crul et al., 2001; Levy et al., 
2010) 
 
2.11.3 Gal-3 in infections and immune responses 
Gal- 3 was found upregulated during inflammation and infection (Vray 
et al., 2004; Bernardes et al., 2006). Increased expression of Gal-3 was 
reported in Trypanosoma cruzi and Streptococcus pneumoniae infections 
(Silva-Monteiro et al., 2007a; Farnworth et al., 2008). Recently, it has been 
demonstrated that Gal-3 binds to multimeric LN (LacNAc) and LDN 
(LacdiNAc) epitopes forming GalNAcβ1-4GlcNAc motifs. Apart from this, 
Gal-3 was shown to have a binding affinity with   other carbohydrate 
structures on glycoproteins and glycolipids (including LPS) from many 
pathogens such as mycobacteria, protozoan parasites, and yeast (Ochieng et 
al., 2004; Breuilh et al., 2007).  
 
More interstingly, Gal-3 was shown to interact with the bacterial LPS 
in a dual manner via both N and C terminals (Mey et al., 1996). For e.g. the C 
terminus CRD binds to lactosyl moieties of Klebsilella. pneumoniae LPS, 
whereas the noncarbohydrate-binding N-terminal domain of Gal-3 binds to the 
lipid A moiety of Salmonella enteric (Vasta, 2009). It was suggested that Gal-
3 bound to these pathogens facilitates phagocytosis by macrophages and thus 
implies a prominent role in enhancing the host responses to infection (Sano et 
al., 2003). Gal-3 has been shown to appear in clearing late Mycobacterium 
tuberculosis infection (Beatty et al., 2002) and, contributing to neutrophil 
recruitment at the site of Streptococcus pneumoniae infection (Sato et al., 
2002; Nieminen et al., 2008). Also, Gal-3 was shown to exert an important 
role in innate immunity during Toxoplasma gondii infection (Bernardes et al., 
2006).  On the other hand, interactions of Gal-3 with certain pathogens were 




shown to favour evasion of immune response, as in Leishmania and 
Salmonella infections (Chen et al., 2005; Li et al., 2008). L. major binds to 
Gal-3 through its surface lipophosphoglycans causing cleavage of Gal-3 and 
disruption of its oligomerization. This interaction proves beneficial to the 
pathogen as it enhances microbial invasion by weakening the functional roles 
of Gal-3 in macrophage activation, neutrophil recruitment, and eosinophil-
mediated cytotoxicity (Chen et al., 2005). Also, Gal-3 can positively or 
negatively impact intracellular signalling pathways by regulating the activities 
of various kinases, including protein kinases C, MAPK, and PI3K (Chen et al., 
2005).  
 
2.12 Gal-3 and H. pylori-associated gastric malignancies 
Gal-3 is widely expressed in gastric epithelial cells and was shown to 
play a role in gastric malignancies (Miyazaki et al., 2002). Increased 
expression of Gal-3 was found to be associated with increased malignancy in 
gastric adenocarcinomas (Baldus et al., 2000). Studies by Fowler et al. have 
shown an intracellular upregulation in Gal-3 mRNA expression in H. pylori-
infected cells. Moreover, Gal-3 was found to be rapidly secreted from gastric 
epithelial cells as a host response to H. pylori infection (Fowler et al., 2006). 
A contributory role of CagA oncoprotein has previously been reported (Fowler 
et al., 2006). Gal-3 upregulation in H. pylori-infected cells is intriguing, as the 
protein could potentially mediate multiple intracellular functions as it 
interferes with various survival responses in cancers and in tumorigensis 
(Matarrese et al., 2000; Takenaka et al., 2004; Fukumori et al., 2006).  H. 
pylori infection was shown to induce growth promoting effects through the up-
regulation of cell cycle regulators and is known to induce hyper- proliferation 
of gastric epithelial cells (Hirata et al., 2001). It is possible that, 
carcinogenesis could have arisen from a disruptive homeostasis between the 
inflammatory and proliferative mechanism of H. pylori-infected cells, where 
different host and bacterial proteins could function in opposite roles 




H. pylori infection is characterised by a host environment rich with 
infilteration of inflammatory cells, coupled with hyper proliferation. Gal-3 
expression has also been linked to the expression of certain regulatory proteins 
and inflammatory mediators which would have major effects in infections and 
malignancies.(Lin et al., 2002; Hohenberger and Gretschel, 2003). Taken 
together, these characteristics would have greater impacts in contributing to 
prolonged and enhanced survival of infected cells, hence favouring cancer 
progression (Peek et al., 1999; Shirin et al., 1999). Although Gal-3 exhibits 
multiple intracellular roles, no prior work has been done to identify its 
functional significance in H. pylori induced gastric infections.  The current 
study aims to explore and elaborate the cellular dynamics of Gal-3 and its 
potential implications in interfering with various signalling pathways and 
cellular responses in H. pylori infected gastric epithelial cells. The protein 
appears to have versatile functions in infections and beyond, and a detailed 
understanding would provide a deeper insight into the molecular mechanism 
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3.1 H. pylori strains used in the study 
H. pylori 26695 wild type (WT) and its cagA isogenic mutant (ΔcagA) 
were used in this study. ΔcagA was constructed using a modified multistep 
polymerase chain reaction (PCR) approach as described by (Gong et al., 
2010). 
 
3.1.1 Growth conditions 
All strains were cultured on non- selective chocolate blood agar (CBA) 
plates comprising Blood Agar base No 2 (Oxoid) supplemented with 5% lysed 
horse blood (Quad Five) (Appendix 1). Isogenic mutant was cultured on 
selective CBA plate supplemented with chloramphenicol (15μg/ml) (Appendix 
2). All cultures were incubated at 37
0
C in an atmosphere of 5% CO2 in a 
humidified incubator (Forma, Scientific) for 3 days.  
 
3.1.2 Maintenance of H. pylori cultures 
Confluent growth of H. pylori cultures were harvested from two CBA 
plates using sterile cotton swabs (Copan). The bacteria were then resuspended 
in a 1.5 ml cryotube (Nunc) containing 1ml of brain heart infusion (BHI) broth 
(Oxoid) supplemented with 10% horse serum and 20% glycerol (Appendix 3). 
The resuspended cultures were stored at -80
o
C until use.  
 
3.2 Genotyping of H. pylori virulence genes 
3.2.1 Genomic DNA extraction 
Bacterial cells from CBA plates were harvested and transferred to 1.5 
ml Eppendorf tubes containing 1.5 ml Tris- EDTA (TE) buffer (Appendix 4). 
The bacterial suspension was centrifuged at 6000 x g for 5 minutes at room 
temperature and the pellet was washed once with TE buffer. Thereafter, 
chromosomal DNA was extracted by silica-membrane-based nucleic acid 
purification system (Qiagen) according to the manufacturer’s protocol. The 
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amount of extracted DNA was measured spectrophotometrically at wavelength 
260nm using NanoDrop™ 1000 spectrophotometer (Thermo Scientific).  
 
3.2.2 Polymerase Chain Reaction (PCR) 
PCR was carried out to determine the presence of various virulence 
genes, namely cagA, vacA and iceA1 in the chromosomal DNA of H. pylori 
strain 26695. The PCR reaction was carried out in an amplification thermal 
cycler (Bio-Rad) according to the method as described by (Zheng et al., 2000). 
A 50 μl reaction mixture consisting of 50 ng genomic DNA, 10 x incubation 
buffer, 50 pmol primers (forward and reverse), 1 unit of Taq DNA polymerase 
(Dynazyme), 200 μM each of dNTPs (dATP, dGTP, dTTP and dCTP) and 
sterile distilled water (Appendix 5) was prepared. The PCR reactions for the 
genes mentioned above are listed in Table 2. The PCR primers for 
amplification of these gene and expected fragment sizes are listed in Table 3.  
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(van Doorn et al., 
1998b) 
 
3.2.3 Agarose gel electrophoresis of PCR amplified DNA samples 
The amplified cagA, vacA and iceA gene products were visualized by 
agarose gel electrophoresis of the PCR samples. Briefly, an aliquot of 10 μl of 
each of the PCR products was mixed with 2 μl of 6 x loading buffer 
(Appendix 6) and electrophoresed in a 1% (w/v) horizontal agarose (Seakem) 
gel containing Syber Safe (Invitrogen) for 1-2 h in 1X Tris Acetate EDTA 
buffer (TAE) (Appendix 7), at 80 V. Molecular weight markers (100 bp 
ladder) (Fermentas) were also included in the run to enable easy identification 
of the band sizes of the PCR products. At the end of each electrophoresis gel 
run, the SyberSafe stained gel was visualized using ultraviolet transilluminator 
(Vilber Lourmat) and images were captured with filtered ultraviolet 
illumination under the Electrophoresis Documentation and Analysis System 
290 (Kodak) 
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3.3 Cell culture 
3.3.1 AGS gastric cancer epithelial cells 
Human gastric adenocarcinoma cell line AGS (CRL-1739; American 
Type Culture Collection, Manassas, VA) was cultured in F-12K nutrient 
mixture, Kaighn’s modification (Sigma- Aldrich) supplemented with 10% 
fetal calf serum (Gibco) (Appendix 8). The culture flasks were incubated at 
37
0
C in a CO2 water-jacketed incubator (Forma Scientific) with 95% humidity 
and 5% CO2.  
 
3.3.2 THP-1  
THP-1 (TIB-202; American Type Culture Collection, Manassas, VA) a 
human acute monocytic leukemia cell line, was cultured in DMEM media 
mixture (Hyclone- Thermo Scientific), supplemented with 10% fetal calf 
serum (Gibco) (Appendix 9). The culture flasks were incubated at 37
0
C in a 
CO2 water jacketed incubator (Forma Scientific) with 95% humidity and 5% 
CO2.  
 
3.4 Host pathogen interaction study 
3.4.1 Enumeration of cells 
AGS cells were first washed twice with 10ml of 1 X PBS (Appendix 
10) to remove floating dead cells before the addition of 2 ml of 1% trypsin- 
EDTA. The cells were then incubated at 37
0
C in a CO2 water-jacketed 
incubator (Forma Scientific) for 10 minutes to ensure that all cells are 
detached from the flask surface. Cells were then enumerated using a cell 
counting chamber (Weber Scientific International Ltd) viewed under the 
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3.4.2 Enumeration of bacteria 
Two CBA plates containing confluent growth of a 3-day old H. pylori 
culture were harvested using cotton swabs (Copan) into 10 ml of sterile PBS. 
The suspension was centrifuged at 6000 x g for 5 minutes at 4
0
C. The bacterial 
cell pellet was washed thrice with sterile PBS. The washed pellet was then 
resuspended in 2 ml of sterile PBS. Subsequently, the bacterial suspension was 
used for enumeration by spread plate method and spectrophotometric reading 
at OD600. 
Serial 10-fold dilutions were made from 1 ml of the bacterial 
suspension obtained. Aliquots of 100 μl of the various dilutions in duplicates 
were spread evenly onto CBA plates using a sterile glass spreader. The plates 
were incubated at 37
0
C in a humidified incubator with 5 % CO2 for 3 days. 
Following which, the number of colonies (within the range of 30- 300 
colonies) formed on the CBA pate were counted.  
Concurrently, serial 2-fold dilutions up to 1: 64 were made from 1 ml 
of the bacterial suspension obtained. The turbidity of the suspension was 
measured at an absorbance of 600 nm using a spectrophotometer (Beckman 
Coulter). The viable bacterial cell count (CFU/ml) was plotted against OD600 
reading to obtain a standard curve. This curve was subsequently used as a 
guide for estimation of H. pylori population based on OD600 of the bacterial 
cultures in subsequent experiments.  
 
3.4.3 Infection study 
The bacterial cultures were harvested using sterile cotton swabs 
(Copan) and washed thrice in sterile PBS. The bacteria were then centrifuged 
at 6000 x g for 10 minutes at 4
0
C. After washing, the bacterial cell pellet was 
resuspended in the appropriate volume of PBS and used for infecting the cells 
at a multiplicity of infection (MOI) of 100:1 for all experiments.  
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3.5 Intracellular expression of Gal-3  
3.5.1 Analysis and Quantification of Gal-3 mRNA Expression  
3.5.1.1 Total RNA extraction 
Total RNA was extracted using the RNeasy RNA isolation kit 
(Qiagen) according to the manufacturer's protocol. The total RNA extract was 
treated with 10U of RNase-free DNase (Sigma) at 37
0
C for 20 minutes to 
remove any contaminating DNA. The reaction was heat inactivated at 95
o
C for 
5 minutes. The extracted total RNA was rapidly frozen and kept in aliquots at -
80
0
C until use.  
 
3.5.1.2 Reverse transcription PCR (RT-PCR) 
RT-PCR was carried out in a two step process. In order to form the 
full- length first strand cDNA, the total RNA was reverse transcribed using the 
random hexamer. , 1 unit AMV reverse transcriptase (Promega) and 40 units 
of Rnasin (Promega) (Appendix 11). The reaction was incubated at 42
0
C for 1 
h followed by heat inactivation at 70
0
C for 10 min. The RNA-cDNA hybrid 
obtained was kept at -20
0
C until the subsequent DNA amplification was 
performed using the gene specific primers according to the conditions as listed 
in Tables 4 and 5 respectively.  
 

















Gal3-F        GGCCACTGATTGTGCCTTAT 
Gal3-R        TCTTTCTTCCCTTCCCCAGT
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β -actin-F   CCAACTGGGACGACATGGAG 
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3.5.1.3 Agarose gel electrophoresis of cDNA samples 
An aliquot of 10 μl of PCR product was mixed with 2 μl of 6 x loading 
buffer and electrophoresed in a 1% horizontal agarose (Seakem) gel as 
described in section 3.2.3. At the end of each electrophoretic run, the gel was 
visualized and images were captured under filtered ultraviolet illumination 
using the Electrophoresis Documentation and Analysis System 290 (Kodak).  
 
3.5.1.4 Quantitative PCR (q-PCR) analysis of Gal-3 mRNA 
To quantify the relative abundance of Gal-3 gene transcripts, the 7500 
Fast Real-Time System (Applied Biosystems) was used in conjunction with 
the Quantifast SYBR Green q-PCR kit (Qiagen). Reaction mixture was 
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prepared as indicated in Appendix 12. An optimized primer concentration of 
0.4 μM was used for gene amplification. The thermal cycling protocol was 
followed as per manufacturer’s instruction (50oC for 10 min, 95oC for 5 min, 
40 cycles of 95
o
C for 10 seconds and 60
o
C for 30 seconds). The data was 
collected at each extension step at 60
o
C. β-actin served as an endogenous 
control and was used to normalize expression data. Melting curve analysis was 
performed after the thermal cycling protocol to ensure only the desired 
amplicon was amplified and detected. Relative expression and standard error 
were calculated by the supplied Fast 7500 Real-Time System software 
(Applied Biosystems). 
 
3.5.2 Preparation of AGS whole cell lysates (WCL) 
The cells infected with H. pylori at an MOI of 1: 100 were harvested 
and washed twice in PBS by centrifugation 500 x g for 5 min at 4
0
C. The cell 
pellet was then suspended in lysis buffer (Appendix 13) and incubated at 4
0
C 
for 2 h, with intermittent vortexing. After lysis the supernatant was extracted 
by centrifugation at 12000 x g for 10 min at 4
o
C. The total amount of protein 
was determined by Bradford protein assay. 
 
3.5.2.1 Bradford protein assay 
Bradford protein assay was used to determine the amount of protein in 
samples. The protocol was carried out according to the manufacturer’s 
instructions (Bio-Rad). A standard curve was constructed using different 
known concentrations (0.2- 1 mg/ml) of bovine serum albumin (BSA; Merck). 
Determination of protein content in samples was carried out by adding 1 μl of 
each sample in 0.1 ml dye reaction solution. The dye solution was earlier 
prepared by mixing 1 part of concentrated Bio-Rad dye solution with 4 parts 
of deionized water and filtered through Whatman filter paper. The mixture 
was vortexed and incubated at room temperature for 15 min. The optical 
density (OD) was measured at 595 nm in a micro plate reader (Bio-Rad). The 
protein concentration of samples was calculated based on the standard curve.  
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3.5.2.2 Detection of Gal-3 protein expression  
AGS cells were grown in 75cm
2
 flasks (Nunc) to 80% confluency and 
incubated with H. pylori strains at an MOI of 1:100. Cells were harvested at 
fixed time intervals and lysed as described in section 3.5.2. The whole cell 
lysates were run on a Sodium dodecyl sulphate (SDS) gel and intracellular 
Gal-3 protein expression was detected by western blotting as described below. 
 
3.5.2.3 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE)  
3.5.2.3.1 Preparation of SDS-polyacrylamide gel 
Vertical mini-slab gels (8.6 x 6.8 cm, 1mm thick) comprising 12% 
resolving gel and 4% stacking gel (Appendix 14) were cast using the Mini-
PROTEAN II system (Biorad). The dual gel system (stacking and resolving 
gel) significantly enhances the sharpness of the bands within the gel.  
 
3.5.2.3.2 Sample preparation and electrophoretic gel run 
Aliquots of 10 µl each of protein samples were mixed with 3µl of 5 X 
SDS loading buffer (Appendix 15) and boiled for 5 min before being loaded 
into the wells of the gel slab placed in a mini-PROTEAN 3 vertical 
electrophoresis system (Bio-Rad). Electrophoresis was performed in running 
buffer (Appendix 16) at 0.03A/gel at room temperature with Power Pac 250 
(Bio-Rad) until the dye front reached the bottom of the gel. Prestained Protein 
Ladder (Bio-Rad) was used as the molecular marker. 
 
3.5.2.4 Western blot analysis of protein expression 
The samples run on a SDS gel were transferred onto a polyvinylidine 
fluoride (PVDF) membrane (ImmobilionP, Millipore) by semi-dry blotting 
using Trans-Blot® SD Semi-dry Transfer Cell (Bio-Rad) for 1 h at 150mA 
(Appendix 17). The non specific binding sites of the membrane were blocked 
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overnight with 2% BSA-PBS with gentle shaking at 4
o
C. The membrane was 
then incubated with rat anti-Gal-3 monoclonal antibody (MAb) (1:1000 
dilution, SantaCruz- sc23938) in 2% BSA-PBS (Appendix 18) for 2 h at room 
temperature on a belly dancer (Stovall Life Sciences, Inc). Following which, 
the membrane was washed with 0.1% PBS-T (Appendix 19) five times for 5 
min each before incubating with horseradish-peroxidase conjugated anti-rat 
secondary antibody (1:10000 dilution; SantaCruz- sc2303) for 2 h at room 
temperature with slight agitation. The membrane was washed again in 0.1% 
PBS-T for five times as before. Signals were detected using enhanced 
chemiluminescence detection kit (Pierce) according to the manufacturer’s 
protocol.  
 
3.5.2.5 Flow cytometric analysis of Gal-3 expression 
AGS cells were grown in 75cm
2
 flasks to 80% confluency and then 
infected with H. pylori strains at an MOI of 1:100. After 24 h of infection, the 
cells were harvested and collected by centrifugation at 500 x g for 5 min at 
4
0
C. The pellet was resuspended in 0.5ml PBS, and formaldehyde was added 
to a final concentration of 4%. The cells were fixed in formaldehyde for 10 
min at room temperature, followed by 1 min incubation on ice. The fixative 
was removed by centrifugation at 500 x g for 5 min and the cells were then 
permeabilized with 90% methanol for 30 min on ice. The permeabilized cells 
were then resuspended and washed twice in PBS at 500 x g for 5 min, 
followed by blocking in incubation buffer (Appendix 20) for 10 min at room 
temperature. After blocking, rat anti-Gal-3 monoclonal antibody (SantaCruz- 
sc23938, 1:100 dilution) was added and incubated at room temperature for 1 h. 
The cells were rinsed twice in incubation buffer by centrifugation at 500 x g 
for 5 min and then incubated with FITC conjugated anti-rat secondary 
antibody (SantaCruz- sc2011, 1:100 dilution) for 30 min at room temperature. 
After rinsing again in incubation buffer, the cells were resuspended in 0.5 ml 
PBS for analysis by flow cytometer (Cyan™ ADP). The data obtained were 
analysed using the Summit 4.3 (Beckman Coulter Inc) 
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3.5.3 CagA mammalian expression plasmid 
The pSP65SRα mammalian vector expressing full length cagA gene 
(pSP65SRα-cagA) as shown in Figure 5 was kindly provided by Dr. M. 
Hatakeyama of Hokkaido University, Japan. 
 
          
Figure 5. Diagrammatical representation of the construction of pSP65srα-
cagA recombinant expression vector. 
 
3.5.3.1 Preparation of competent DH5-α E. coli 
Competent cells were prepared according to the method as described 
by Sambrook et al (1989). Briefly, a single bacterial colony of E. coli grown in 
LB agar was inoculated into 5 ml LB broth (Appendix 21 A,B) and incubated 
overnight at 37
0
C on a shaker incubator (Braun) at 200 rpm. From the 
overnight bacterial culture, 1 ml was transferred into 100 ml LB broth and 
incubated at 37
0 
C on the shaker incubator at 200 rpm for 2-4 h. The growth of 
bacteria was monitored by measuring at OD600. The cells were harvested when 
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OD600 reached approximately 0.3. Thereafter, 30 ml of bacterial culture was 
transferred into sterile 50 ml centrifuge tubes (Falcon) and cooled on ice for 10 
min. The tubes were then centrifuged at 6000 x g for 5 min at 4
0
C to obtain the 
cell pellet. The supernatant was discarded and the tubes were inverted to drain 
off excess liquid. The cell pellet was resuspended in 15 ml of ice-cold 0.1 M 
CaCl₂ (filtered with 0.22 μm filter) (Appendix 22). The cells were placed on 
ice for 30 min. The CaCl2- treated cells were centrifuged at 6000 x g for 5 min 
at 4
0
C. The supernatant was discarded and the tubes were inverted to remove 
excess fluid. The cell pellet was then resuspended in 2 ml of ice cold 0.1 M 
CaCl2. Aliquots of 200 μl of cells were mixed with 20 % (v/v) glycerol and 
stored in microfuge tubes at -80
0
C until use. 
 
3.5.3.2 Transformation of plasmids into competent DH5-α E. coli 
Approximately 50 ng of plasmid DNA was added into 200 µl of 
thawed E. coli competent cells and gently mixed by tapping. The suspension 
was incubated at 42
0
C in a water bath for 90 seconds without shaking before 
transferring to an ice bath and incubated for 2 min. An aliquot of 800 µl of LB 
broth was added into the DNA-cell suspension and incubated at 37
0
C for 1.5 h 
with shaking at 90 rpm. From the suspension, 200 µl was spread onto agar 
plates containing 50 µg/ml of ampicillin (Appendix 23) and incubated 
overnight at 37
0
C for no more than 20 h.  
 
3.5.3.3 Preparation of plasmid DNA 
A single colony was selected from the LB agar plates containing 50 
µg/ml ampicillin and inoculated into a starter culture of 5 ml LB broth 
containing 50 µg/ml ampicillin. The medium was then incubated for 8 h at 
37
0
C with vigorous shaking (230 rpm).  
 
From the starter culture, 1 ml was transferred into 250 ml LB medium 
containing 50 µg/ml ampicillin. The medium was then incubated overnight at 
37
0
C, shaken at 230 rpm. Following incubation, the bacterial cells were 
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harvested by centrifugation at 6000 x g for 15 min at 4
0
C. The plasmids were 
extracted using the Plasmid DNA Purification Maxi Kit (Qiagen), according to 
manufacturer’s instructions. The concentration of DNA was determined 
spectrophotometrically at wavelength 260 nm (OD260 of 1= 50µg/ml).  
 
3.5.3.4 Restriction enzyme digest of plasmid DNA 
An analytical scale restriction enzyme digest is usually performed in a 
volume of 20 µl on 0.2-1.0 µg of substrate DNA, using a two-to-ten-fold 
excess of enzyme over DNA (Promega). As a confirmatory test for the 
respective plasmids extracted, restriction enzyme digestion of the plasmids 
was carried out.  
 
For pSP65SRα, only KpnI was used for the restriction enzyme digest. 
The restriction enzyme digest for pSP65SRα comprised of: 16.5 µl of distilled 
water, 2 µl of Buffer J (Promega) and 0.5 µl of KpnI (Promega). For 
pSP65SRα-cagA, KpnI and SacI were used for the double resriction enzyme 
digest. Each restriction reaction consisted of : 16.0 µl of distilled water, 2 µl of 
MULTI-CORE
TM
 buffer (Promega), 1 µl of plasmid DNA, 0.5 µl of KpnI 
(Promega) and 0.5 µl of SacI for each of the plasmid tested. 
 
The mixture was then incubated at 37
0
C for 2 h. The restriction 
enzyme digestion products were then subjected to gel electrophoresis to check 
the size of the bands.  
 
 3.5.3.5 PCR confirmatory test of plasmid DNA 
PCR was carried out to check whether the plasmids obtained were 
correct according to the method as described in section 3.2.2. The PCR 
reaction mixture used for the detection of cagA included 50 ng plasmid DNA, 
50 pmol primers (forward and reverse), Taq DNA polymerase (DynaZyme) 
dNTPs (dATP, dGTP, dCTP and dTTP), 10 X incubation buffer and sterile 
distilled water. 
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3.5.3.6 Transient transfection of AGS cells with pSP65SRα-cagA 
AGS cells were seeded at a density of 1 x 10
5
 cells into a 92-mm dish 
(Greiner Bio One) the day before transfection. The cell media was changed to 
Opti-MEM
® 
I Reduced-Serum Medium (Invitrogen) pre-warmed to 37
0
C 
before transfection. For transfection, 30 µg of the respective CagA cDNA 
plasmid was added into a 15 ml tube. Following this, 8 ml of Opti-MEM
® 
I 
Reduced-Serum Medium and 30 µl of Lipofectamine
®
 2000 transfection 
Reagent (Invitrogen) were added. The mixture was vortexed for 10 seconds to 
ensure proper mixing. This transfection mix was then left to incubate for 20 
min. After the 30 min, Opti-MEM I Reduced-Serum Medium was removed 
from the cells and the transfection mix was added. The AGS cells were 
incubated for 6 more h with the transfection mix, after which the media was 
changed to F12 K complete medium and was incubated for another 36 h.   
 
Harvesting of the transfected AGS cells were carried out by aspirating 
F12 K from the flasks and washing the cells with the 10 ml of pre-chilled PBS. 
The cells were then lysed and protein concentration was determined as 
described in section 3.5.2. The lysates were stored at -20
o
C until use. 
 
3.5.3.7 Detection of CagA expression in pSP653Rα transfected AGS cells 
Successful expression of CagA protein in pSP65SRα transfected AGS 
cells were examined by western blot analysis of the whole cell lysates as 
described in section 3.5.2.4. The immunoblot membranes were incubated with 
mouse anti-CagA primary antibodies (1:1000 dilution, SantaCruz- sc28368) 
overnight and then probed with horseradish peroxide conjugated secondary 
antibody (1: 1000 dilution, Dakocytomation- P 0260). Untransfected cells 
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3.5.3.8 Role of CagA in induction of Gal-3 expression  
The role of CagA in Gal-3 expression was investigated in AGS cells 
transfected with pSP653Rα-cagA as described in section 3.5.3.6. The total 
protein concentration were determined by Bradford protein assay as described 
in section 3.5.2.1 and Gal-3 expression was detected by western blot analysis 
as described in section 3.5.2.4. Untrasfected cells served as negative control 
and H. pylori-infected cells served as positive control.  
 
3.5.4 Detection of Gal-3 sub cellular localization 
3.5.4.1 Confocal laser scanning microscopy (CLSM) analysis 
AGS cells (1 x 10
5
 cells/ml) were seeded on sterile coverslips (22 x 22 
mm) placed in 6- well plates. After 24 h, the cells were serum starved and 
treated with H. pylori strains at an MOI of 100:1. After 24 h, the culture 
medium was decanted and the AGS monolayer was washed with pre- chilled 
PBS. The cells were then fixed in 3.7% formaldehyde (Merck) in PBS for 20 
min at room temperature before being permeabilized with 0.2% Triton X-PBS 
for 10 min at room temperature. The permeabilized cells were washed thrice 
for 5 min each with PBS and blocked with 2% BSA-PBS overnight at 4
0
C. 
The monolayer was then incubated with rat anti-Gal3 MAb (1:100 dilution, 
SantaCruz- sc23938) in 0.2% BSA for 60 min at room temperature. After 
washing with PBS thrice for 5 min each, the monolayer was incubated with 
FITC labeled anti-rat IgG (SanataCruz- sc2011 ) at 1:100 dilutions in 0.2% 
BSA-PBS for 1h at room temperature in the dark. The treated cells were once 
again washed thrice for 5 min each with PBS. Cell nuclei were stained with 
4,6-diamidino-2-phenylindole (DAPI) (2μg/ml; Molecular Probes) for 10 min. 
Cover slips were then mounted onto microscope slides, sealed with 
FluorSave
TM
 reagent (Calbiochem) and viewed at 100 x magnification using a 
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3.5.4.2 Immunogold- labeling Transmission Electron Microscopy (TEM) 
Post embedding immunogold-labeling TEM was performed as 
described by (Kaur et al., 2002) with slight modifications. A 3 day old plate 
culture of H. pylori was harvested and washed twice with PBS. It was then 
fixed in PBS containing 4% paraformaldehyde, 0.2% glutaraldehyde and 2% 
sucrose for 5 h at 4
0
C. The fixed cells were washed in 2% sucrose- PBS thrice 
for 5 min each and resuspended in 2% sucrose-PBS overnight at 4
o
C. The next 
day, the cells were washed twice with water for 10 min each and subsequently 
dehydrated in an ascending graded series of ethanol (ranging from 25% to 
absolute) at room temperature. Infiltration using LR white resin (Ted Pella) 
was carried out over 2 days. On the first day, the sample was passed through 4  
changes of LR white (1 part ethanol: 1 part LR white for 30 min, 3 parts 
ethanol: 7 parts LR white for 30 min, 1 change of pure LR white for 30 min, 
followed by another change of pure LR white overnight). On the second day, 
the sample was infiltrated with 4 changes of pure LR white for 30 min each. 
After the fourth change, the sample was embedded in gelatin capsule. Briefly, 
1mm of block sample was placed in the gelatin capsule and was filled to the 
brim with LR white. The capsule was then incubated at 50
0
C for a minimum 
of 48 h until polymerization of LR white had occurred. Ultrathin sections (70-
100 nm) of the sample were cut using an ultramicrotome (Ultracut E, Leica) 
and subjected to immunogold- labeling on a nickel grid (100 mesh). 
 
3.5.4.3 Detection of Gal-3 sub cellular localization by using imunogold – 
labeling TEM 
The ultrathin sections were washed twice with PBS for 5 min each and 
neutralized with 3 change of 0.05M glycine-PBS for 5 min each. Following 
which the sections were blocked with 5 % BSA-PBS for 1 h to reduce non- 
specific binding. The sections were then washed with 0.1% BSA- PBS before 
incubating with rat anti-Gal3 MAb (1:50 dilution) for 2 h at room temperature. 
This was followed by incubation with anti-rat secondary antibody conjugated 
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with 10 nm gold (1:25 dilution, Ted Pella- 15766) for an additional 2 h at 
room temperature. After washing, sections were then fixed with 2 % 
gluteraldehyde-PBS for 5 min. Thereafter, the sections were stained with 1% 
osmium tetroxide, 8% uranyl acetate, followed by lead citrate for 5 min each 
before viewing under JOEL JEM- 1010 transmission electron microscope. 
Uninfected cells served as negative control.  
 
3.5.4.4 Analysis of Gal-3 nuclear export 
3.5.4.4.1 Extraction of cytosolic and nuclear fractions 
AGS cells were grown to 80% confluency in 75cm
2
 tissue culture 
flasks. The cells were serum starved and infected with H. pylori WT and 
ΔcagA at an MOI of 100:1. Uninfected cells served as control. After 4 h post-
infection, the cells were harvested with a cell scraper, washed thrice with PBS 
and pelleted by centrifugation at 250 x g for 5 min. Following which, the cells 
were lysed in 2 pellet volumes of hypotonic buffer A (Appendix 24A) and 
incubated on ice for 10- 15 min with occasional tapping. The cell lysates were 
centrifuged at 500 x g for 5 min. The supernatant (cytosolic fraction) was 
collected after centrifugation and stored. The nuclear pellet was washed twice 
with buffer A before adding 100 μl of nuclear extraction buffer B (Appendix 
24B) to the pellet and incubated on ice for 45 min with periodic tapping. The 
sample was then centrifuged at 20,000 x g for 10 min and the supernatant 
(nuclear extract) was collected. Protein concentrations of cytosolic and nuclear 
fractions were determined by Bradford protein assay (as described in section 
3.5.2.1), following which the samples were quickly frozen at -20
0
C until use.  
 
3.5.4.4.2 Western blot analysis of Gal-3 nuclear export 
The cytosolic and nuclear fractions were subjected to SDS-PAGE 
(20µg/lane) and transferred onto PVDF membranes by electroblotting. The 
blots were then blocked with 2% BSA overnight at 4
o
C. Gal-3 expression in 
the nuclear and cytosolic fractions was screened by western blot analysis using 
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anti-Gal-3 MAb (1: 1000 dilution, Santa Cruz- sc23938), as described in 
section 3.5.2.4. Lamin (1:1000 dilution, Cell Signalling- 2032) and actin 
(1:3000 dilution, Cell Signalling- 5125) were used as loading controls for the 
nuclear and cytosolic fractions, respectively. Consecutively, the blots were 
then incubated with anti-rat, anti-mouse and anti-rabbit secondary antibodies 
conjugated with horseradish peroxidase (1:10000 dilution, SantaCruz- sc2032; 
1:1000, 1:2000 dilution, DakoCytomation- P 0161 and P 0448, respectively).   
 
3.5.5 Inhibition of Gal-3 nuclear export 
AGS cells were pre-treated with (20 ng/ml) of nuclear export inhibitor 
Leptomycin B (LMB) (SigmaAldrich) at 37
0
C for 4 h as per the 
manufacturer’s protocol.  LMB treated cells were then infected with H. pylori 
strains and Gal-3 nuclear export was detected as described in the following 
sections. 
 
3.5.5.1 Western blot and CLSM analysis of Gal-3 nuclear export 
inhibition 
The nuclear and cytosolic fractions were extracted from LMB treated 
AGS cells as described in section 3.5.4.4.1. Gal-3 nuclear export was detected 
by western blot analysis as described in section 3.5.2.4. Additionally, LMB 
treated cells were fixed, permeabilized and labeled with FITC labeled anti-
Gal-3 MAb and analyzed by CLSM as described in section 3.5.4.1.  
 
3.5.6 Host signalling events in Gal-3 upregulation 
3.5.6.1 Detection of ERK activation in H. pylori-infected cells 
ERK signalling in H. pylori-infected AGS cells were detected by 
western blot analysis as described in section 3.5.2.4. The blots were incubated 
with rabbit anti-p-ERK primary antibodies (1:1000 dilution, Cell Signaling 
Technology- 9101) over night and then probed with horseradish peroxidise 
conjugated anti-rabbit secondary antibody (1:2000 dilution, DakoCytomation- 
P 0448).   
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3.5.6.2 Inhibition of ERK activation  
ERK phosphorylation in AGS cells were inhibited using MEK/ERK 
inhibitor U0126 (Cell Signaling Technology- 9903) as described by (Mitsuno 
et al., 2001). Briefly, AGS cells were pre-treated with U0126 at a 
concentration of 10µM for 2 h. To confirm the inhibition of ERK activation, 
the whole cell lystaes of the U0126 treated cells were subjected to western blot 
analysis as described in section 3.5.6.1.  
 
3.5.6.3 Effect of ERK inhibition in Gal-3 expression  
U1026-treated cells were detected for Gal-3 mRNA and protein 
expression by RT-PCR and Western blotting as described in sections 3.5.1.2 
and 3.5.2 respectively. The data were further confirmed by flow cytometric 
and CLSM analysis of Gal-3 expression as described in sections 3.5.2.5 and 
3.5.4.1 respectively.  
 
 3.5.7 Pro-inflammatory response in H. pylori infection 
3.5.7.1 Detection of IL-8 production 
AGS cells were seeded in 12-well plates for 24 h. The culture medium 
was replaced by fresh medium prior to infection with WT and ΔcagA strains 
of H. pylori. The cell supernatants were collected at 4 and 24 h post-infection. 
The supernatants were aliquoted and stored at -20
o
C until use. 
The concentration of IL-8 in cell culture supernatants was determined 
by commercially available ELISA kit (BD Biosciences) according to the 
manufacturer’s instructions. Briefly, 96 well plates (Nunc) were coated 
overnight at 4
0
C with 100 μl per well of capture antibody diluted in coating 
buffer (Appendix 25). Thereafter, the wells were washed thrice with 0.05% 
PBS-T (Appendix 26) and blocked with PBS containing 10% fetal calf serum 
for 1 h at room temperature. Cytokine standards and cell culture supernatant 
samples were added to the wells which would cause the IL-8 present to bind to 
the immobilized antibody. The wells were washed with 0.05% PBS-T and 
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avidin-horseradish peroxidase conjugate mixed with biotinylated anti-human 
IL-8 specific antibody was then added and incubated for 1 h. The wells were 
then washed with 0.05% PBS-T and reacted with 100 μl/well of TMB 
substrate solution (BD OptEIA
TM
) for 30 min. A blue color was generated in 
direct proportion to the amount of specific cytokine present in the initial 
sample. The reaction was stopped with 2N H2SO4 solution (0.05 ml) and the 
color was seen to change from blue to yellow. The OD was measured within 
30 min using a micro plate reader (Bio-Rad) at 450nm with subtraction of 
absorbance at 570nm.  
 
3.5.7.2 Gal-3 knockdown in AGS cells 
AGS cells were grown in two 6-well plates until 80% confluency. 
Transient silencing of endogenous Gal-3 expression was performed using anti-
Gal-3 siRNA (SantaCruz) as per manufacturer’s instruction. Non-targeting 
siRNA’s (SantaCruz) were used as transfection controls. Briefly, a 10 µl 
aliquot of 5 µM siRNA solution in 1 X siRNA buffer (SantaCruz) was diluted 
with serum-free F12K medium (Tube 1). Simultaneously, 190 µl volume of 
serum-free F12K was mixed with 10 µl of siRNA transfection reagent 
(SantaCruz) to give a 1:20 dilution (Tube 2). The contents of each tube were 
mixed by pipeting up and down gently, followed by 5 min of incubation at 
room temperature. The contents of Tube 1 were then mixed with Tube 2, 
giving a total volume of 400 µl. The suspension was gently mixed and 
incubated at room temperature for another 20 min. A volume of 1.6 ml of 
complete F12K was then added to the mixture to give a final volume of 2 ml 
trasnfection medium with a final siRNA concentration of 25 nM. The spent 
F12K medium from each wells of the 6-well plates was then replaced with 2 
ml of the transfection medium. Following which, AGS cells were incubated at 
37
0
C in 5% C02 for 36 h and transfection efficiency was then detected by 
western blot analysis of Gal-3 expression as described in section in 3.5.2. 
 
 
Materials and Methods                                                                                          
 55   
 
3.5.7.3 NFκB Luciferase assay 
The NFκB promoter activity in H. pylori-infected AGS cells were 
detected using a Ready-To-Glow™ Secreted Luciferase Reporter System 
(Clontech). AGS cells were trasfected with 30 µg of pNFκB-MetLuc2-
Reporter vector containing the NFκB promoter element upstream of the 
secreted Metridia luciferase (MetLuc) gene, as described in section 3.5.3.6. 
pMetLuc2-control vector was used as a positive control. The transfected cells 
were incubated at 37
0
C in 5% C02 for 24 h. After incubation, the spent F12K 
transfection medium was replaced with fresh F12K complete medium 
followed by infection with H. pylori strains. Activation of NFκB promoter 
sequence would induce extracellular secretion of Metridia luciferase, which 
can be detected in the supernatant of the transfected cells. Hence, 50 µl of 
media supernatant was collected 24 h post-infection and the secreted luciferase 
activity was measured by adding an enzyme specific substrate resulting in 
chemiluminescence (Figure. 6). Untransfected cells served as an internal 
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Figure 6. Flowchart of the Ready-To-Glow™ Secreted Luciferase 










Transfection of AGS cells with  
               pNFκB-MetLuc2-Reporter vector 
NFκB promoter activation leads to 
expression of secreted luciferase 
protein in the medium 
Detection of luciferase activity 
.Transfer supernatant to 96-well plate 
.Add substrate reaction buffer 
.Assay luciferase activity in a luminometer 
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3.5.7.4 EGFR, RAS and PI3K activation 
The expression of EGFR, RAS and PI3K in AGS cells were detected 
by western blot analysis (as described in section 3.5.2) using primary 
antibodies of rabbit anti-EGFR and anti-p-EGFR (1: 200 dilution, 
CellSignalling- 2234 and 2232 respectively), mouse anti-Ras (1:1000 dilution, 
e-Biosciences) and anti-p-PI3K (1: 2000 dilution, SantaCruz). After overnight 
incubation the blots were then incubated with horseradish peroxide conjugated 
anti-rabbit and anti-mouse secondary antibodies described in section 3.5.4.4.2 
(1:1000 dilution, DakoCytomation). 
 
3.5.7.5 Inhibition of EGFR and PI3K expression 
EGFR and PI3K phosphorylation in AGS cell were inhibited using 
Tyrphostin AG 1478 (CellSignalling) and Wortmannin (Tocris Bioscience) 
inhibitors as described by (Mitsuno et al., 2001; Keates et al., 2005) and 
(Slomiany and Slomiany, 2006), respectively. Briefly, AGS cells were 
pretreated with 1M Tyrphostin AG1478 or 500nM Wortmannin for 2 h, prior 
to infection with H. pylori. To confirm the inhibition, the whole cell lystaes 
were subjected to western blot analysis as described in section 3.5.7.4. 
 
3.5.8 Proliferation of H. pylori-infected cells 
3.5.8.1 MTT assay 
The cellular viability of AGS cells were analyzed by MTT assay as 
described by (Mosmann, 1983). The cells were cultured for a period of 3 days 
at 37
o
C with 5% CO2 and 95% humidity. The medium was then changed prior 
to adding 100 μl of MTT working solution (Appendix 27) and incubated with 
the culture for a period of 2 h at 37
o
C. The supernatants were carefully 
removed and the formazan crystals formed was released from the cells with 
the addition of 100 μl of DMSO. Absorbance was measured at 570 nm using a 
microplate spectrophotometer (Bio-Rad Benchmark Plus). 
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3.5.8.2 Detection of β-catenin expression 
AGS cells were infected with H. pylori and β-catenin expression was 
detected by western blotting of whole cell lysates with mouse anti-β-catenin 
primary antibody (1:200 dilution, SantaCruz) as described in section 3.5.7.4. 
The blots were probed with horseradish peroxide conjugated anti-mouse 
secondary antibody (1:1000 dilution, DakoCytomation). The sub-cellular 
localization of β-catenin was further confirmed by CLSM analysis (as 
described in section 3.5.4.1) using mouse anti-β-catenin primary antibody 
(1:50 dilution, SantaCruz) and Cy3 conjugated anti-mouse secondary antibody 
(1:100 dilution, DakoCytomation).  
 
3.5.8.3 Detection of GSK 3β expression 
GSK3β phosphorylation was detected in AGS cells by western blotting 
with mouse anti-p-GSK3β primary (1:500 dilution, SantaCruz) and 
horseradish peroxide conjugated secondary antibodies (1:1000 dilution, 
DakoCytomation) as described in section 3.5.2.4.  
 
 3.5.8.3.1   Co-immunoprecipitation (Co-IP) of GSK 3β 
Co-IP analysis was carried out according to the protocol  described 
previously with slight modifications (Yahiro et al., 2003). AGS cells infected 
with H. pylori were harvested 12 h post infection and washed thrice in PBS. 
The cell pellet was then suspended in lysis buffer and incubated on a rotary 
shaker in a slow head-to-tail motion at 4
0
C for 2 h. Following this, the cell 
lysates were centrifuged at 10,000 X g for 10 min at 4
0
C. The resultant protein 
supernatants were mixed and pre- cleared with protein A/G sepharose (50 μl 
slurry) for 2 h at 4
o
C on a rotary shaker. For pull down using recomibant Gal-3 
(r-Gal-), the cell lysates were incubated with 5 μg of the r-Gal-3 and then 
cleared using sepharose beads. Cleared lysates were then incubated with 1μg 
of anti-GSK3b MAb (SantaCruz) and the antibody complex was pulled down 
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by protein A/G sepharose beads (50μl slurry) for 2 h at 40C on a rotary shaker. 
Protein A/G sepharose beads with antibody complex were centrifuged briefly 
and washed 5 times with lysis buffer to remove unbound proteins. Thereafter, 
the beads where resuspended in 50μl of 5 X SDS sample buffer and subjected 
to SDS-PAGE analysis as described in section 3.5.2.3.  
 
3.5.8.3.2 Silver staining. 
AGS cell lysates were incubated with 10 μg of rGal-3 for 4 hours at 40C 
followed by Co-IP with anti Gal-3 mAB as decribed in section 3.5.8.3.1. The 
pull down lysates were visualized following silver staining as as described 
previosly (Chevallet et al., 2006). Briefly, The PAGE gels run with the pull 
down lyastes were fixed in fixer solution for 2 h with changing the solution 
once in between. After fixing, the gel was washed once with 20% ethanol and 
once with distilled water for 10 min each. The gel was then sensitized with 
0.02% sodium thiosulphate for 1 min. Following sensitisation the gel was 
washed three times with distilled water for 20 s and then stained with staining 
solution for 30 min. Before developing, the gel was washed two times with 
distilled water for 20 s. The bands were developed with developing solution. 
The development was stopped with stop solution once the bands were clearly 
visible. The gel was then washed once with 20% ethanol before drying the 
gels. 
3.5.8.3.3 Proximity Ligation Assay (PLA) 
AGS cells (1 X 10
5
) were grown on sterile 22 x 22 mm coverslips to 
90% confluency before being infected with H. pylori WT. PLA was carried 
out at specific time points post-infection according to manufacturer’s 
instruction (Olink Bioscience). Rabbit anti-Gal-3 (SantaCruz); mouse anti-
GSK3β (SantaCruz) were used to detect a potential interaction. Actin was 
stained with Alexa Flour 488 phalloidin. Coverslip samples were mounted 
with Vectashield (Vector Laboratories) incorporated with DAPI to visualize 
DNA. The negative control was performed in the absence of primary antibody. 
Images were acquired with a FluoView™ FV100 confocal laser scanning 
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microscope (Olympus) under a 100 X oil immersion objective with constant 
exposure and gain. Images taken were analyzed using Imaris version 7.3 
(Bitplane) 
3.5.8.4 Detection of cyclin D1 expression 
Cyclin D1 expression was detected in AGS cells by western blotting as 
described in section 3.5.2.4 using mouse anti-cyclinD1 primary (1:100 
dilution, SantaCruz) and horseradish peroxide conjugated secondary 
antibodies (1:1000 dilution, DakoCytomation). 
 
 
3.6 Extracellular Gal-3 expression 
3.6.1 Detection of extracellular Gal-3 expression 
Gal-3 expression in the H. pylori-infected AGS cell culture 
supernatants were detected by western blot analysis as described in section 
3.5.2.4  
3.6.2 Adhesion assay 
3.6.2.1 Labeling of H. pylori 
D-biotin-N-hydroxysuccinimide ester (Biotin-NHS) (Roche) was 
dissolved in DMSO (1µg/ml) and was mixed with H. pylori suspension (1 x 
10
5
/ml) at a ratio of 1:10. The activated ester reacts under mild conditions with 
amino groups and thus biotin residues get incorporated into amino acids, 
peptidies or protein (Roche catalogue 1999). The stock solution was 
comprised of 1 mg of Biotin NHS in 1 ml of sterile distilled water. Prior to 
labelling 1 µl of this solution was added into 1 ml of DMSO to make the 
working solution. The solution was stored at 4
0
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3.6.2.2 Enzyme-linked Biotin-Streptavidin bacterial adhesion assay 
Detection of H. pylori adhesion to AGS cells were performed as 
previously described (Guzman-Murillo et al., 2001). AGS cell (1x10
4
/ml) 
were seeded on a 24-well plate and incubated until 80 % confluency. The cells 
were then fixed with 0.5% formaldehyde (Merck) in PBS at 37
o
C for 30 min. 
Fixed cells were shown to enhance bacterial adherence as compared to live, 
unfixed cells (Guzman-Murillo et al., 2001). The monolayers were then 
washed three times with 0.05% PBS-T . For blocking against non-specific 
binding, 600 µl of freshly prepared 3% BSA was added to each well. 
Incubation was carried out for 1 hr at 37
0
C. The monolayers were washed 3 
times with PBS-T and was used for enzyme linked, biotin streptavidin 
bacterial adhesion assay described as follows. AGS cells (3 x 10
4
/ml) were 
incubated for 2 h at 37
0
C with a suspension of biotin labeled H. pylori cells (3 
x 10
6
/ml). After incubation, plates were washed 3 times with PBS-T to remove 
non-adhering bacteria. This was followed by adding 250 µl of horseradish 
peroxidase conjugated streptavidin (Roche) to each well and the plates were 
incubated for 90 min at 37
0
C (Appendix 28). After washing the plates thrice 
with PBST, 250 µl of O-phenylenediamine-dichloride (Sigma) was added to 
each well and the plates were incubated for another 20 min in the dark 
(Appendix 29). The reaction was stopped by the addition of 100 µl of 2M 
sulphuric acid (Merck) (Appendix 30) and color development was measured at 
495 nm using a Tecan Infinite® plate reader. The adhesion of biotin labeled H. 
pylori to AGS cells were expressed in terms of optical density (OD) units.  
3.6.3 Apoptosis assay 
Apoptosis was detected by Annexin V-FITC (fluorescein 
isothiocyanate) kit (BD Pharmingen) according to manufacturer’s instructions. 
Briefly, cells were grown to 80% confluency in 25cm
2
 flasks in F12K 
supplemented with 10% fetal calf serum. Prior to infection the medium was 
replaced with serum free F12 K and then co-cultured with H. pylori at 37
0
C. 
After 24 h of incubation, cells were harvested, and washed thrice with cold 
PBS and then resuspended in 1x binding buffer. An aliquot of 100µl of the 
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resuspended cell volume (1 X 10
5
 cells) were transferred into a microfuge 
tube, mixed with equal volumes of (5µl) of Annexin V- FITC and Propidium 
Iodide (PI). The cells were gently vortexed and incubated for 15 min at 37
0
C 
in the dark, before the addition of 400µl of 1X binding buffer in each tube. 
The cells samples were then analysed using a flow cytometer within one h.  
3.6.4 Migration assay 
3.6.4.1 CarboxyFluorescien DiAcetate Succinimidyl Ester Staining 
(CSDA-SE) of THP-1 monocytes 
CFDA-SE molecules are highly membrane permeant. Once inside cells, the 
acetate groups are removed by intracellular esterases and the resultant 
fluorescent CSFE then covalently couple to intracellular proteins, forming 
fluorescent CFSE-conjugated proteins as shown in Figure 7(Parish, 1999; 
Wang et al., 2005).The labeling of cells with CFDA-SE was carried out with 
reference to product recommendation (Molecular Probes) and protocol from 
Current protocols in Immunology, Unit 4.9. Briefly, cell number was 
determined, and the cells were resuspended in 1 ml of PBS to obtain 10
6
 
cells/ml suspension. The original CFDA-SE 5mM stock was diluted to obtain 
a 5µM working concentration by adding 1 µl of the 5mM stock to 1ml of the 
THP-1 cell suspension in DMEM (HyClone) media. The suspension was 
mixed thoroughly and labeling performed by incubating the mixture at 37
0
C 
for 10 min. An equal volume of DMEM media was then added to quench the 
labeling process. The cells were then collected by centrifugation at 1000 x g 
for 10 min at 4
0
C. The cell pellet was washed twice in 2 ml of DMEM by 
centrifugation and then resuspended in DMEM for subsequent 
experiments.
 
Adapted from  (Wang et al., 2005) 
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Figure 7. Schematic representation of the mechanism involved in the 
fluorescent labeling of cells using CFDA-SE. CFDA-SE readily diffuses into 
the cell. Intracellular esterases remove the two acetate groups from CFDA-SE 
to yield fluorescent CFSE. In some cases, CFSE covalently couples to 
intracellular molecules (R1-NH2) to form conjugate 1 that can still exit from 
the cell or are rapidly degraded. However, a proportion of CFSE becomes 
couples to long-lived intracellular molecules (R2-NH2) to form conjugate 2 
that cannot escape from the cell and thus stable labeling is achieved (Wang et 
al., 2005)  
3.6.4.2 CLSM analysis of THP-1 migration 
AGS cells (1x105) were seeded on the bottom well of a Costar 
Tranwell
® 
migration plate with a pore size of 4µm. (Figure 8). The wells were 
infected with WT H. pylori upon reaching 80% confluency. CFDA-SE labeled 
THP-1 monocytes were then added on to the trans-well inserts. After 24 hours 
of incubation, the number of THP-1 cells which migrated across the trans-well 
chamber towards AGS cells were counted by random selection of fields under 
a fluorescent microscope (Olympus Fluoview FV1000, 100X objective, 
Numerical Aperture 1.25). Furthermore, the trans-well microporous membrane 
was then excised and viewed by CLSM together with Z-stacking of the filter 
planes. Images taken were analyzed using Imaris version 7.3 (Bitplane)                                  
Figure 8. Diagrammatic representation of a migration plate assembly. 
 
3.7 Statistical Analysis 
 
The Student’s t-test was used to evaluate the in vitro data as the comparison 
was made between the means of different treatment groups. Each experiment 
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wass carried out in triplicates and the error bars are represented as mean +/- 


































4.1 Genotyping of H. pylori 
Chromosomal DNA extracted from WT H. pylori was amplified by 
PCR and analysed by gel electrophoresis. Figure 9 shows the presence of 




Figure 9. Genotyping of virulence genes in WT H. pylori. M, 100 bp DNA 
ladder marker; PCR products showing: Lane 1, 400 bp cagA; Lane 2, 1160 bp 















4.2 Enumeration of H. pylori 
A plot of viable bacterial count (CFU/ml) against the OD600 reading 
based on different dilutions of a 3-day-old WT H. pylori culture was obtained 
as illustrated in Figure 10. The data and equation obtained were used in 




Figure 10 Standard curve for enumeration of H. pylori. Viable cell count 
(CFU/ml) was plotted against OD600 for H. pylori strain 26695. Data shown 











4.3 Identification and confirmation of cagA isogenic mutants of H. pylori  
H. pylori cagA isogenic mutant (ΔcagA) was constructed earlier by Dr. 
S. Y. Lui of our lab. Genomic DNA of the ΔcagA mutant was extracted and 
analyzed by PCR to check for the presence of cagA. Figure 11A shows WT H. 
pylori possessing cagA, whereas the gene was absent in ΔcagA strain. To 
further confirm the deletion of cagA, total cell lysates of the WT H. pylori and 
ΔcagA strains were obtained and immunoblotted with anti-CagA antibody 
(Figure 11B). WT H. pylori showed expression of CagA protein, whereas the 
latter showed no detectable CagA expression.  
                                
 
                                            
Figure 11. Identification and confirmation of H. pylori cagA isogenic 
mutants. A) Detecting the presence of cagA (400bp) by PCR. M, 100 bp 
DNA ladder marker; Lane 1, WT H. pylori; Lane 2, ΔcagA H. pylori. B) 
Detection of CagA by western blotting of H. pylori lysates.  Lane 1, WT H. 
pylori; Lane 2, ΔcagA H. pylori. The images are respresentative of 3 
independent experiments.        
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4.4 Intracellular Gal-3 expression in H. pylori-infected cells 
4.4.1 Detection of Gal-3 mRNA expression 
Gal-3 mRNA expression level was detected by standard RT-PCR and 
the relative expression was detected by real time q-PCR. Gal-3 mRNA was 
found significantly increased in a time dependent manner upon infection with 
WT and ΔcagA strains of H. pylori (Figure 12A). The expression levels 
peaked and stabilized at about 8-12 h post-infection. Interestingly, cells 
infected with ΔcagA strains showed a delay and reduction in Gal-3 up-
regulation during early time points (approximately, up till 8hrs), suggesting 
the role of CagA in early induction of Gal-3 expression. However, Gal-3 
expression was found to be independent of CagA during later time intervals of 
infection (from 8hrs onwards). The data was further confirmed by relative 
quantification of Gal-3 mRNA expression by q-PCR. Consistent with the RT-
PCR data, q-PCR analysis also yielded similar results, showing a time 
dependent increase in Gal-3 expression, which peaked at 8-12 h post-infection 
















                                         
       





        
 
 
Figure 12. Analysis of Gal-3 mRNA expression. AGS cells were infected with WT and 
ΔcagA strains of H. pylori. The cells were harvested at specific time intervals and total 
RNA was extracted and analysed by (A) RT PCR and (B) q-PCR for Gal-3 expression. β-
actin served as loading control. Uninfected cells serve as experimental control. The data 
represent means ± SD of three independent experiments. 
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4.4.2 Gal-3 protein expression 
Further to an observed increase in mRNA expression, Gal-3 protein 
expression was detected in AGS cells infected with H. pylori strains (Figure 
13). As shown by western blot analysis (Figure 13A), a time-dependent up-
regulation of Gal-3 expression was observed in cells infected with WT H. 
pylori. This increase in expression was delayed in cells infected with ΔcagA 
strains, hence suggesting the role of CagA as an initiator/enhancer of Gal-3 
expression. However, as infection progresses, Gal-3 up-regulation was found 
to be independent of CagA (8 h onwards) as shown by similar levels of 
expression in cells infected with WT and ΔcagA H. pylori. The results were 
further confirmed by flow cytometric analysis of H. pylori-infected cells 
(Figure 13B).  Numbers in histogram plots represents the mean fluorescence 
intensity (MFI) of Gal-3 expression. Consistently, cells infected with WT and 
ΔcagA strains of H. pylori showed an up-regulation of Gal-3 expression with 
an MFI of 19.3 and 18.6 respectively. Whereas, uninfected cells showed no 
















    





                   
 
 
Figure 13. Analysis of Gal-3 protein expression. AGS cells were infected 
with WT and ΔcagA strains of H. pylori for various time intervals up to 24 hrs. 
(A) Serum starved cell lysates were resolved by SDS-PAGE and Gal-3 
expression was detected by immunoblotting with anti-Gal-3 MAb. β-actin 
served as loading control. (B) Cells infected for 24 h with H. pylori were 
harvested, fixed, permeabilised and stained with anti-Gal-3 MAb followed by 
FITC conjugated secondary antibody. Gal-3 expression was detected by flow 
cytometry and was compared against uninfected cells, which served as 
experimental control. The bar graph represents the mean fluorescent intensity 
of Gal-3 expression ± SD of three independent experiments.  
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4.5 Role of CagA in Gal-3 expression 
Since, cells infected with ΔcagA showed a reduction in Gal-3 
upregulation during early h of infection, the role of CagA in induction of Gal-
3 upregulation was investigated. Further to this, cells were transfected with 
CagA expression plasmid and its effect in Gal-3 expression was analysed. 
 
4.5.1 Restriction enzyme digests of CagA expression plasmid  
The study used a eukaryotic expression vector pSP65SRα containing 
full length cagA gene (pSP65SRα-cagA) from H. pylori strain 26695. 
Restriction enzyme digest of pSP65SRα and pSP65SRα-cagA plasmid were 
carried out to confirm the presence of full length cagA gene. As shown in 
Figure 14, the double restriction enzyme digestion of cagA plasmid yielded 
fragments of 4.3kb and 3.9 kb, corresponding to the expression vector and full 
length cagA gene, respectively. The pSP65SRα expression vector, upon 
digestion using a single restriction enzyme showed a fragment size of 4.3kb 
only.  
                            
Figure 14. Restriction enzyme digest of cagA clones. M, 1 Kb DNA ladder 
marker; Lane 1, pSP65SRα-cagA (digested with KpnI and SacI); Lane 2, 
pSP65SRα expression vector (digested with KpnI only)  
 





4. 5.2 CagA transfection in AGS cells  
As shown in figure 15A, transfection with pSP65SRα-cagA resulted in 
successful expression of cagA gene. Cells infected with H. pylori served as 
positive control displayed cagA expression levels similar to the transfected 
cells, hence suggesting its translocation from the bacteria to the host. On the 
other hand, cells transfected with empty vector pSP65SRα, acted as negative 
control showing no cagA gene expression. The results were further confirmed 
by immunoblot analysis of the whole cell lysates (Figure 15B). Both H. pylori-
infected and pSP65SRα-cagA transfected cells showed significant amounts of 
CagA protein expression. Whereas, control cells transfected with empty vector 
showed no detectable CagA expression.  
                                                                          
          
 
                         
 
 
                                  










Figure 15. Analysis of cagA transfection in AGS cells. AGS cells were 
either transfected with pSP65Srα-cagA expression vector or infected with H. 
pylori respectively. Uninfected cells transfected with empty pSP65Srα vector 
served as negative control. Lane1: Empty pSP65SRα transfected cells; Lane2: 
pSP65SR α-cagA transfected cells; Lane 3: WT H. pylori-infected cells (A) 
The DNA extracted from the tranfected and infected cells were amplified by 
PCR and a 400 bp cagA gene fragment was visualised by gel electrophoresis. 
(B) CagA protein expression was detected by Western blotting with polyclonal 
anti-CagA antibody. β-actin served as loading control.  
 
4.5.3 Role of CagA in Gal-3 expression 
As shown in Figure 16, cells transfected with an empty vector served 
as experimental control showing basal levels of Gal-3 expression (Lane 1). 
However, transfection of AGS cells with pSP65Srα-cagA resulted in 
significant up-regulation of Gal-3 protein expression (Lane 2). Similarly, cells 
infected with WT H. pylori showed significant amounts of Gal-3 up-regulation 
(Lane 3).  
                                      
 
Figure 16 Effect of cagA transfection in Gal-3 expression. AGS cells were 
either transfected with pSP65Srα-cagA expression vector or infected with H. 
pylori respectively. Uninfected cells transfected with empty pSP65Srα vector 
served as experimental control. Gal-3 expression was detected by western 
blotting of the whole cell lysates with anti-Gal-3 MAb. β-actin served as 
loading control. Lane1: Empty pSP65SRα transfected cells; Lane2: pSP65SR 











4.6 Intracellular dynamics of Gal-3 expression 
Earlier studies have reported changes in cellular localization and 
biological functions of Gal-3 depending on the cell type, proliferative state and 
treatment conditions (Okada et al., 2006). Hence, the intracellular dynamics of 
Gal-3 was examined in H. pylori-infected AGS cells.  
 
4.6.1 Detection of Gal-3 sub cellular localization by CLSM 
Using CLSM, the sub cellular localization of Gal-3 was detected in H. 
pylori-infected AGS cells (Figure 17). Uninfected cells showed a basal level 
of Gal-3 expression, and was seen restricted mostly in the nucleus. 
Interestingly, cells infected with the WT and ΔcagA strains of H. pylori 
showed a predominant cytoplasmic localization, suggesting the change in 
cellular localization as a host response to infection.  
 
4.6.2 TEM analysis of Gal-3 subcellular localization  
Gal-3 subcellular expression was further confirmed by immunogold- 
labelling TEM of Gal-3. Ultrathin sections of uninfected AGS cells show the 
presence of Gal-3 localised predominantly in the nucleus, as indicated by the 
presence of 20nm gold particles (Figure 18A). On the other hand, H. pylori-
infected cells showed a shift in subcellular expression as majority of the Gal-3 
were found to be localised in the cell cytoplasm concomitantly exhibiting a 











                     
Figure 17. CLSM analysis of Gal-3 subcellular expression. AGS cells were 
infected with H. pylori WT and ΔcagA strains for 24 hrs. Uninfected cells 
serve as experimental control. Gal-3 is stained green with anti-Gal-3MAb 
conjugated to FITC while the cell nucleus fluoresces blue as stained by DAPI. 
Panels a-c, signals Gal-3 expression; panels a’-c’ shows merged images of 
Gal-3 fluorescence and nuclear fluorescence. Panels d-f and d’-f’ shows 
magnified images of Gal-3 expression and merged images of Gal-3 and 











































Figure 18. Localization of Gal-3 in H. pylori-infected AGS cells. AGS cells 
were infected with H. pylori for 12 h and then processed for immunogold 
labelling TEM. Uninfected cells served as control (A) Uninfected AGS cells 
(B) AGS cells infected with WT H. pylori. Gal-3 was labelled with anti-Gal-3 
MAb and 20 nm immunogold secondary antibody. Red circles indicate 
presence of 20 nm gold labelled Gal-3 expression. Micrographs are 












4.6.3 Nuclear export of Gal-3 as a host response to H. pylori infection 
The shift in subcellular localization observed in CLSM and TEM 
analysis suggests an active nuclear export of Gal-3 in H. pylori-infected AGS 
cells. The observed change in intracellular dynamics was further confirmed by 
immunoblot analysis of the nuclear and cytosolic fractions.  
 
4.6.3.1 Western blot analysis of Gal-3 nuclear export 
Figure 19 depicts western blots of the cytosolic (Figure 19A) and 
nuclear (Fig. 19B) fractions of AGS cells infected with WT and ΔcagA strains 
of H. pylori. Consistent with the CLSM and TEM data, uninfected cells 
showed a basal level of Gal-3 expression, which was found restricted to the 
nucleus. However, infection with WT H. pylori caused an up-regulation 
coupled with a time dependent decrease in Gal-3 nuclear expression. 
Subsequently, the cytosolic fractions of H. pylori-infected cells showed a time 
dependent increase in Gal-3 expression, suggesting an active intracellular 
export of Gal-3 from the nucleus to cytoplasm. Interestingly, a delay in Gal-3 
nuclear export was observed in cells infected with ΔcagA strains. The ΔcagA 
infected cells showed basal level of cytosolic Gal-3 expression comparable to 
the level of expression observed in uninfected cells up for the first 6 h. 
However, as the infection progressed, ΔcagA strains also induced an active 
nuclear export of Gal-3 with significantly high cytosolic expression by 24 h of 
infection. Taken togother, the data implies that Gal-3 nuclear export is 
independent of H. pylori cagA, despite showing an effect at early time points 










                                 
 
 
                                 
 
Figure 19. Gal-3 expression in cytosolic and nuclear fractions: AGS cells 
were infected with WT and ΔcagA strains of H. pylor for 24 h.The cytosolic 
and nuclear fractions were extracted at various time intervals and subjected to 
western blot analysis using anti-Gal-3 MAb. Uninfected cells served as 
experimental control. β-tubulin and lamin serve as loading controls for the 
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4.6.3.2 Effect of Leptomycin B (LMB) treatment on Gal-3 nuclear export 
In order to verify if Gal-3 is being exported from nucleus to cytoplasm, 
the mechanism of Gal-3 nuclear export was tested using a well characterized 
nuclear export inhibitor, LMB. LMB binds to and inhibits the interaction of 
exportin1 (CRM1) receptor with proteins having a leucine rich nucler export 
signal (NES). Since Gal-3 express a leucine rich NES between residues 241-
246 (Li et al., 2006), its export mechanism was investigated by incubating 
AGS cells with LMB.  
 
In this study, as observed under CLSM analysis (Figure 20A), 
uninfected AGS cells show a basal level of Gal-3 expression in the nucleus. 
Upon H. pylori infection there was an up-regulation of Gal-3 expression as 
shown by the green florescence, located predominantly in the cytoplasm.  In 
contrast, pre-treatment of H. pylori-infected AGS cells with LMB caused the 
retention of Gal-3 expression within the nucleus. The results were further 
confirmed by western blot analysis of the nuclear fractions (Figure 20B).  
Uninfected cells serving as experimental control show a basal level of nuclear 
expression. Upon H. pylori infection, AGS cells show an up-regulation of  
nuclear Gal-3 expression which however got reduced in a time dependent 
manner. Consistently, LMB treatment of H. pylori-infected cells resulted in 
the retention of Gal-3 within the nucleus, suggesting an inhibition of Gal-3 
nuclear export. The result highlight a CRM1 mediated nuclear export of Gal-3 










    
 




                              
 
Figure 20. Effect of LMB in Gal-3 nuclear export. . AGS cells pre-
incubated with LMB (10ng/ml) were infected with H. pylori for 24 h. 
Uninfected cells serve as control. (A) CLSM analysis of Gal-3 in AGS cells; 
Gal-3 is stained green (arrows) with anti-Gal-3 MAb conjugated to FITC 
while the cell nucleus fluoresces blue as stained by DAPI. Scale bar, 10 μm. 
(B) Western blot analysis of Gal-3 nuclear expression in LMB treated cells; 
nuclear fractions were extracted from H. pylori-infected cells (12 & 24 h) and 
immuno-blotted with anti-Gal-3 MAb. Lamin and β tubulin serve as loading 
controls for nuclear and cytoplasmic fractions, respectively.  
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4.6.4 Host signalling events in Gal-3 upregulation 
4.6.4.1 Activation of ERK signalling in H. pylori-infected cells 
H. pylori infection induces phosphorylation of ERK signalling kinases 
(p-ERK), resulting in the activation of ERK signalling pathway(Nozawa et al., 
2002).  Consistent with the previous studies, a time dependent increase in p-
ERK levels was observed in cells infected with WT H. pylori (Figure 21). 
Interestingly, p-ERK expression was delayed in cells at the early h of infection 
with H. pylori ΔcagA, hence suggesting a role of cagA in the early induction 
of ERK phosphorylation.  
 
4.6.4.2 Inhibition of ERK activation in H. pylori-infected cells 
Earlier studies by (Mitsuno et al., 2001)  had shown an arrest in ERK 
phosphorylation by targeting the upstream kinase, MEK, using U0126 
inhibitor.The current study used MEK/ERK inhibitor U0126 at a working 
concentration of 10µM/ml in order to inhibit ERK phosphorylation. As shown 
in Figure 22, U0126 treatment induced no cytotoxic effects as the viability of 
AGS cells remained unaffected. Also, uninfected cells showed no detectable 
levels of p-ERK expression, upon treatment with U1026. On the other hand, 
U0126 treatment inhibited H. pylori-induced ERK phosphorylation as shown 
by a substantial depreciation in p-ERK expression in cells infected with WT 
and ΔcagA strains as compared with the untreated cells (Figure 23). However, 
it was noted that MEK/ERK inhibitor did not exert a complete inhibition of 
ERK phosphorylation. Therefore, despite demonstrating the prominent role of 
MEK in phosphporylation of ERK, the finding also indicates alternative routes 
of ERK signalling which could be effected through a MEK independent 









                           
 
 Figure 21. ERK activation in H. pylori-infected cells. AGS cells were 
infected with WT and ΔcagA strains of H. pylori. Untreated cells serve as 
experimental control. The cells harvested at various time intervals were lysed 
and p-ERK expression was detected by western blot analysis using anti-p-
ERK antibody. Detection of unphosphorylated ERK expression served as 





                        
 
 
Figure 22. Effect of U0126 inhibitor on AGS cell viability. The viability of 
AGS cells treated with U0126 inhibitor was analysed by MTT assay. 
Untreated cells served as experimental control. Data are presented as mean ± 





H post infection 
        4            8              12          24          4              8             12           24 
p- ERK ERK 








             
 
                                                    
   
Figure 23. Effect of U0126 treatment of ERK phosphorylation. AGS cells 
were pretreated with MEK inhibitor U0126 (10µM for 2 h) before being 
infected with WT or ΔcagA strains of H. pylori. Uninfected cells serve as 
experimental control. The cells harvested at various time intervals were lysed 
and p-ERK expression was detected by western blot analysis using p-ERK 
antibody. Detection of unphosphorylated ERK expression served as standard 
loading control.  
 
4.6.5 Effect of MEK/ERK inhibition in Gal-3 expression    
4.6.5.1 RT PCR analysis of Gal-3 mRNA expression in MEK/ERK 
inhibited cells  
The effect of MEK/ERK inhibition in Gal-3 mRNA expression was 
detected. As shown by standard RT PCR, an increase in Gal-3 mRNA 
expression was observed in cells infected with H. pylori WT and ΔcagA 
strains (Figure 24).  In contrast, a marked decrease in expression was observed 
in U0126 treated cells infected with the H. pylori. Incidentally, the reduction 
in expression was found conspicuously similar for cells infected with both WT 
and ΔcagA strains (Figure 24. Lane 2 & 3). Uninfected cells showed a basal 
level of Gal-3 expression which remained largely unaltered before and after 
treatment with U0126 inhibitor.  
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Figure 24. Effect of MEK/ERK inhibition in Gal-3 mRNA expression. AGS cells 
were pre-treated with MEK/ERK inhibitor U0126 (10µM for 2 h) and its effect in Gal-3 
mRNA expression was analysed 12 h post infection with WT and ΔcagA strains of H. 
pylori. Untreated cells served as experimental control. The total RNA was extracted and 
analysed by RT PCR using specific primers. β-actin expression was used as a standard 
control.  Lane 1, Uninfected cells; Lane 2, WT H. pylori-infected cells; Lane 3 ΔcagA H. 
pylori-infected cells. 
 
4.6.5.2 Western blot analysis of Gal-3 expression in MEK/ERK inhibited 
cells 
As shown in the earlier experiments, a time dependent increase in Gal-
3 protein expression was seen in AGS cells infected with WT and ΔcagA 
strains of H. pylori (Figure 25A). However, H. pylori-infected cells pre-treated 
with U0126 inhibitor showed a significant reduction in Gal-3 protein 
expression (Figure 25B). The reduction was found to be more prominent 
during early time intervals (up to 8 h) of infection where the level of 
expression remained at the basal level as detected in uninfected cells. 
Interestingly, similar to WT H. pylori-infected cells, the Gal-3 expression in 
ΔcagA-infected cells following U0126 treatment also display a basal level of 














                 
   
                           
                          
 
 
                    
                        
 
 
                                                               
 
Figure 25. Effect of MEK/ERK inhibition in Gal-3 protein expression. 
AGS cells, pre-treated with U0126 (10µM for 2 h) were infected with WT and 
ΔcagA strains of H. pylori. Untreated cells served as experimental control.  
The whole cell lysates where subjected to western blot analysis and Gal-3 
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Fig 4.6.5.3 CLSM analysis of Gal-3 expression in MEK/ERK inhibited 
cells 
In order to follow up with the effect of U0126 has on Gal-3 expression, 
CLSM was used to detect Gal-3 localization in U0126 treated cells. Figure 26 
(a-c) displays uninfected AGS cells with a basal level of Gal-3 nuclear 
expression which was found to be independent of U0126 treatment. 
Consistently, cells infected with WT and ΔcagA strains of H. pylori showed an 
up-regulation and shift in localization of Gal-3. However upon treatment with 
U0126, cells infected with WT and ΔcagA strains of H. pylori showed a 
reduction in Gal-3 expression which was restricted within the nucleus, as 
compared to a profusely abundant cytoplasmic expression in untreated cells 





Figure 26. Gal-3 localization in MEK/ERK inhibited cells. AGS cells were 
pretreated with 10µM U0126 for 2h before being infected with H. pylori WT 
and ΔcagA strains for 24 h. Untreated cells serve as experimental control. Gal-
3 is stained green with anti-Gal-3 MAb conjugated to FITC while the cell 
nucleus fluoresces blue as stained by DAPI. Scale bars, 10 μm. 
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4.6.5.4 Flow cytometric analysis of Gal-3 expression in MEK/ERK 
inhibited cells 
Consistent with the RT PCR and Western blot analysis, an upregulated 
Gal-3 expression was observed in AGS cells infected with WT and ΔcagA 
strains of H. pylori (at 82% and 72% respectively) (Figure 27), while 
comparing with the uninfected cells (16%). As expected, the amount of Gal-3 
expression was found to be significantly lower (p  < 0.05) in U0126 treated 






Figure 27 Flow cytometric analysis of Gal-3 expression upon MEK/ERK 
inhibition. AGS cells were pretreated with 10µM U0126 for 2h before being 
infected with H. pylori WT or ΔcagA strains. Untreated cells serve as 
experimental control. The cells were harvested at 24 h post-infection and 
stained with anti-Gal3 MAb conjugated to FITC. Gal-3 expression was 
analyzed by flow cytometry. The data are representative of three independent 
experiments. * p value < 0.05 was considered significant. 
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U0126 treated AGS 
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4.7   Pro-inflammatory response in H. pylori infection  
4.7.1 Detection of IL-8 response in H. pylori-infected cells 
 As shown in Figure 28, H. pylori-infected cells induced significantly 
higher levels of IL-8 production at 4 (A) and 24 (B) h post-infection as 
compared to uninfected cells (p <0.05). Additionally, the data also supports 
the role of H. pylori CagA in IL-8 induction, wherein a 22.4 % decrease in IL-
8 secretion was observed in cells infected with the ΔcagA strain at 24 h post 
infection. Uninfected cells served as experimental control showing a basal 
level of IL-8 secretion with no significant change in expression levels 
throughout the time points.  
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Figure 28. IL-8 production in H. pylori-infected AGS cells. AGS cells were 
infected with H. pylori WT and ΔcagA strains. Uninfected cells serve as 
experimental control. The culture supernatant was collected at 4 (A) and 24(B) 
h post-infection and IL-8 was assayed using ELISA. Data are presented as 
mean ± SD of 3 independent experiments. **, p value < 0.005 and *, p value < 
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4.7.2 Effect of MEK/ERK inhibition in IL-8 secretion 
To detect the role of ERK phosphorylation in IL-8 secretion, p-ERK 
expression in H. pylori-infected AGS cells was inhibited using MEK/ERK 
inhibitor U0126 and its subsequent effect in IL-8 secretion was analysed. As 
shown in Figure 29, inhibition of ERK phosphorylation using MEK/ERK 
inhibitor caused a decline in IL-8 secretion by H. pylori-infected cells. U0126 
treated cells, followed by infecting with WT H. pylori showed a 48.4% 
reduction in IL-8 secretion, as compared to the untreated cells. Similarly, 
U0126-treated cells, infected with ΔcagA H. pylori showed a reduction of 
49.65% in IL-8 secretion. Uninfected cells served as experimental control 
showing a basal level of IL-8 secretion with no significant change in 




Figure 29. Effect of MEK/ERK inhibition in H. pylori-induced IL-8 
production AGS cells were pretreated with 10 µM U0126 for 2h (grey bars) 
before being infected with H. pylori WT and ΔcagA strains. Untreated cells 
(black bars) serve as experimental control. The culture supernatant was 
collected at 24 h after infection and assayed for IL-8 using ELISA; Data are 
presented as mean ± SD of 3 independent experiments. * p value < 0.05 was 
considered significant.  
 
I              I 
* 
 I             I 
* 
Uninfected WT        ΔcagA 
Untreated AGS cells 




4.7.3. Gal-3 and IL-8 secretion 
Since up-regulation of Gal-3 in H. pylori-infected cells was found to be 
dependent on ERK phosphorylation (section 4.6.5), the role of Gal-3 in 
contributing to the ERK-induced activation of IL-8 secretion was further 
investigated using Gal-3 knockdown AGS cells  
 
4.7.3.1 Knockdown of Gal-3 expression in AGS cells  
Figure 30 shows siRNA mediated knockdown of Gal-3 expression in 
AGS cells where transfection with Gal-3 siRNA resulted in an almost 
complete inhibition of Gal-3 protein expression. Cells transfected with non-
targeted siRNA showed no inhibition of Gal-3 expression, as indicated by a 
basal level of expression.  
 
 
                                      
Figure 30. siRNA mediated knockdown of Gal-3 expression. AGS cells 
were transfected with Gal-3 siRNA. Total cell lysates were prepared 36 h after 
transfection and subjected to western blotting with anti-Gal-3 MAb. β- actin 













4.7.3.2 Effect of Gal-3 knockdown in IL-8 secretion 
Figure 31 suggests an important role of Gal-3 in contributing to the IL-
8 secretion in H. pylori-infected cells. In comparison with the untransfected 
AGS cells (Gal-3 siRNA-), Gal-3 knocked down cells (Gal-3 siRNA+) 
showed a marked reduction in H. pylori-induced IL-8 secretion. A significant 
reduction of 39.4% in IL-8 secretion (p < 0.05) was observed in Gal-3 
knockdown cells which were infected with WT H. pylori. Similarly, Gal-3 
knockdown cells, infected with ΔcagA strains caused a 40.6% reduction in IL-
8 secretion (p < 0.05).  
 
                                             
 
 
Figure 31. Effect of Gal-3 knockdown in H. pylori-induced IL-8 secretion. 
AGS cell, either untransfected (Gal-3 siRNA+) or Gal-3 knockdown (Gal-3 
siRNA+),were infected with WT or ΔcagA strains of H. pylori. Uninfected 
cells serve as experimental control. The culture supernatant was collected 24 h 
post-infection and IL-8 secretion was assayed using ELISA. Data are 
presented as mean ± SD of 3 independent experiments. * p value < 0.05 was 
considered significant.  
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4.7.3.2.1 Effect of Gal-3 knockdown in NFκB activation 
Activation of NFκB is strongly associated with the induction of IL-8 
secretion, thus contributing to a pro–inflammatory response. And, H. pylori 
has been shown to activate NFκB and to increase IL-8 production (Torok et 
al., 2005; Gong et al., 2010). The NFκB promoter activity in H. pylori-
infected cells were detected using a luciferase reporter assay (Figure 32). High 
levels of NFκB activity was observed in cells infected with WT H. pylori. 
Notably, cells infected with ΔcagA showed a 0.9 fold (p < 0.05) reduction in 
the NFκB activity, suggesting the importance of cagA in IL-8 secretion.  Of 
interest is the role of Gal-3 in NFκB activation detected in Gal-3knockdown 
AGS cells (Gal-3 siRNA+). Gal-3 knockdown caused a 1.9 and 1.8 fold 
reduction (p < 0.05) of NFκB promoter activity in cells infected with the WT 
and ΔcagA strains of H. pylori respectively. The data suggest Gal-3 as an 
enhancer of NFκB activation in H. pylori-infected cells.         
 
 
Figure 32. NFκb activation in Gal-3 knockdown AGS cells. AGS cells, 
either untransfected (Gal-3 siRNA-) or Gal-3 knockdown (Gal-3 siRNA+), 
were infected with WT or ΔcagA strains of H. pylori. The level of NFκB 
activation was evaluated with Ready-To-Glow secreted luciferase reporter 
system. Uninfected cells serve as background control. Data are presented as 
mean ± SD of triplicate samples. *, p value < 0.05 was considered significant. 
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4.7.4 Gal-3 and ERK activation- A reverse feedback loop of signal 
transduction  
Earlier, Gal-3 expression was shown to be dependent on ERK 
phosphorylation as inhibition of ERK activation resulted in a drastic reduction 
of Gal-3 up-regulation (section 4.6.5). However, a cross talk event of 
signalling was also found to exist between Gal-3 and ERK activation.  
 
As shown in Figure 33, untransfected AGS cells (Gal-3 siRNA-) upon 
infection with WT and ΔcagA strains of H. pylori exhibited a time dependent 
increase in p-ERK expression, suggesting H. pylori-induced activation of ERK 
signalling cascade. In contrast, Gal-3 knockdown AGS cells (Gal-3 siRNA+) 
show a significant decrease of ERK phosphorylation upon infection with WT 
and ΔcagA strains of H. pylori. Uninfected cells acted as experimental control 
showing no detectable ERK phosphorylation. Taken together, the data suggest 
a Gal-3 mediated alternative pathway in ERK activation, which would 






























                                                                       
 
 
Figure 33. Effect of Gal-3 knockdown in H. pylori-induced p-ERK 
expression: AGS cells, either untrasfected (Gal-3 siRNA-) or Gal-3 
knockdown (Gal-3 siRNA+), were infected with WT or ΔcagA strains of H. 
pylori. Uninfected cells serve as experimental control. The cells were 
harvested at various time intervals and p-ERK expression was detected using 
western blot analysis. The expression of ERK was considered as a standard 
loading control.  
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4.7.5 Gal-3 and EGFR activation 
Since earlier studies (Keates et al., 2007; Normanno et al., 2006)  have 
suggested a role of EGFR signalling in ERK activation, an association 
between Gal-3 and EGFR which could lead to an enhancement of ERK 
phosphorylation was investigated.  
 
4.7.5.1 EGFR inhibition in H. pylori-infected cells 
Figure 34 shows H. pylori-induced EGFR phosphorylation in AGS 
cells. Infection with H. pylori resulted in a rapid induction of EGFR 
phosphorylation. In addition, EGFR activation was found to be independent of 
H. pylori CagA, as cells infected with the WT and ΔcagA strains showed 
similar levels of p-EGFR expression. Furthermore, pretreatment of H. pylori-
infected cells with EGFR inhibitor Tyrphostin AG1478 caused an attenuation 
of EGFR activation, causing significant reduction in p-EGFR levels. 
Unphosphorylated EGFR served as loading control showing unperturbed 
expression levels throughout.  
 
 
                                            
 
Figure 34 Inhibition of EGFR activation. AGS cells were pretreated with 
Tyrphostin AG1478 (500nM, 2 h) prior to infection with H. pylori WT and 
ΔcagA strains. Untreated cells served as experimental control. Lane 1, 
Uninfected cells; Lane 2, WT H. pylori-infected cells; Lane 3, ΔcagA-H. 
pylori-infected cells. The cells were harvested 4 h post infection and p-EGFR 
expression was analyzed by western blotting with anti-p-EGFR antibody. 
Detection of EGFR expression served as standard loading control. 
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4.7.5.2 Effect of EGFR inhibition in ERK activation 
The effect of EGFR inhibition in ERK activation was investigated in 
AGS cells pretreated with Tyrphostin AG1478. Figure 35 shows a 
considerable increase of p-ERK levels in cells infected with WT and ΔcagA 
strains of H. pylori. Interestingly, pretreatment of the cells with Tyrphostin 
AG1478 resulted in significantly lower levels of p-ERK expression, 
suggesting an effective inhibition which was most significant during early 
time points of infection (upto 4 h). Nevertheless expectedly, ERK 
phosphorylation in Tyrphostin AG1478 treated cells was rescued at later time 
intervals, as shown by elevated p-ERK expression levels from 8 h post-
infection. The data implies ERK phosphorylation being partially dependent of 
EGFR activation; and the inhibition of p-ERK expression at early time 
intervals of Tyrphostin AG1478 treatment suggests a contributory role of 
EGFR in p-ERK expression atleast upto 4 h of H. pylori infection.  
 
4.7.5.3 Effect of Gal-3 knockdown in EGFR activation 
Since a reduction in H. pylori-induced ERK phosphorylation was 
observed in both Gal-3 knockdown and EGFR inhibited AGS cells, a direct 
association between the two was suspected. Further to this, the role of Gal-3 in 
EGFR activation was investigated using Gal-3 knockdown AGS cells (section 
4.7.3.1). Figure 36 shows the p-EGFR expression in untrasfected (Gal-3 
siRNA-) and Gal-3 knockdown AGS cells (Gal-3 siRNA+), infected with WT 
and ΔcagA strains of H. pylori. Infection with WT and ΔcagA strains showed 
a rapid up-regulation of p-EGFR expression in both Gal-3 siRNA (+) and Gal-
3 siRNA (-) AGS cells, suggesting EGFR phosphorylation to be independent 























Figure 35 Effect of EGFR inhibition in ERK activation: AGS cells were 
pretreated with 100nM Tyrphostin AG1478 for 30 min prior to infection with 
H. pylori WT or ΔcagA strains for upto 8 h. Untreated cells served as 
experimental control. The cells were harvested at various time intervals and p-
ERK expression was analyzed by western blotting. The expression of ERK 
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Figure 36. Effect of Gal-3 depletion in H. pylori-induced EGFR activation: 
AGS cells, either untransfected (Gal-3 siRNA-) or Gal-3 knockdown (Gal-3 
siRNA+), were infected with WT or ΔcagA strains of H. pylori. Uninfected 
cells serve as experimental control. Lane 1, Uninfected cells; Lane 2, WT H. 
pylori-infected cells; Lane 3, ΔcagA H. pylori-infected cells. The cells were 
harvested at 4hrs post-infection and p-EGFR expression was detected by 
western blot analysis. β- actin was used as a loading control.  
 
 
4.7.6 Effect of Gal-3 knockdown in RAS activation 
The down stream effector of EGFR in the activation of ERK signalling 
pathways is the Ras protein (Kolch, 2000). Later in 2010, Aksamitiene et al. 
have demonstrated MEK independent activation of ERK signalling in breast 
cancer cells, where Ras was shown to play a mediatory role. Hence, it was of 
interest to determine the role of Gal-3 in Ras activation using Gal-3 
knockdown AGS cells. As shown in Figure 37, Untransfected cells (Gal-3 
siRNA-) showed a time dependent increase in Ras expression upon infection 
with WT and ΔcagA strains of H. pylori. Intriguingly, Gal-3 knockdown cells 
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(Gal-3 siRNA+) infected with WT and ΔcagA strains exhibited a reduction in 
Ras expression level, which remained undetectable until 12 h post infection 
with H. pylori. Thus, the data suggest an important role of Gal-3 in regulating, 
at least in part, Ras expression and downstream signalling cascades in H. 











   
                                  
 
 
Figure 37. Effect of Gal-3 depletion in Ras expression: AGS cells, either 
untransfected (Gal-3 siRNA-) or Gal-3 knockdown (Gal-3 siRNA+), were 
infected with WT or ΔcagA strains of H. pylori. Uninfected cells serve as 
experimental control. Activated Ras expression was detected by western blot 
analysis using anti-Ras Ab. β-actin was used as a loading control.  
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4.7.7 Gal-3 and PI3K activation 
Since Gal-3 knockdown showed a regulatory effect in Ras activation, 
the study further investigated the downstream elements of Ras activation 
which could act as an enhancer of ERK phosphorylation in a MEK 
independent pathway. Activated Ras was shown to induce PI3K 
phosphorylation which would lead to an MEK independent activation of ERK 
phosphorylation. The study aimed at investigating a role of Gal-3 in mediating 
Ras induced activation of PI3K phosphorylation, which in turn would lead to 
an enhancement in MEK independent ERK phosphorylation.   
 
4.7.7.1  PI3K activation in H. pylori-infection 
As shown in Figure 38, H. pylori-infection caused an induction of 
PI3K phosphorylation. However, this activation of PI3K expression  was 
found to be independent of CagA, since the expression levels remained same 
in cells infected with both WT and ΔcagA strains of H. pylori 
 
                                          
 
Figure 38. PI3K phosphorylation in H. pylori-infected cells: AGS cells 
were infected with WT and ΔcagA strains of H. pylori. Lane 1, Uninfected 
cells; Lane 2, WT H. pylori-infected cells; Lane 3, ΔcagA H. pylori-infected 
cells. The cells were harvested 24 h post infection, lysed and p-PI3K 
expression was detected by western blotting using anti-p-PI3K Ab. Uninfected 














4.7.7.2 Effect of Gal-3 knockdown in PI3K phosphorylation 
Consistent with the previous section (4.7.7.1), H. pylori infection of 
untransfected AGS cells (Gal-3 siRNA-) induced an upregulation of p-PI3K 
expression (Figure 39). However, infection of Gal-3 knockdown AGS cells 
(Gal-3 siRNA+) with H. pylori rendered minimal levels of p-PI3K expression. 
On the other hand, the data suggests a regulatory role of Gal-3 in inducing 
PI3K phosphorylation.  
 
 
                                                      
 
Figure 39. Effect of Gal-3 knockdown in PI3K phosporylation. AGS cells, 
either untransfected (Gal-3 siRNA-) or Gal-3 knockdown (Gal-3 siRNA+), 
were infected with WT H. pylori. Uninfected cells serve as experimental 
control Lane 1, Uninfected cells; Lane 2, WT H. pylori-infected cells. The 
cells were harvested at 24 h post-infection and p-PI3K expression was 
detected by western blot analysis using anti-p-PI3K antibody. 
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4.7.8 Effect of Gal-3 knockdown and PI3K inhibition in ERK 
phosphorylation 
Since Gal-3 knockdown showed an inhibitory effect on PI3K 
phosphorylation, the study further analyzed the significance of p-PI3K 
expression in H. pylori-induced ERK phosphorylation. To investigate this, 
PI3K phosphorylation in H. pylori-infected cells was inhibited using a 
previously characterized PI3K inhibitor, Wortmannin. As shown in Figure 40, 
treatment of AGS cells with Wotrmannin resulted in complete inhibition of 
PI3K phosphorylation  
 
                                       
 
Figure 40 Inhibition of PI3K phosphorylation in AGS cells. AGS cells 
were pretreated with Wortmannin A (500nM, 2 h) prior to infection with H. 
pylori. Untreated cells served as experimental control. Lane 1, uninfected 
cells; Lane 2, Wortmannin treated cells infected with WT H. pylori; Lane 3, 
WT H. pylori-infected cells. The cells were harvested 4 h post infection and p-
PI3K expression was analyzed by western blotting with anti-p-PI3K antibody. 












Figure 41 shows p-ERK expression in H. pylori-infected cells under 
different treatment conditions. Consistent with the earlier results, H. pylori-
induced significant upregulation of p-ERK expression. Whereas, knockdown 
of Gal-3 caused a reduction in p-ERK expression. Interestingly, PI3K 
inhibition also caused a similar reduction in ERK phsophorylation, suggesting 
an association between Gal-3 and PI3K which contributes to an enhanced 
ERK phosphorylation. The results were further confirmed by double inhibition 
of Gal-3 and PI3K expression in AGS cells through, siRNA knockdown and 
Wortmannin treatment respectively. Expectedly, Gal-3-PI3K double inhibition 
also leads to a similar reduction in ERK phosphorylation. 
 
To further investigate, if the association between Gal-3 and PI3K in 
ERK phosphorylation were MEK independent, AGS cells were treated with 
MEK/ERK  inhibitor U0126 and its effect in p-ERK expression was detected 
under different treatment conditions. Despite inhibition with U0126, H. pylori-
infection caused a up-regulation in p-ERK expression, thereby suggesting 
MEK independent alternative loops of ERK phosphorylation . However, this 
expression was arrested in Gal-3 knockdown cells, thus confirming the 
mediatory role of Gal-3 in MEK independent activation of p-ERK expression. 
The Gal-3 mediated effect was found to be channeled through PI3K 
phosphorylation, as indicated by a similar reduction of p-ERK levels in PI3K 
inhibited cells. Similarly, double inhibition of Gal-3 and PI3K also led to 
complete inhibition of p-ERK expression in MEK inhibited cells, hence 



















Figure 41. Effect of PI3K and Gal-3 inhibition in ERK phosphorylation. 
AGS cells were pretreated with 10µM UO126 for 2h before being infected 
with H. pylori WT under different experimental conditions. Untreated cells 
serve as experimental control. Lane 1, Uninfected cells; Lane 2, H. pylori-
infected cells; Lane 3, H. pylori-infected Gal-3 knockdown cells; Lane 4, H. 
pylori-infected PI3K inhibited cells; Lane 5, H. pylori-infected  Gal-3 














4.8 Cell proliferation 
 
4.8.1 Effect of H. pylori on AGS cell proliferation 
The effect of H. pylori infection in AGS cells proliferation was 
detected by MTT assay.  AGS cells infected with WT H. pylori showed a 
significant increase (p < 0.05) in cell proliferation as compared with the 
uninfected cells. The increase in OD value represents an increase in cell 
number upon infection with H. pylori (Table 6). However, cagA seems to have 
no effect in cell proliferation, since cells infected with the ΔcagA mutant 
showed similar proliferation rates as compared with those cells infected with 
WT H. pylori 
 
Stimulant             O.D value               P value* 
 





(H. pylori WT) 
 
AGS cells 





0.221 (± 0.0080) 
 
0.256 (± 0.0061)  
 








Table 6. Effects of H. pylori on AGS cell proliferation: AGS cells were 
infected with WT and ΔcagA strains of H. pylori for 48 h and the cell 
proliferation was measured using MTT assay. Uninfected cells served as 







4.8.2 Role of Gal-3 in proliferation of H. pylori-infected AGS cells 
As shown in Figure 42, Uninfected AGS cells did not show any 
significant increase in proliferation. However, an increase in proliferation was 
observed in untransfected AGS cells (Gal-3 siRNA-) at 24 and 48 h post-
infection with WT H. pylori. Interestingly, infection of Gal-3 knockdown AGS 
cells (Gal-3 siRNA+) with H. pylori resulted in a significant reduction in 
proliferation. The results were normalized to the optical density (O.D) at time 
point zero (T0) for each treatment groups.  
 
The proliferation percentages were quantified based on the difference 
in gain on cell number at T 0 and T X, where ‘X’ is the time in h post-
infection as calculated according to MTT assay (Table 7). A significant 
difference was observed between the proliferation rates of untransfected (Gal-
3 siRNA-) and  Gal-3 knockdown (Gal-3 siRNA+) AGS cells, infected with 
WT H. pylori. Gal-3 knockdown  cells showed a proliferation rate of 77.3% 
and 73.7% at 24 and 48 h post infection respectively. This accounted for a 
significant difference of 45.7 and 55.3% in proliferation, while comparing 
with the proliferation percentages of untransfected AGS cells that were 











Figure 42. Effect of Gal-3 knockdown in cell proliferation: AGS (Gal-3 
siRNA
_
 and Gal-3 siRNA+) cells were infected with WT H. pylori and the cell 
proliferation was analyzed using MTT assay at 24 and 48 h. Uninfected cells 
served as experimental control. Data are representative of triplicates of three 




  Time 
(H) 
   Uninfected 
(Gal-3 siRNA-) 
  Uninfected 
(Gal-3 siRNA+) 
WT H. pylori 
(Gal-3 siRNA-) 
WT  H. pylori 
(Gal-3 siRNA+) 
0 100 100 100 100 
24 107.5 102 123 *77.3 
48 117.08 111.5 129 *73.7 
 
Table 7. Quantification of proliferation in Gal-3 knockdown cells. The 
table represents the percentage of cell proliferation in Gal-3 siRNA
_
 and Gal-3 
siRNA+ AGS cells at time points 24 and 48 h post-infection with WT H. 
pylori. Uninfected cells served as experimental control. Results were 
normalized to cells proliferation percentage at time point 0 (T0). *p value < 
0.05  represents the significant difference in cell proliferation rates between 
WT and Gal-3 knockdown AGS cells, infected with WT H. pylori.   
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4.8.3 Wnt  pathway and cell proliferation  
H. pylori infection was shown to enhance gastric cell proliferation , 
through activation of  Wnt  pathway (Polk and Peek, 2010). The mechanism 
involves a series of signalling events which would lead to the down steam 
activation of Wnt target genes (Gnad et al., 2010). As Gal-3 knockdown 
caused a reduction in the proliferation of H. pylori-infected AGS cells, the 
current study investigated the potential role of Gal-3 in contributing to the 
activation of various components of Wnt signalling cascade.  
 
4.8.3.1 β- catenin expression in H. pylori-infected cells 
Since nuclear translocation of β-catenin is a crucial event in WNT 
signalling pathway, CLSM was used to study β- catenin expression in H. 
pylori-infected AGS cells. As shown in Figure 43, uninfected cells presented a 
basal level of β-catenin expression which was found to be concentrated more 
towards the cell membrane. In contrast, in H. pylori-infected cells, β-catenin 
was found to be upregulated and translocated into the nucleus, thereby 


















Figure 43 β-catenin expression in H. pylori-infected AGS cells. AGS cells 
were infected with WT H. pylori for 24 h and β-catenin expression was 
detected by confocal microscopy. Uninfected cells served as experimental 
control. β-catenin is stained red with anti-β-catenin MAb conjugated to Cy3 
while the cell nucleus fluoresces blue as stained by DAPI. Panels a,a’- nuclei 
staining, b,b’- β-catenin staining, c,c’-merged images of nuclear and β-catenin 
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4.8.3.2 GSK3β phosphorylation in β- catenin nuclear translocation 
Previous studies have shown an important role of GSK3β in β-catenin 
nuclear translocation. Phorphorylation of GSK3β (p-GSK3β) is one of the pre-
requisites for the aforementioned, which induces the β-catenin nuclear 
translocation (Hung et al., 2009). Hence, GSK3β phosphorylation in H. pylori-
infected gastric epithelial cells was investigated.  
 
4.8.3.2.1 Detection of GSK3β phosphorylation in H. pylori-infected cells 
Consistent with the previous studies, a significant increase of p-GSK3β 
expression in H. pylori-infected cells was observed as compared to the basal 
level of expression in the uninfected control (Figure 44). Unphosphorylated 
GSK3β expression levels remained the same for both uninfected and infected 
cells (Figure 4.35) 
 
 
                                                 
 
Figure 44. GSK3β phosphorylation in H. pylori-infected cells. AGS cells 
were infected with WT H. pylori. GSK3β phosphorylation was detected by 













4.8.3.2.2 Role of Gal-3 in GSK3β phosphorylation 
Th role of Gal-3 in GSK3β phosphorylation was detected using Gal-3 
knockdown AGS cells (section 4.7.3.1). As shown in Figure 45 untransfected 
AGS cells (Gal-3 siRNA-) displayed a time dependent increase in p-GSK3β 
expression upon infection with WT H. pylori. Interestingly, infection of Gal-3 
knockdown cells (Gal-3 siRNA+) with H. pylori caused a significant decrease 
in p-GSK3β expression levels (Figure 45). The data suggests a regulatory role 
of Gal-3 in contributing to GSK3β phosphorylation. 
 
 










Figure 45. Effect of Gal-3 knockdown in GSK phosphorylation. AGS cells 
either untransfected or transfected with Gal-3 siRNA (siRNA
_
 and siRNA+, 
respectively) were infected with WT H. pylori. The level of p-GSK3β 
expression was detected using western blotting of the whole cell lysates with 
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4.8.3.3.1 Co-immunoprecipitation (Co-IP) of GSK3β and Gal-3 
Co-IP of GSK3β was carried out to detect a potential interaction 
between GSK3β and Gal-3 in H. pylori-infected AGS cells. Western blot 
analysis of the pull down lysates revealed a direct interaction, as GSK3β was 
found to be co-immunoprecipitated with Gal-3 (Figure 46). The data was 
further conformed by reverse co-IP analysis, which showed Co-IP of Gal-3 
with GSK3β.  
 
                              IP: Gsk3β                                                 IP: Gal-3 
                                                                
                                                       
             
Figure 46. Co-immunoprecipitation of GSK3β and Gal-3. Whole cell 
lysates of H. pylori-infected AGS cells were subjected to Co-IP using MAb 
against GSK3β followed by immunoblotting with anti-Gal3 MAb. Reverse 
Co-IP was carried out using MAb against Gal-3, followed by immunoblotting 
with anti-GSK3B antibody. In all experiments, lysates incubated with Protein 
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4.8.3.3.2 Detection of GSK3β and Gal-3 interaction using rGal-3 mediated 
in-vitro pull down. 
The interaction between GSK3β and Gal-3 was detected using by an in vitro 
pull down assay using rGal-3. As shown in Figure 46.1, incubation of AGS 
cell lysates with rGal-3 caued a direct pull down of a 45 kDa band in the silver 
stained gel, which corresponds to GSK3β. The data was further confirmed by 
western blotting of the pull down lysates which detected GSK3β expression.  
 
                           
 
                                                              
Lane 1- rGal-3 pull down lysate; Lane 2- AGS cell whole cell lysate 
Figure 46.1 In-vitro pull down of GSKβ in AGS cell lysates using rGal-3. 
Whole cell lysates of AGS cells were subjected to Co-IP using rGal-3 and anti 
Gal-3 mAb. The lyastes were run by SDS-PAGE and presence of interacting 
partners was visualized by silver staining. The presence of GSK3β  in the 
lysates were detected by immunoblotting with anti- GSK3β antibody. 
  1               2 





4.8.3.3.3 Detection of GSK3β and Gal-3 interaction using Proximity 
Ligation Assay (PLA) 
In situ PLA is a technology that extends the capabilities of traditional 
immunoassays to include direct detection of protein-protein interactions with 
high specificity and sensitivity. Protein targets can be readily detected and 
localized with single molecule resolution in unmodified cells and tissues. 
Hence PLA was employed to confirm the interactions of GSK3β with Gal-3. 
Figure 46.1 represnts a direct interaction between Gal-3 and GSK3β in the 
cytoplasm of H. pylori infected AGS cells, as indicated by the presence of 
red fluorescence  
 
 
Figure 46.2 Detection of GSK3β with Gal-3 interaction using PLA: A 
direct interaction between GSK and Gal-3 is shown as red signals upon using 
insitu PLA (DUOlink®). Actin is stained green with Alexa Fluor 488 









4.8.3.4 Role of β-catenin in proliferation of H. pylori-infected AGS cells 
4.8.3.4.1 Knockdown of β-catenin in AGS cells 
Figure 47 shows siRNA mediated knockdown of β-catenin expression 
in AGS cells. Transfection with β-catenin siRNA resulted in an inhibition of 
β-catenin protein expression. Cells transfected with control siRNA showed no 
inhibition of β-catenin, as indicated by a basal level of expression  
 
 
                                                
Figure 47.  siRNA mediated knockdown of β-catenin expression. AGS 
cells were transfected with β-catenin siRNA. Total cell lysates were prepared 
36 h after transfection and subjected to western blotting with anti-Gal-3MAb. 
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 4.8.3.4.2 Effect of β-catenin knockdown in proliferation of H. pylori-
infected AGS cells 
Figure 48 shows the effect of β-catenin knockdown in the proliferation 
of H. pylori-infected AGS cells. Consistent with the previous results (section 
4.8.2), an increase in proliferation was observed in untransfected AGS cells 
(β-catenin siRNA-) at 24 and 48 h post-infection with WT H. pylori. 
Interestingly, infection of β-catenin knockdown AGS cells (β-catenin 
siRNA+) with H. pylori resulted in a significant reduction in proliferation. The 
results were normalized to the optical density (O.D) at time point zero (T0) for 
each treatment groups.  
 
The proliferation percentages were quantified based on the MTT assay 
(Table 8).A significant difference was observed between the proliferation rates 
of untransfected (β-catenin siRNA-) and  β-catenin knockdown (β-catenin 
siRNA+) AGS cells, infected with WT H. pylori. β-catenin knockdown  cells 
showed a proliferation rate of 66.3% and 62.7% at 24 and 48 h post-infection 
respectively, which accounted for a significant difference of 58.9 and 67.8% 
respectively (p < 0.05), while comparing with the proliferation percentages of 
untransfected AGS cells (125.2% and 130.5 % respectively) that were infected 
















Figure 48. Effect of β-catenin knockdown in cell proliferation: AGS cells 
either untransfected or transfected with siRNA (β-catenin siRNA_ and β-
catenin siRNA+, respectively) were infected with WT H. pylori and the cell 
proliferation was detected by MTT assay at 24 and 48 h post-infection. 
Uninfected cells served as experimental control. Data are presented as mean ± 





   Uninfected 
(β-catenin siRNA-) 
  Uninfected 
(β-catenin siRNA+) 
WT  H. pylori 
(β-catenin siRNA-) 
WT  H. pylori 
(β-catenin siRNA+) 
0 100 100 100 100 
24 107.5 102 125.2 *66.3 
48 117.08 111.5 130.5 *62.7 
  
Table 8. Quantification of  proliferation β-catenin knockdown cells. The 
table represents the percentage of cell proliferation in AGS cells either 
transfected (β-catenin siRNA+)or untrasfected (β-catenin siRNA_) with β-
catenin siRNA at time poits 24 and 48 h post infection with WT H. pylori. 
Results were normalized to cells proliferation percentage at time point zero 
(To). * p value < 0.05, represents the significant difference in cell proliferation 
rates between transfected and untransfected AGS cells that were infected with 
WT H. pylori.   
 














4.8.3.5 Detection of Gal-3 and β- catenin expression using CLSM 
Since knockdown of β-catenin showed similar effects in cell 
proliferation as shown by Gal-3 knockdown cells, we suspected a potential 
link between Gal-3 and β- catenin which could play a crucial role in Wnt 
signal transduction. Gal-3 was hypothesised to play a contributory role in β-
catenin nuclear translocation, since the later was shown to be exported out of 
the nucleus as a host response to H. pylori infection (Gnad et al., 2010).  
 
In order to investigate this, Gal-3 and β-catenin expression in H. 
pylori-infected cells were studied using CLSM which revealed a basal level of 
Gal-3 expression in the nucleus and β-catenin expression in the cytoplasm 
(Figure 49). Infection with H. pylori caused an upregulation of both Gal-3 and 
β-catenin expression, together with a shift in cellular localization, as Gal-3 
was found to be exported to the cytoplasm whereas β-catenin was translocated 
from the cytoplasm to nucleus.  Treatment of cells with the nuclear export 
inhibitor, Leptomycin B (LMB) caused retention of Gal-3 in the cell nucleus. 
Intriguingly, LMB treatment also resulted in inhibition of β-catenin nuclear 






















Figure 49. CLSM analysis of Gal-3 and β- catenin expression. AGS cells, 
either treated or untreated with LMB, were infected with WT H. pylori for 24 
hrs. Uninfected cells serve as experimental control. Gal-3 is stained green with 
anti-Gal-3 MAb conjugated to FITC. β-catenin is stained red with anti-β-
catein Ab conjugated to Cy3. Cell nucleus fluoresces blue as stained by DAPI. 
Panels a1-a3, b1-b3, c1-c3 and d1-d3 signals expression of Gal-3, β- catenin, 
merged expression of Gal-3 and β- catenin and phase contrast images, 
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4.8.3.6 Role of Gal-3 in β-catenin nuclear translocation 
4.8.3.6.1 Western blot analysis of β-catenin localization in Gal-3 
knockdown cells 
The sub cellular localization of β-catenin in relation to the role of Gal-
3 (Gal-3 was further analyzed using untransfected (Gal-3 siRNA-) and Gal-3 
knockdown AGS cells (Gal-3 siRNA+), infected with H. pylori. The results 
revealed a gradual increase of β-catenin expression in the cytoplasmic fraction 
of Gal-3 siRNA (-) AGS cells up to 8 h of infection which was then reduced 
and maintained at a basal level at 24 h. On the other hand, a time dependent 
increase in expression was seen in the nuclear fraction, which peaked and 
remained constant at  24 h post infection (Figure 50A). Interestingly, H. 
pylori-infection of Gal-3 siRNA (+) AGS cells resulted in the retention of β-
catenin expression in the cytoplasm. A basal level of β-catenin expression was 
detected in the nucleus, which remained constant throughout various time 
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Figure 50. Effect of Gal-3 knockdown in β-catenin nuclear translocation. 
AGS cells either untransfected or transfected with Gal-3 siRNA (siRNA
_
 and 
siRNA+, respectively) were infected with WT H. pylori. The cytosolic and 
nuclear fractions were extracted and β-catenin expression was detected by 
western blotting with anti-β-catenin antibody. Tubulin and lamin served as 
loading controls for cytosolic and nuclear fractions respectively.   
 
4.8.3.7 Double knockdown of Gal-3, β-catenin expression in AGS cells  
Considering the observed effects of Gal-3 and β-catenin knockdown in 
proliferation of H. pylori-infected cells, a double knockdown of Gal-3 and β-
catenin was constructed in AGS cells in order to analyze its effect in cell 
proliferation. Transfection with Gal-3 and β-catenin siRNA (siRNA+) resulted 
in an almost complete inhibition of Gal-3 and β-catenin protein expression 
(Figure 51). Cells transfected with control siRNA showed no inhibition of 
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Figure 51 Double knockdown of Gal-3 and β-catenin AGS cells were 
transfected with Gal-3 and β-catenin siRNA (+). Untransfected (siRNA-) cells 
serve as experimental control.  Total cell lysates were prepared and subjected 
to western blotting with anti Gal-3 antibody and β-catenin antibodies. β- actin 
serve as loading control 
 
4.8.3.7.1 Effect of Gal-3, β-catenin double knockdown in proliferation of 
H. pylori-infected AGS cells 
As shown in Figure 52, double knockdown of Gal-3 and β-catenin 
expression (Gal-3, β-catenin siRNA +/+) did not show any impact on the 
proliferation of uninfected cells.  Untransfected AGS cells (Gal-3, β-catenin 
siRNA -/-)  showed a slight increase in proliferation as detected at 24 and 48 h 
post-infection with WT H. pylori. However, infection of double knockdown 
(Gal-3, β-catenin siRNA ++) AGS cells with H. pylori resulted in a significant 
reduction in proliferation (Fig.52). The results were tabulated by normalizing 
to the optical density (O.D) at time point zero (T0) for each treatment groups.  
 
The proliferation percentages were quantified based on the MTT assay 
(Table 8). A significant difference was observed between the proliferation 





) AGS cells, infected with H. pylori. Gal-3, β-catenin siRNA 
(+/+) cells, infected with H. pylori showed a proliferation percentage of 62.89 
and 61.16 at time points 24 and 48 h respectively. In contrast, the proliferation 
percentages of H. pylori infected Gal-3, β-catenin siRNA (-/-) cells were at 
127.95, 133.3% respectively. 
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Figure 52. Effect of Gal-3, β-catenin double knockdown in cell 
proliferation. AGS cells either untransfected or transfected with Gal3 and β-
catenin siRNA (β-catenin,Gal-3 siRNA __,__ and β-cat,Gal-3 siRNA +,+, 
respectively) were infected with WT H. pylori and the cell proliferation was 
detected by MTT assay at 24 and 48 h post infection. Uninfected cells served 
as experimental control. Data are presented as mean ± SD of 3 independent 







   Uninfected 
(Gal-3  siRNA-, 
β-catenin siRNA-) 
  Uninfected 
(Gal-3 siRNA+, 
β-catenin siRNA+) 
WT  H. pylori 
(Gal-3 siRNA-, 
β-catenin siRNA-) 
WT  H. pylori  
(Gal-3 siRNA+, 
β-catenin siRNA+) 
0 100 100 100 100 
24 105.04 100.4 127.95 *62.89 
48 111.7 106.27 133.3 *61.16 
 
Table 8. Quantification of proliferation in Gal-3, β-catenin double 
knockdown cells. The table represents the percentage of cell proliferation in 
AGS cells either transfected (β-catenin & Gal-3 siRNA+) or untrasfected (β-
catenin & Gal-3 siRNA
_
) with β-catenin siRNA at 24 and 48 h post infection 
with WT H. pylori. Results were normalized to cells proliferation percentage 
at time point 0 (T0). * p value <0.05, p value represents the significant 
difference in cell proliferation rates between transfected and untransfected 
























4.8.3.8 Detection of cyclin D1 expression in H. pylori-infected AGS cells 
As previous studies have shown cyclin D1 as one of the target genes of 
Wnt activation (Udhayakumar et al., 2007), we analyzed cyclin D1 expression 
levels in H. pylori-infected AGS cells. A significant increase in cyclin D1 
expression was observed in cells 24 h post-infection with H. pylori (Figure 
53). A basal level of expression was seen in the uninfected cells.  
                                         
                                           
 
Figure 53. Cyclin D1 expression in H. pylori-infected AGS cells: AGS cells 
were infected with WT H. pylori and the level of cycin D1 expression was 
detected by immunoblotting with anti-cyclin D1 antibody. Uninfected cells 
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4.8.3.8.1 Effect of Gal-3 and β-catenin knockdown in cyclin D1 expression 
Previously, cyclin D1 was shown to be a key regulator of cell cycle 
progression and proliferation in H. pylori-infected cells (Hirata et al., 2001; 
Chang et al., 2006). Since, Gal-3 and β-catenin knockdown reduced the 
proliferation rate of H. pylori-infected AGS cells, a corresponding reduction in 
cyclin D1 expression levels was investigated in this study. Figure 54 illustrates 
the role of Gal-3 and β-catenin in cyclin D1 expression. As shown before in 
Figure 53, Cyclin-D1 was upregulated in H. pylori-infected AGS cells. 
However, a significant reduction in expression was observed in Gal-3 and β-
catenin knockdown AGS cells infected with H. pylori.  
 
 
                                  
 
 
Figure 54. Effect of Gal-3 and β-catenin knockdown in cyclin D1 
expression.AGS cells transfected with Gal-3 and β-catenin siRNA’s were 
infected with H. pylori WT strain for 24 h. Untransfected cells served as 
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4.9 Extracellular Gal-3 expression 
4.9.1 Detection of extracellular Gal-3 expression 
Studies have shown that, the capacity to secrete extracellular Gal-3 
varies from cell line to cell and is dependent on various external stimuli 
including adhesion, membrane fusion events, heat shock and calcium 
ionophores (Hughes, 1999). The current study was sought to determine the 
effect of H. pylori-infection on extracellular secretion of Gal-3 in AGS cells. 
Consistent with the previous studies (Fowler et al., 2006), a rapid secretion of 
Gal-3 was observed in AGS cells, as a host response to H. pylori infection. 
Figure 55 shows the extracellular expression of Gal-3 in AGS cells infected 
with WT and ΔcagA strain of H. pylori. The extracellular Gal-3 expression 
levels remained the same throughout the time points, for the length of until 24 
h post-infection and were found to be independent of H. pylori cagA.  A very 
low, but detectable level of expression was seen in the culture supernatant of 
uninfected cells also.  
 
                                    
 
Figure 55. Extracellular secretion of Gal-3: AGS cells were infected with 
WT and ΔcagA strains of H. pylori. The culture supernatant was collected at 
specific time intervals and the amount of extracellular Gal-3 was detected by 













4.9.2 Role of extracellular Gal-3 in H. pylori adhesion 
To investigate the role extracellular Gal-3 in relation to the 
adhesion of H. pylori to AGS cells, an in vitro binding assay was utilized 
using recombinant Gal-3 (rGal-3). Through a dose dependent analysis, a 
concentration of 8μg/ml of rGal-3 was found to be optimal in causing 
maximum decrese of H. pylori adhesion (Figure 56). H. pylori adhered to the 
AGS cells within 2 h of incubation. However, the level of adherence observed 
in the presence of rGal-3 was significantly lowered by 22.1% (p  < 0.005), as 
compared with the mock (PBS) treated cells (Figure 57). On the other hand, 
neutralization of extracellular Gal-3 using anti-Gal-3 MAb resulted in 10.1% 
increase  in the adhesion of H. pylori to AGS cells (p value < 0.005), as 
compared with the mock treated cells. 
  
Figure 56. Dose dependent effect of rGal-3 in H. pylori adhesion. AGS 
cells treated with with varying concentrations of rGal-3, were infected with 
biotin labeled H. pylori WT (black line). The amount of bacterial adhesion 
was quantified by a biotin- streptavidin based bacterial adhesion assay. 
Untreated cells, infected with H. pylori served as a negative control (grey 
line). The data are representative of three separate experiments and the error 










Figure 57. Extracellular Gal-3 inhibits H. pylori adhesion. AGS cells pre-
treated with either r-Gal-3 (grey bar) or anti-Gal-3 MAb (black bars) for 2 h, 
were infected with Biotin labeled WT H. pylori. The total attachment of H. 
pylori to AGS cells was quantified by a biotin- streptavidin based bacterial 
adhesion assay. Untreated cells serve as experimental control. The data are 
representative of three separate experiments and the error bars represent the 
standard deviation of triplicate samples. * p value < 0.05 and  **p value < 
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4.9.3 Effect of Extracellular Gal-3 in H. pylori-induced apoptosis 
To investigate the effect of extracellular Gal-3 in apoptosis of H. 
pylori-infected AGS cells, an AnnexinV-FITC based apoptosis assay was 
performed (Figure 58). The amount of cell death was confirmed by flow 
cytometric analysis of cells stained with annexin V-FITC. The assay detects 
early stage apoptosis, by using FITC conjugated annexin V as probe for the 
detection of phosphatidyl serine on the outer membrane of apoptotic cells. To 
analyze only living cells committed to apoptosis, both necrotic and late 
apoptotic cells stained with propidium iodide were gated out. As illustrated in 
figure,the percentage of annexin V-labeled   apoptotic cells was 23.8% after 
infection with WT H. pylori for 24 h. Uninfected cell didn’t show any 
significant amounts of apoptotis, irrespective of the presence or absence of 
rGal-3.  Interestingly, H. pylori infection of AGS cells co-incubated with rGal-
3 showed a 12.3% apoptosis, hence suggesting a significant reduction of 
11.1% as compared with the untreated cells. The results were further 
confirmed by inhibiting extracellular Gal-3 in H. pylori-infected cells by co-
incubating with anti-Gal-3 MAb. Inhibition of extracellular Gal-3 resulted in 
partial rescuing of apoptosis inhibition (16.42%), as indicated by a lesser 





















Figure 58. Flow cytometric analysis of the role of extracellular Gal-3 in H. 
pylori-induced apoptosis. AGS cells were co incubated with either antiGal-3 
MAb or rGal-3 and then infected with WT H. pylori. Uninfected cells served 
as experimental control. The percentages of apoptotic cells (lower right 
quadrant) were then detected by annexin V-FITC based apoptosis assay and 
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4.9.4 Role of Gal-3 in chemo attraction of THP-1 monocytes 
Using a trans-well migration chamber, rGal-3 was shown to induce 
migration of THP-1 monocytes in a dose dependent manner (Figure 59). 
Presence of rGal-3 significantly increased THP-1 migration at concentrations 
>0.5 µM compared with diluents and showed a bell shaped dose-dependent 
pattern like many chemo attractants (control, 13.67 ± 2.08; 0.1 µM 29 ± 3.60; 
0.5 µM 63.7 ± 3.05; 1μM, 93.33 ± 6.65; 2.5μM 135.30 ± 7.50; 5μM, 177.33 ± 





Figure 59. Gal-3 induced migration of THP-1 cells.  Various concentrations 
of rGal-3 (0-10μM) were applied to the lower chambers of a transwell 
migration chamber. Thp-1 monocytes were applied to the upper chambers, and 
the migration assay was performed by counting the number of cells migrated 
from the upper chamber to the lower chamber, using phase- contrast 
microscopy. Data are presented as mean ± SD of 3 independent experiments. * 












4.9.4.1 Analysis of Gal-3 induced THP-1 migration using fluorescent 
microscopy 
The cell migration across a transwell migration chamber was 
detected by fluorescent microscopic analysis of Carboxyfluorescein 
Succinimidyl Ester (CSFE) stained THP-1cells from an upper chamber across 
the 4µm porous membrane towards the lower chamber . Figure 60 displays an 
absence of any chemo attraction as indicated by insignificant numbers of 
migrated THP-1 cells towards unstimulated AGS cells. Intriguingly, presence 
of rGal-3 could induce an active migration as shown by high amounts of THP-
1 cells. Similarly, co-incubation of AGS cells with H. pylori also triggered an 
active migration of THP-1 cells toward the lower chamber.  
          
 
 
Figure 60. Migration of THP-1 cell across the transwell chamber. AGS 
cells were seeded on to the lower wells of tanswell migration chamber and 
were incubated either with rGal-3 or WT H. pylori. Untreated AGS cells 
served as experimental control. THP-1 cells were stained with CSFE 
fluorescent dye (green). The cells migrating across the filter membrane was 
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4.9.4.2 THP-1 migration across the transwell filters membrane 
To further confirm Gal-3 induced migration of THP-1 cells, the 
trans-well membrane was excised and the presence of CSFE stained THP-1 
cells, stuck within the filter was detected using confocal microscopic analysis. 
Figure 61 shows the confocal Z-stacking and phase contrast microscopic 
images of THP-1 monocytes passing through the 4µm pores on the transwell 
chamber filters. The cells appear to squeeze through the pores, an indication of 
an active chemo attraction towards the lower chamber. No migration was 
observed towards AGS cells in the absence of either rGal-3 or H. pylori 
stimulus. Addition of rGal-3 resulted in the migration of THP-1 cells across 
the filter membrane. Similarly, infection of AGS cells with WT H. pylori also 





















Figure 61. Migration of THP-1 cell across the trans-well filters 
membrane. AGS cells were seeded on to the lower wells of transwell 
migration chamber and were incubated either with rGal-3 or WT H. pylori. 
Untreated AGS cells served as experimental control. THP-1 cells were stained 
with CSFE fluorescent dye (green). The cells migrating across the filter 
membrane was detected by excision and fixation of the filter, followed by 
confocal microscopic analysis.   
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The consequence of H. pylori infection ranges widely from 
asymptomatic colonisation to severe gastric malignancies. The interactions 
between various host and various microbial proteins result in a chronic 
infection, where enhanced inflammation and proliferation were reported as 
major risk factors (Moss and Blaser, 2005; Robinson et al., 2007).  
 
Recently, a growing amount of literature suggests the role of Galectins 
in infections and malignant transformation. Among these, Gal-3 is a widely 
studied multi functional lectin and changes in its expression are commonly 
seen in cancers and in microbial infections (Yang et al., 2008). The 
implication of Gal-3 during malignancy progression has been suggested in 
several cancers, including gastric cancer (Miyazaki et al., 2002). The protein 
appears to function through both intracellular and extracellular actions, 
thereby modulating health and disease (Rabinovich and Toscano, 2009). 
Fowler et al. (2006) has suggested Gal-3 expression to play a role in H. pylori 
induced gastric abnormalities, as it is upregulated and rapidly secreted from 
gastric epithelial cells, most likely as a host response to infection. Although 
the protein reportedly has various intracellular roles in various cancers, no 
prior work has been done to identify its functional significance in H. pylori 
induced gastric infections. Given its diverse functions, it appears that Gal-3 
would play a regulatory role in H. pylori infection by interfering with various 
associated host response events.  Hence, the current study aims to discuss the 
cellular dynamics of Gal-3 as well as the molecular mechanisms by which it 
contributes to the pathophysiological events in H. pylori infected gastric 
epithelial cells.  
 
5.1 Gal-3 upregulation in H. pylori-infected cells 
The current study elucidates the previously undescribed intracellular 
dynamics, expression as well as the functional roles of Gal-3 in modulating 
crucial host survival responses in H. pylori infection. Previously, (Fowler et 
al., 2006) have shown an upregulation of Gal-3 mRNA in H. pylori-infected 
AGS cells . Consistent with this, an upregulation of intracellular Gal-3 mRNA 
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and protein expression was observed in H. pylori-infected cells (Figure 12 and 
13A). Of interest, upregulation of Gal-3 expression is not unique to H. pylori 
infections but has also been shown to occur in human cells infected with 
Trypanosoma. cruzi (Silva-Monteiro et al., 2007a), Streptococcus. pneumonia 
(Farnworth et al., 2008) human immunodeficiency virus-1 (Fogel et al., 1999) 
and human T-lymphotropic virus-1 (Hsu et al., 1996). The ability of these 
diverse microbial pathogens to stimulate infected cells to increase Gal-3 
expression suggests that this protein may play a vital role in host response to 
infection. Previously, CagA was identified as a potent inducer of Gal-3 
expression in H. pylori-infected cells (Fowler et al., 2006) as the translocation 
of CagA into the host cells contributed to an early upregulation of Gal-3 
expression. In the current study, transfection of AGS cells with pSP65SRα-
cagA expression vector induced significant amounts of Gal-3 protein 
expression during early stages of infection (Figure 16), thus adding credence 
to its previously identified role as an initiator of Gal-3 upregulation. However, 
it was noted that in the absence of CagA, Gal-3 expression was not repressed 
relative to the basal level observed in uninfected cells. Hence, the whole 
process of Gal-3 induction and upregulation appears to be independent of 
CagA expression at least during progressive time intervals of infection. In a 
clinical setting, this could potentially have further implications towards 
pathogenesis as Gal-3 is present in all gastric epithelial cells. Whereas, CagA 
is not present in all H. pylori strains. Hence, upregulation of Gal-3 in cells 
infected with ΔcagA H. pylori further strengthens the independence of Gal-3 
even in the presence of CagA. 
 
5.2 Gal-3 sub cellular localization and H. pylori-induced nuclear export 
The cellular localization of Gal-3 correlates well with its biological 
roles and is dependent on various factors such as cell type, proliferation status 
and culture condition (Haudek et al., 2010). Since alteration in Gal-3 
expression and localization was reported to participate in the acquisition of the 
malignant phenotype (Califice et al., 2004), the present study investigated the 
intracellular dynamics and localization of Gal-3 in H. pylori-infected cells. 
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CLSM analysis of Gal-3 expression revealed a predominantly nuclear 
localization in AGS cells (Figure 17). Nuclear expression of Gal-3 is generally 
associated with the normal functioning of cellular activities which involves 
transcriptional regulation, mRNA splicing and apoptosis (Lu et al., 2004). In 
cancer cells, nuclear Gal-3 was reported to have a major negative impact on its 
malignant capacities (Califice et al., 2004). 
 
Interestingly, H. pylori infection triggers an upregulation of Gal-3 
which was accompanied by a shift in cellular localization from the nucleus to 
the cytoplasm. As a matter of fact, this could probably be an initial step 
towards malignancy as reported by (Lotz et al., 1993)  that exclusion of Gal-3 
from the nucleus indicates transition from normal mucosa to adenoma and 
carcinoma. The cellular localization was further confirmed using post 
embedding immunogold-labelling TEM analysis, which enabled a precise 
localization of intracellular Gal-3 expression (Figure 18). This technique 
provided an advantage over pre-embedding labelling as the latter requires 
extensive detergent treatment necessary for the penetration of gold conjugates 
into cells which may lead to loss of specimen ultra structure (Yi et al., 2001). 
 
The change in sub cellular localization from the nucleus to cytoplasm 
is suggestive of an export of Gal-3. Though, nuclear export of Gal-3 was 
previously reported in other cell lines and cancers (Davidson et al., 2002; Li et 
al., 2006), H. pylori infection induced changes in Gal-3 sub cellular 
localization was never been explored before. Western blot analysis of H. 
pylori-infected cells revealed a time dependent increase in cytosloic Gal-3 
expression while the nuclear fraction showed a sustained basal level (Figure 
19). Thus, the results clearly imply an active nuclear export of Gal-3 in AGS 
cells which could likely be occurring as a host response to H. pylori infection. 
Further to this, the mechanism of Gal-3 nuclear export was investigated. 
CLSM and western blot analysis which revealed a complete inhibition of Gal-
3 nuclear export in H. pylori-infected cells when pre-treated with LMB 
(Figure 20). Of interest, LMB is a cytotoxin that binds to and inhibits CRM-1 
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mediated nuclear export of proteins. Incidentally, CRM-1 is an export receptor 
for proteins with leucine-rich nuclear export signals (NES) (Fornerod et al., 
1997), which is found to be present in between residues 241-246 of Gal-3 as 
reported by (Dumic et al., 2006). Thus, it could well be plausible that nuclear 
export of Gal-3 in H. pylori-infected is mediated through the CRM-1 exportin. 
These results are in agreement with previous studies which showed a CRM-1 
mediated export of Gal-3 in cancer cells (Davidson et al., 2002; Li et al., 
2006), and further confirms the similarity of Gal-3 nuclear export mechanism 
across cell lines. 
 
5.3 Mechanism of Gal-3 upregulation 
Since CagA was shown to act as an inducer of Gal-3 expression during 
the onset of infection, it was therefore pertinent to investigate the potential 
involvement of downstream elements which are activated upon CagA 
translocation. H. pylori infection is characterised by activation of the ERK 
signalling pathway (Nozawa et al., 2002). In addition, a role of CagA in early 
activation of ERK signalling pathway has previously been reported (Zhao et 
al., 2010), although it was reported that ERK signalling can also be activated 
independent of CagA (Ishiguro et al., 2009; Wessler et al., 2000)(Ishiguro et 
al.; Wessler et al., 2000).Taking these reports into consideration, the present 
study aimed at exploring the role of ERK signalling in Gal-3 expression. 
Intriguingly, Gal-3 upregulation in H. pylori-infected cells was found to be 
regulated distinctly by ERK activation. The results were confirmed by pre-
treatment of H. pylori-infected cells with MEK/ERK inhibitor which resulted 
in a drastic reduction in Gal-3 mRNA (Figure 24) and protein (Figure 25) 
expression, hence suggesting an ERK depending activation of Gal-3 
upregulation. However, ERK dependent activation of Gal-3 expression doesn’t 
appear to be an exclusive and unique event in H. pylori infection. A stress 
induced upregulation of Gal-3  in differentiating macrophages (Kim et al., 
2003) and neuronal cells (Kuklinski et al., 2003) is also reported to be 
controlled by the ERK signalling pathway. Since ERK signalling is pivotal in 
initiating an effective inflammatory response during H. pylori infection, the 
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data also strengthens the likelihood that Gal-3 may regulate the activation of 
certain effecter proteins associated with the ERK signalling cascade.  
 
5.4 Inflammatory response in H. pylori-infected cells  
One of the key pathophysiological events in H. pylori infection is the 
initiation and continuance of an inflammatory response leading to gastric 
inflammation.  This is characterised histologically by surface epithelial 
degeneration and infiltration of the gastric mucosa by acute and chronic 
inflammatory cells (Bodger and Crabtree, 1998). Accumulating evidences 
suggest that inflammation is a salutary response to insult or injury and an 
important part of innate immunity; however, chronic inflammation has been 
linked to the development of cancer (Hagemann et al., 2007). Activation of 
ERK signalling pathway may directly  be responsible for the NFkB activation 
and subsequent synthesis of IL-8, an important pro-inflammatory cytokine 
(Nozawa et al., 2002).Moreover, IL-8 released by infected gastric epithelial 
cells was shown instrumental in regulating neutrophil infiltration of the gastric 
mucosa in H. pylori gastritis (Keates et al., 1999).  
 
The present study investigated IL-8 secretion in H. pylori-infected 
cells. Previous studies have shown a role of CagA in IL-8 secretion. However, 
its role remains debatable as conflicting results have been shown by others 
(Sharma et al., 1995; Nozawa et al., 2002). Consistent with the previous 
studies, a significant increase in IL-8 secretion was observed in H. pylori-
infected cells (Figure 28). Furthermore, a contributory role of CagA in IL-8 
secretion is also suggested which falls in line with recent studies (Lai et al., 
2011; Papadakos et al., 2013). More importantly, a significant upregulation in 
IL-8 levels was still observed in the absence of CagA, which can be attributed 
to other virulence factors like CagPAI (Audibert et al., 2001), OipA (Yamaoka 
et al., 2002a) and VacA (Hisatsune et al., 2008) as described previously.  
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5.4.1 A role of ERK signalling pathway in IL-8 secretion 
ERK activation is a complex cellular process that transduces a variety 
of extracellular stimuli through a cascade of protein phosphorylations that lead 
to the activation of transcription factors (Bhattacharyya et al., 2002). Since 
ERK activation is regarded to be under the control of dual specificity kinases, 
MEK 1/2 (Roberts and Der, 2007), the current study utilized targeted MEK 
inhibitor molecule U0126 to inhibit the ERK phosphorylation in H. pylori-
infected cells. Inhibition of MEK activity resulted in an inhibition of ERK 
phosphorylation in H. pylori-infected cells (Figure 23). The data is in 
agreement with (Mitsuno et al., 2001) and further confirms the role of MEK 
1/2 upstream kinases as inducers of ERK signalling pathway.  Notably, an 
effect of ERK inhibition was reflected on the inflammatory response, wherein 
H. pylori-infected cells showed a 50% (approx.) reduction in IL-8 secretion 
(Figure 29). These findings are in accordance with the previous studies, which 
identifies ERK signalling as a prominent event in IL-8 secretion (Hoffmann et 
al., 2002; Nguyen et al., 2008). Activation of ERK could therefore be 
considered as a major step towards development of a stable inflammatory 
response. However, it is to be noted that MEK inhibition did not result in a 
complete inhibition of ERK phosphorylation. Hence, the current study also 
suggests an alternative loop of ERK signalling in H. pylori-infected cells 
which could be activated independent of MEK activation.  
 
 
5.4.2 Gal-3 acts as a mediator of IL-8 response in H. pylori-infected cells 
Since Gal-3 expression in H. pylori-infected cells was found to be 
regulated by ERK activation, a contributory role of Gal-3 in the ERK induced 
IL-8 secretion was suspected. Previous studies have shown a role of Gal-3 in 
acute tissue injury and inflammation where it acted as a key component in the 
host defence against microbes such as S. pneumonia (Sato et al., 2002; 
Nieminen et al., 2008). Moreover, studies in Gal-3 deficient mouse exhibited 
reduced NF-kB responses and decreased cytokine production in several cell 
types (Hsu et al., 2000; O'Shea and Murray, 2008). Even though these studies 
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lack a deeper mechanistic insight, it was postulated that under conditions of 
repetitive tissue injury, Gal-3 may be involved in the transition to chronic 
inflammation, facilitating the walling-off of tissue injury with fibro genesis 
and organ scarring (Henderson and Sethi, 2009).  
  
The current study discusses a previously undescribed pro-inflammatory 
role of Gal-3 in H. pylori-infected cells. Using Gal-3 knockdown AGS cells 
(Figure 30), this study shows a 2 fold reduction in NFκB promoter activity, 
hence suggesting a role of Gal-3 in the transcriptional regulation of NFκB 
expression (Figure 32). Further to this, it was observed that the Gal-3 
knockdown cells infected with H. pylori showed a 40% (approx.) reduction in 
IL-8 secretion (Figure 31), thereby highlighting the downstream effect of 
NFκB regulation. Thus Gal-3 appears to be a mediator of IL-8 secretion in H. 
pylori-infected cells, by acting as an enhancer of NFκB promoter activity. 
Since IL-8 secretion is part of the host innate immune response to infection 
(Ando et al., 1998), an upregulated Gal-3 expression may be considered as an 
important host response event which is pro-inflammatory and protective 
during H. pylori-infection. Hence, by identifying the intermediate events in IL-
8 secretion, this study provides a deeper knowledge into the role of Gal-3 in H. 
pylori-infected cells. However, it is to be noted that during progressive stages 
of infection, an enhanced inflammatory response may also contribute to 
continuous infiltration of inflammatory cells. Hence, it is likely that an 
upregulation in Gal-3 expression coupled with an infiltration of inflammatory 
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5.4.3 Gal-3 and ERK activation- A reverse feedback loop of signal 
transduction 
Even though an upregulation of Gal-3 was reported previously in 
infections and in cancers (Bernardes et al., 2006; Yang et al., 2008; Vasta, 
2009), its significance in host response and malignant transformation remains 
largely undefined. The present study explores a role of Gal-3 in interfering 
with various intracellular pathways associated with crucial host response 
events in H. pylori-infected cells.  As described previously in the current 
study, ERK activation is pivotal in the upregulation of Gal-3 expression. 
However, interestingly, a cross talk event of signal transduction was found to 
exist between Gal-3 and ERK in H. pylori-infected cells as knockdown of Gal-
3 expression caused a significant reduction in ERK phosphorylation (Figure 
33). Taken together, the data indicate that the ERK induced upregulation of 
Gal-3 expression would potentially result in a further enhancement of ERK 
phosphorylation through a reverse feedback loop of signal transduction. Hence 
a Gal-3 mediated alternative pathway of ERK activation was investigated.   
 
ERK activation in H. pylori-infected cells is more complicated than a 
simple linear pathway and is achieved through multiple pathways (Nguyen et 
al., 2008). These pathways may be differentially utilized by the host or the 
pathogen that will determine the amount and duration of ERK signalling 
during infection. In the current study, no absolute inhibition of ERK 
phosphorylation was achieved in H. pylori-infected cells pre-treated with 
MEK inhibitor, hence suggesting an MEK independent activation of ERK 
signalling. Previous studies also failed to achieve a complete inhibition of 
ERK phosphorylation by targeting the MEK (Mitsuno et al., 2001; Horiuchi et 
al., 2006). Further to this, the present study explored the possibility that Gal-3 
mediated reverse activation of ERK phosphorylation could well be occurring 
without the activation of MEK, there by suggesting an alternative loop of ERK 
signal transduction which is independent of MEK. Hence, the role of Gal-3 in 
the expression of various upstream effector proteins which either directly or 
indirectly contribute to ERK activation in H. pylori-infected cells was 
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investigated. Among others, the role of EGFR and Ras signalling cascade in 
ERK activation was previously characterised (Kolch, 2000; Avruch et al., 
2001). Infection of gastric epithelial cells with H. pylori triggers EGFR 
induced activation of Ras proto-oncogenes which then phophorylates the 
downstream Raf kinases ultimately leading to ERK activation (Moodie and 
Wolfman, 1994).  
 
5.4.4 EGFR activation is independent of Gal-3 expression 
As shown previously (Keates et al., 2007), EGFR activation was 
observed in H. pylori-infected cells which is indicated by elevated levels of 
phosphorylated EGFR (Figure 34). No difference in expression was observed 
in cells infected with ΔcagA strains, suggesting EGFR signalling in H. pylori-
infected cells is independent of CagA. Consistent with previous studies 
(Keates et al., 2001; Pillinger et al., 2007), a regulatory effect of EGFR 
signalling was reflected in ERK activation as inhibition of EGFR 
phosphorylation resulted in a significant reduction in ERK phosphorylation 
(Figure 35). The data further emphasizes EGFR signalling as a major event in 
H. pylori infection which upon activation would lead to an augmentation of 
ERK phosphorylation. 
 
Two years ago, (Merlin et al., 2011) suggested a role of Gal-3 in the 
intracellular trafficking of EGFR surface expression. Besides this,  Gal-3 was 
shown to have a role in  EGFR transactivation as well (Liu et al., 2012a). 
Considering these findings, the present study investigated if Gal-3 mediated 
ERK activation in H. pylori-infected cells is channelled through the EGFR 
signalling pathway. However, knockdown of Gal-3 expression had little 
impact on EGFR phosphorylation in H. pylori-infected cells (Figure 36). This 
not only illustrates EGFR activation being independent of Gal-3 expression, 
but also points out that Gal-3 mediated ERK activation is not channelled 
through the EGFR phosphorylation.   
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5.4.5 Gal-3 plays a role in augmenting Ras activation 
The current study further investigated a potential association of Gal-3 
with the downstream effectors of EGFR signalling pathway that would lead to 
an enhancement of ERK phosphorylation. Previous studies have shown that 
induction of EGFR signalling directly activates Ras proteins (Moodie and 
Wolfman, 1994). Activated Ras protein is known to interact with a number of 
effectors to trigger downstream signalling pathways, including activation of 
the RAF/MEK/ERK, PI3K/AKT (Pillinger et al., 2007; Castellano and 
Downward, 2011). Although H. pylori infection induced a time dependent 
upregulation in Ras activation, knockdown of Gal-3 expression resulted in a 
significant reduction in Ras expression levels (Figure 37). This signifies a 
major role of Gal-3 in regulating the expression of Ras proteins. In addition, 
such an effect will have further implications in inflammation and 
carcinogenesis since studies have shown a role of Ras signalling pathway in 
ERK activation, IL-8 secretion and cell differentiation (Sparmann and Bar-
Sagi, 2004). 
 
5.4.6 Gal-3 activates PI3K phosphorylation 
PI3K signalling was suggested to be involved in the regulation of H. 
pylori-related inflammatory signalling related to gastric carcinogenesis 
(Tabassam et al., 2009, 2012).  In this context, the Gal-3 mediated Ras 
activation was suspected to play a role in PI3K phosphorylation, since 
previous studies have shown Ras activation as an upstream inducer of PI3K 
(Castellano and Downward, 2011; Liu et al., 2012b; Park et al., 2012). An 
increase in PI3K phosphorylation was observed in cells infected with H. pylori 
(Figure 38). Intriguingly, knockdown of Gal-3 caused a drastic reduction in 
PI3K phosphorylation, confirming a mediatory role of Gal-3 in PI3K 
activation (Figure 39). Reading together with earlier studies, the current study 
signifies a contributory role of Gal-3 in PI3K activation which is regulated in a 
Ras dependent manner. These findings confirms and elaborates the studies by 
Castellano and Downward (2011) that showed a direct association between 
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Ras and PI3K activation in H. pylori-infected cells.  On the other hand, the 
study also shows CagA being ineffective in PI3K activation, unlike other 
virulence factors like VacA which was shown to play  a contributory role in 
PI3K activation (Nakayama et al., 2009).  
 
 
5.4.7 Gal-3-Ras-PI3K signalling - an MEK independent alternative ERK 
signalling pathway 
Although MEK inhibition of H. pylori-infected cells caused a 
significant reduction in ERK phosphorylation, a complete inhibition of ERK 
phosphorylation was achieved only through the simultaneous inhibition of 
PI3K and MEK (Figure 41). Similarly, knockdown of Gal-3 expression in 
MEK inhibited cells also resulted in a complete inhibition of ERK 
phosphorylation (Figure 41). Aksamitiene et al. (2010) have shown a ligand-
induced PI3K sensitive but MEK independent activation of ERK signalling in 
breast cancer cells. However, to date no studies have shown an MEK 
independent route of ERK activation in H. pylori infection and in gastric 
cancer. The data presented here highlights a previously uncharacterised 
signalling pathway in H. pylori-infected cells and cancer cells in general, 
where Gal-3 mediates a feedback loop of ERK signalling in an MEK 
independent manner. This process appears to take place in a sequential manner 
once Gal-3 is exported out to cytoplasm in H. pylori-infected cells. Cytosolic 
Gla-3 would activate the Ras protein, which then activates the PI3K 
phosphorylation. And, activation of PI3K results in ERK phsphorylation in an 
MEK independent manner. The two critical partners in this event are Gal-3 
and PI3K, of which the knockdown or inhibition of one of the partners itself 
would lead to a complete inhibition of ERK phosphorylation. Thus, the study 
unveils a dynamic, Ras-PI3K sensitive and MEK independent pathway which 
enhances ERK signalling in H. pylori-infected cells. This would have 
farfetched effects in developing a chronic infection and carcinogenesis, as 
ERK pathway acts central in regulating many cellular processes including cell 
differentiation, transformation and inflammation.  





5.5 H. pylori infection increases proliferation of gastric epithelial cells 
H. pylori is reported to augment the risk for carcinogenesis by altering 
cellular turnover (Cover et al., 2003). Increased proliferation of epithelial cells 
is considered an important biomarker for increased risk of gastrointestinal 
adenocarcinoma. Mucosal hyper proliferation was demonstrated in H. pylori-
infected gastric tissue (Peek et al., 1999; Scheider et al., 2011) and also in in 
vitro infections (Fan et al., 1996). Interestingly, a significant increase in cell 
proliferation was observed in AGS cells infected with H. pylori (Table 6), 
which supports the findings as reputed earlier by (Blaser, 1998), in H. pylori-
infected gastric epithelial cells. On the other hand, these findings are in 
contrast with studies by (Smoot et al., 1999) that reported a reduction in cell 
proliferation upon infection with H. pylori. Also of interest, various studies 
have reported contradictory results regarding the role of CagA in cell 
proliferation. (Rokkas et al., 1999; Smoot et al., 1999) reported a contributory 
role of CagA in cell proliferation. Whereas the current study identified no 
significant variation in proliferation between the cells infected with wild type 
and cagA mutant strains of H. pylori. The findings of this study are in accord 
with studies by Ricci et al. (1996) and Figura et al. (1998) that showed no 
effect of CagA in the proliferation of gastric epithelial cells either in vitro or in 
vivo respectively. Nevertheless, the observed difference in outcome may be 
attributed to varied culture conditions and differences in strains and cell lines 
used.  
 
5.5.1 Gal-3 expression enhances cell proliferation  
 A direct correlation between Gal-3 expression and cell proliferation 
was shown previously in gastric cancer, where an increase in Gal-3 expression 
resulted in an increase in cell proliferation (Baldus et al., 2000). In addition, 
Gal-3 was shown to enhance the proliferative responses in various other 
cancers including pancreatic and colorectal cancer (Tsuboi et al., 2007; Song 
et al., 2012). Further to this, the current study evaluated the role of Gal-3 in 
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the proliferation of H. pylori-infected gastric epithelial cells. Interestingly, 
Gal-3 upregulation bestowed the cells with a significant growth advantage, 
wherein a 29% increase in proliferation was observed 48 h post-infection with 
H. pylori. In contrast, knockdown of Gal-3 expression made the cells 
susceptible to H. pylori-induced cytotoxicity resulting in a 22% reduction in 
proliferation (Figure 42). This could also be inferred as a decline in cell 
survivability, in other words, a potential reflection of enhanced sensitivity to 
H. pylori-induced apoptosis. The data provides suggestive evidence that Gal-3 
upregulation during H. pylori infection plays a crucial role in increasing 
epithelial cell proliferation and hence potentially favouring the development of 
gastric carcinogenesis. However, a deeper insight is still lacking which 
restricts our understanding of the Gal-3 mediated proliferative mechanisms in 
H. pylori infection. Hence, the current study aimed at providing experimental 
evidence regarding the mechanism by which Gal-3 stimulates the proliferation 
in H. pylori-infected gastric epithelial cells.  
 
5.5.2 Gal-3 as a regulator of Wnt signalling 
Studies have reported activation of certain signalling pathways and 
effector proteins which are pivotal in cell cycle regulation and proliferation of 
H. pylori infection. One such pathway that is abnormally active in H. pylori 
infection is the Wnt/β-catenin pathway (Yang et al., 2012b). Notably, aberrant 
activation of wnt signalling components has been described in about 30% of 
the gastric cancer patients (Clements et al., 2002). Inhibition of Wnt signalling 
was shown to induce cell apoptosis and suppress proliferation in various 
carcinomas (Zhuo et al., 2009; Zhang et al., 2013). This effect could be 
attributed to the association of Wnt signalling with cyclin D1 activation, since 
studies have shown cyclin D1as a target gene in Wnt pathway which plays a 
major role in cell cycle regulation and proliferation (Pradeep et al., 2004; 
Zhang et al., 2012). Amplification of the gene encoding cyclin D1 and 
overexpression of cyclin D1 protein have frequently been found in several 
types of human malignant neoplasms (Takahashi-Yanaga and Sasaguri, 2008). 
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Furthermore, studies by (Hirata et al., 2001) also showed trans-activation of 
cyclin D1 in H. pylori infection, an effect of which was reflected by 
acceleration of cell cycle and enhanced cell proliferation.  
 
Recent studies have implied the role of Gal-3 in wnt signalling in 
human breast and colonic cancer cells (Shimura et al., 2004; Song et al., 
2009). Although wnt signalling was shown to be activated in H. pylori-
infected gastric epithelial cells, the role of Gal-3 in Wnt activation has never 
been explored.  In this regard, the present study investigated the potential role 
of Gal-3 and the mechanism by which it regulates various effector proteins in 
the Wnt pathway.  Since nuclear translocation of β-catenin is a critical event in 
Wnt activation, the study investigated if Gal-3 would interfere with 
intracellular localization of β-catenin in H. pylori-infected cells. The results 
shows that H. pylori infection induced an upregulation of β-catenin expression 
which occurred simultaneously with its translocation into the nucleus (Figure 
43). This finding is akin to that described by (Shimura et al., 2004) who 
reported that Gal-3 binds to β-catenin, co-localizes with it in the nucleus of 
breast cancer cells. 
 
 Further to this, Co-IP was employed to search for any potential 
interaction partners of Gal-3 in H. pylori-infected cells. This technique is 
relatively inexpensive, very reproducible and can be applied to purify protein 
complexes from whole cell lysates. The current study was unable to show a 
direct interaction between Gal-3 and β-catenin in H. pylori-infected gastric 
epithelial cells. But instead, a novel interaction was shown to exist between 
Gal-3 and GSK3β, an upstream inducer of β-catenin nuclear translocation. Co-
IP of Gal-3 in H. pylori-infected AGS cell lysates resulted in the pull down of 
Gsk3β. The results were further confirmed by reverse Co-IP where Gsk3β 
was immunoprecipitated with Gal-3 (Figure 46). 
 
Interestingly, the interaction between Gal-3 and GSK-3β was found to 
be beneficial in Wnt signalling activation.  Knockdown of Gal-3 expression 
lead to reduced levels of phosphorylated GSK-3β at Ser9 (Figure 45), an event 
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which enhances GSK-3β activity leading to phosphorylation and degradation 
of β-catenin (Liu et al., 2002) .The results supports and further explains the 
studies by (Song et al., 2009), who reported a Gal-3 mediated regulation of 
GSK3β phosphorylation in colonic epithelial cells . Subsequently, analysis of 
β-catenin expression in Gal-3 knockdown cells revealed an inhibition in its 
nuclear translocation as the expression appeared predominantly cytoplasmic 
(Figure 49, 50). The data suggest a role of Gal-3 in facilitating β-catenin 
nuclear translocation by regulating GSK3β phosphorylation.   
 
In the nucleus, β-catenin forms a complex with the transcription factor 
TCF-4 and induces the transcriptional upregulation of Wnt target gene cyclin 
D1 (Takahashi-Yanaga and Sasaguri, 2008). An upregulation of cyclin D1 was 
observed in this study (Figure 53), which is in accordance with studies by 
(Hirata et al., 2001; Chang et al., 2006). Furthermore, over expression of Gal-
3 in breast cancer cells was reported to regulate cyclin D1 expression through 
the TCF-4 transcriptional activation (Lin et al., 2002). Since Gal-3 played a 
role in the regulation of β-catenin together with GSK3β in H. pylori-infected 
cells, a downstream effect of this in cyclin D1 expression was explored using 
Gal-3 knockdown cells. Expectedly, Gal-3 knockdown resulted in a significant 
reduction in cyclin D1 expression levels. A similar reduction in expression 
was also observed in β-catenin knockdown cells as well (Figure 54).  
 
Taken together, the current study shows that Gal-3 facilitates β-catenin 
nuclear translocation and augments Wnt signalling during H. pylori infection 
by regulating GSK-3β phosphorylation there by resulting in the upregulation 
of target gene cyclin D1. The data unveils a previously undefined role of Gal-3 
in the functional regulation of key molecules in H. pylori-induced Wnt 
activation and thus provides a better understanding of the molecular 









5.6 H. pylori infection triggers an extracellular secretion of Gal-3  
Atypically, Gal-3 lacks the classical secretion signal sequence and does 
not pass through the standard ER/Golgi pathway. However, studies have 
shown extracellular secretion of Gal-3 which occurs through a non classical 
pathway (Hughes, 1999; Menon et al., 2011). Importantly, studies have 
reported significantly  high levels of Gal-3 in the sera of patients with breast 
cancer, lung cancer, ovarian cancer and gastrointestinal cancer (Iurisci et al., 
2000). Moreover, Gal-3 is widely expressed in the gastric epithelium and an 
increase in expression was shown to be associated with an increase in 
malignancy (Lotan et al., 1994; Baldus et al., 2000). Interestingly, a rapid 
extracellular secretion of Gal-3 was reported in H. pylori-infected gastric 
epithelial cells (Fowler et al., 2006) .  
 
Consistent with the findings of (Fowler et al., 2006), the present study 
demonstrated a rapid secretion of extracellular Gal-3 in H. pylori-infected cells 
(Figure 55).  Notably, the amount of extracellular Gal-3 secretion remained 
consistent over a period of up to 24 h post-infection and was found to be 
independent of CagA. The data suggest extracellular secretion of Gal-3 as an 
initial event in H. pylori-infected cells and may likely to be attributed to an 
immediate host response mechanism against the pathogen. This assumption is 
well supported by previous studies which suggests secreted Gal-3 as a pro-
inflammatory signal that activates NADPH oxidase (Karlsson et al., 1998) and 
superoxide production from neutrophils (Yamaoka et al., 1995). 
 
 
5.7 Extracellular Gal-3 inhibits adhesion of H. pylori  
As an extracellular protein, Gal-3 can interact with the glyco proteins 
within the extra cellular matrix or can act as a ligand to cross link 
carbohydrates of surface protein s by N-terminal oligomerization (Li et al., 
2008). In addition, Gal-3 was also shown to have a binding affinity towards β-
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galectoside carbohydrates which are common structures on the LPS of many 
pathogens (Mandrell et al., 1994). Of interest, H. pylori LPS is characterized 
by a long O antigen side chain which comprises a polymer of N-
acetyllactosamine, a known ligand for Gal-3 (Sato and Hughes, 1992). 
Binding of Gal-3 to the O antigen side chain of H. pylori LPS was previously 
reported (Fowler et al., 2006).  However, the significance of this binding in the 
pathogenicity of H. pylori infection is not fully understood. .  
 
The ability of H. pylori to adhere and colonize the gastric epithelium is 
believed to play a central role in gastric infections(Su et al., 1999). Since Gal-
3 exhibits N terminal and C terminal binding, a cross linking property was 
previously attributed to its extracellular expression (Nangia-Makker et al., 
2008). On account of these, the current study investigated the consequence of 
extracellular Gal-3 secretion in H. pylori adhesion using an enzyme-linked 
Biotin-streptavidin bacterial adhesion assay (Figure 57). This assay method 
was previously shown successful in evaluating the participation of lectin 
interactions in the adhesion of H. pylori to cultured gastric cells (Guzman-
Murillo et al., 2001).  Interestingly, neutralization of secreted Gal-3 using anti-
Gal-3 MAb resulted in an increase in H. pylori adhesion to AGS cells, hence 
suggests a potential inhibitory role of extracellular Gal-3 on H. pylori 
adhesion. The data presented here appears unique but contradictory to 
previous reports that showed Gal-3 as an LPS receptor  which plays a role in 
the adhesion of Klebsiella pneumoniae (Mey et al., 1996), Pseudomonas 
aeruginosa (Gupta et al.,1997) and  Neisseria gonorrhoea (John et al., 2002), 
to their target cells. However, the reverse trend observed in the present study 
could be related to the differences in LPS composition of H. pylori, the 
localization of Gal-3 (whether cell surface bound or extracellular) and also the 
variations in target cell lines. Additionally, the results presented in this study 
are further confirmed by adding recombinant Gal-3 into the cell culture media. 
Presence of rGal-3 in the cell culture media induced a dose dependent 
reduction in H. pylori adhesion with saturation attained at 8μg/ml (Figure 56).  
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5.8 Extracellular Gal-3 acts as a negative regulator of H. pylori-induced 
apoptosis 
Apart from adhesion, neutralization of secreted Gal-3 was found to 
have a regulatory effect on H. pylori-induced apoptosis (Figure 58). H. pylori-
infected cells treated with Gal-3 neutralizing antibodies showed an increased 
sensitivity to apoptosis. Furthermore, addition of recombinant Gal-3 resulted 
in a decrease in H. pylori-induced apoptosis hence confirming its inhibitory 
effects. The data does not implicate extra-cellular Gal-3 as an anti-apoptotic 
molecule by itself, but its binding to H. pylori LPS and subsequent 
interference with adhesion of the bacteria to the receptors sites on gastric 
epithelial cells may inadvertently result in a down regulation of apoptosis. 
Although anti-apoptotic functions of intra-cellular Gal-3 was reported in many 
cell lines and cancers, little evidence is available regarding its extra cellular 
roles. By identifying the regulatory role of extracellular Gal-3 in apoptosis, the 
current study provides further understanding of the role of Gal-3 in host 
response to H. pylori infection. 
 
 
5.9 Gal-3 acts as a chemo attractant for monocytes  
Using in vitro migration assays, recombinant Gal-3 has been shown to 
promote monocyte and macrophage migration (Sano et al., 2000). Studies by 
(Bhaumik et al., 2013) reported neutrophil recruitment by Gal-3 during early 
stages of Leishmania infection. It was suggested that the rapid release of Gal-3 
from infected cells may represent an early warning system and instigate the 
immediate trafficking of phagocytic cells to the site of infection (Fowler et al., 
2006). Since monocytic migration is a characteristic event in H. pylori-
induced inflammation (Mori et al., 2001), the current study investigated a 
chemo attractant role of secreted Gal-3  on monocytes. The study employed a 
trans well migration chamber assay which utilized CFDA-SE staining of THP-
1 monocytes for detection using confocal microscopy. CFDA-SE is a live cell 
stain which at reasonable concentration does not affect the normal functioning 
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of cells. A final concentration of 5mM was used to stain THP-1 monocytes as 
described previously (Figure 59).  
 
Interestingly co-incubation of AGS cells with H. pylori could induce 
the migration of THP-1 monocytes towards the site of infection which is 
suggestive of a chemo attraction. In contrast, absence of H. pylori-induced no 
THP-1 cell migration. Interestingly, the addition of extracellular recombinant 
Gal-3 could rescue THP-1 migration towards uninfected AGS cells in a dose 
dependent manner (Figure 60, 61). Thus, the data not only implies a Gal-3 
induced monocyte migration but also suggests its role as a major chemo 
attractant, since a significantly high number of THP-1 cells were seen 
migrated in the presence of recombinant Gal-3. It is therefore proposed that 
extracellular Gal-3 in H. pylori infection could play a role in innate immune 




5.10 Role of Gal-3 in H. pylori infection –A proposed model 
Current study proposes a multi functional role of Gal-3 where it 
interferes with a cascade of intracellular signalling pathways which is capable 
of modulating the host response events in H. pylori-infected cells (Figure 61). 
H. pylori infection induced an upregulation in Gal-3 expression where ERK 
signalling was found to play a major role. This was found to be independent of 
CagA, although its presence predisposed the cells to initiate an early 
upregulation of Gal-3 expression. Intriguingly, Gal-3 upregulation appears to 
be a crucial event in H. pylori infected cells wherein its depletion caused an 
alteration in the proliferative and pro-inflammatory potential of host cells. In 
addition, a hitherto undescribed role of Extracellular Gal-3 is also discussed.  
 
The role of ERK signalling pathway in H. pylori infection is well 
characterised. (Nozawa et al., 2002) showed that the stimulation of ERK 
signalling pathway by H. pylori may be directly responsible for the NFkB 
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activation and subsequent synthesis of IL-8. The current study identifies a 
novel pro-inflammatory role of Gal-3 in H. pylori-infected cells where it 
mediates ERK induced IL-8 secretion through the direct activation of NFκb 
expression. The study presented here describes a model of multiple, temporary 
distinct pathways converging on ERK.  
 
Interestingly, a cross talk event of signal transduction was found to 
exist between ERK and Gal-3, where activation of Gal-3 led to further 
enhancement of ERK signalling, likely through an alternative signalling 
pathway. Since EGFR inhibition was shown to affect ERK signalling, the 
present study analysed if Gal-3 would act as a regulator of EGFR activation 
leading to an enhancement of ERK signalling. However, EGFR activation in 
H. pylori-infected cells was found to be independent of Gal-3, as Gal-3 
depletion showed no effect in EGFR phosphorylation. Nonetheless, this study 
proposes an alternative pathway of ERK signalling, where Gal-3 upregulation 
would lead to ERK activation through the activation of Ras-PI3K signalling 
cascade. Furthermore, the data provides compelling evidence which suggests 
an MEK independent reverse feedback loop of ERK activation in H. pylori-
infected cells transduced through the Gal-3-Ras-PI3K signalling pathway 
 
 On the other hand, Gal-3 was also found to enhance the proliferation 
in H. pylori-infected cells. Knockdown of Gal-3 in H. pylori-infected cells 
lead to a significant reduction in proliferation. This effect was attributed to its 
association with the partners of the Wnt pathway. A critical step in Wnt 
pathway involves the phosphorylation of GSK3β leading to the nuclear 
translocation of β–catenin. Gal-3 was found to be co- expressed with GSK3β 
in H. pylori-infected cells, resulting in enhanced phosphorylation of GSK3β, 
thereby facilitating the nuclear translocation of β-catenin. Knockdown of Gal-
3 lead to the cytosolic retention of β-catenin, a downstream effect of which 
was observed in the expression of cyclin D1, a key regulator of cell cycle 
regulation and proliferation. Taken together, the study presented here unveils a 
proliferative role of Gal-3 and also provides a better understanding of the 
regulatory events in Wnt signalling pathway in H. pylori-infected cells. 




Apart from the intracellular roles, the current study also explored the 
extracellular secretion of Gal-3 and its functional significance in H. pylori-
infected cells. A rapid extracellular of Gal-3 secretion was observed in H. 
pylori-infected cells. Gal-3 secretion appeared to be an initial event during 
infection and was found to be independent of CagA. Previously, (Fowler et al., 
2006) showed the binding of secreted Gal-3 to H. pylori LPS. The present 
study elaborates the significance of this binding as extracellular Gal-3 was 
shown to inhibit the adhesion of H. pylori to the gastric epithelial cells. It is 
likely that Gal-3 interaction with H. pylori LPS would interfere with the 
binding of the bacteria to its receptor on the gastric epithelial cell surface. 
More importantly, a decrease in H. pylori adhesion resulted in a decrease in 
apoptosis, suggesting a probable regulatory role of extracellular Gal-3 in H. 
pylori-induced apoptosis. Furthermore, the study also identifies a 
chemoattractent role of extracellular Gal-3, where its secretion resulted in the 
recruitment of THP-1 monocytes towards the site of infection. The data is 
suggestive of a chemo attractant property of Gal-3 which could potentially 




In conclusion, the current study unravels a previously uncharacterised 
role of Gal-3, where its up-regulation would increase the propensity towards 
malignant transformation by enhancing the proliferative and pro- 
inflammatory responses in H. pylori-infected cells. However, the resultant 
effect of Gal-3 in mediating these cellular responses may inadvertently favour 
the chronic persistence of infected cells, as the cells garner a survival 
advantage. These findings may contribute to our understanding of how Gal-3 
acts as a modulator under pathological conditions. It is speculated that the 
augmentation of cell proliferation and inflammation may present the cells with 
a prolonged persistence to infection which could be pivotal in the development 
of gastric carcinomas.  However, more work has to be done to unwind the 
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underlying molecular mechanism by which Gal-3 mediates these multiple 
cellular responses in H. pylori infection. The protein appears to have versatile 
functions in infections and beyond, and a detailed understanding of would 
provide valuable information into their potential use in therapeutic 
interventions and would ideally have clinical implications in the treatment of 




Figure 62. Gal-3 acts as a mediator of cellular responses in H. pylori 
infection- A proposed model. The ERK induced activation of Gal-3 
upregulation would trigger an intracellular signalling pathway which would 
lead to a further activation of ERK phosphorylation in a Ras-PI3K dependent 
pathway. Gal-3 expression would also contribute to an enhancement of 
inflammatory and proliferative responses through the activation of IL-8 
secretion and cyclin D1 upregulation, respectively. On the other hand, an 
extracellular secretion of Gal-3 would inhibit H. pylori adhesion, an effect  
which would be reflected on the apoptosis induction. Moreover, a chemo 
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5.12 Clinical relevance and future studies 
High levels of serum Gal-3 was detected in patients with breast, 
gastrointestinal, lung, ovarian cancer, melanoma, and non-Hodgkin’s 
lymphoma when compared with healthy individuals (Iurisci et al., 2000). 
Moreover, Gal-3 concentrations in sera from patients with metastatic disease 
were higher than in sera from patients with localized tumors. Maximum serum 
concentrations of Gal-3 (median, 320 ng/ml; range, 20–950 ng/ml) were found 
in patients with metastatic gastrointestinal carcinoma. A recent study has 
implicated the presence of Gal-3 in patient serum as a distinguishing factor 
between infectious diseases and non-infectious inflammation (Oever et al 
2013). The current study opens up an area which is previously unexplored and 
warrents further analysis of Gal-3 expression in H. pylori associated gastric 
malignancies. To validate the clinical significance of this multifunctional 
protein in H. pylori associated gastric malignancies, the sera and gastric 
biopsies of infected patients should be further analysed for Gal-3 expression.   
Since Gal-3 appears to promote proliferation and inflammation during 
infection, it would be necessary to explore its role as a therapeutic target in H. 
pylori associated gastric cancer. A study by Takenaka et al (2004) showed that 
inhibition of Gal-3 nuclear export using Leptomycin B plays an important role 
in chemotherapeutic sensitivity of breast cancer cells. Hence, silencing Gal-3 
expression could reduce the inflammatory response in host cell in an event of 
infection. Future studies in gastric cancer should explore if a combinational 
adjuvant therapy involving inhibition of Gal-3 expression would contribute to 
enhanced susceptibility of gastric cancer cells to chemotherapeutic drugs. It is 
unlikely that Gal-3 expression alone can as a predictive biomarker for H. 
pylori infection. However, detection of Gal-3 expression, together with an 
upregulated expression of other proliferative markers (e.g. Cyclin D1, β- 
catenin) in gastric biopsies could be suggestive of an active H. pylori 
infection.  
Although Gal-3 upregulation in H. pylori-infected cells was shown to be 
mediated by ERK signalling pathway, the data suggest the potential 
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involvement of other factors which could either be bacterial or host and hence 
warrants further analysis. The protein appears to have a major role in 
inflammation and proliferation which are known risk factors of H. pylori-
induced gastric abnormalities. The elevated presence of Gal-3 is a clear 
indication of malignant transformation. Hence, the intracellular upregulation 
of Gal-3 coupled with its extracellular presence in H. pylori-infected cells 
opens up the possibility of using these proteins as prognostic marker for H. 
pylori infection.  
 
Furthermore, the study presented here needs further validation by in 
vivo experimentation, which would necessitate replication of these findings by 
using animal models. This could be achieved by the engrafting of Gal-3 
knockout cell lines in mouse models and then comparing it with the xenografts 
expressing high levels of Gal-3.  Additionally, future studies should aim at 
exploring the consequences of Gal-3 binding to H. pylori LPS. Nevertheless, it 
is likely that bacteria utilizes host Gal-3 to mask their surface danger signals 
on the LPS which may serve as a mechanism of camouflage, helping the 
pathogen to evade recognition by the immune system. Also, this binding may 
interfere with the binding of LPS to its receptor complexes of gastric epithelial 
cells, an effect of which may lead to the repression of LPS induced activation 
of downstream signalling cascades. 
 
. Taken together, future studies should aim at understanding the 
molecular mechanisms and significance of Gal-3 expression in greater detail, 
not only to develop more effective treatments against H. pylori infection, but 
also because it might serve as a paradigm for the role of chronic inflammation 
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Note: “qsp” stands for “quantite suffisante pour” or “quantity sufficient for”. 
 
APPENDIX 1 
Chocolate blood agar 
For a 500ml preparation: 
Blood agar base No. 2 (Oxoid)                                             20.0 g 
Distilled water                                                                       475 ml 
Horse blood (Quad Five)                                                         25 ml 
 
1. The blood base No.2 and distilled water were mixed in 500 ml bottle. 
2. The mixture was then autocalved at 121
o
C for 20 min. 
3. The agar was cooled to 50
o
c before the horse blood was added aseptically. 
4. The blood was lysed by immersing the bottle contain molten agar in an 80oc      
water bath for 10 min with constant swirling 
5. The chocolate blood agar was subsequently cooled to 50
o
c before pouring 
into sterile petri dishes (Sterilin) 
6. The plates were stored at 4
o











Medium for screening antibiotic resistant constructs 
Chloramphenicol stock (15mg/ml) 
For a 10 ml preparation: 
Chloramphenicol (Sigma- Aldrich)                                     150 mg  
Absolute ethanol (Merck)                                                       10 ml (qsp) 
1. The antibiotic solution as sterilized by filtering through a 0.22 μm filter 
(Millipore).  
2. Then solution was then kept as 500 μl aliquots at -20oc until use. 
Chocolate blood agar + Cholramphenicol (15 μg/ml)  
For a 500 ml preparation: 
Blood agar base No.2 (Oxoid)                                                20.0 g 
Distilled water                                                                           475 ml 
Horse blood (Quad Five)                                                            25 ml 
 
1. The blood agar base No.2 and ditilled water were mixed in a 500 ml bottle.  
2. The mixture was then autocalved at 121
o
C for 20 min. 
3. The agar was cooled to 50
o
c before the horse blood was added aseptically. 
4. The blood was lysed by immersing the bottle contain molten agar in an 80oc      
water bath for 10 min with constant swirling 
5. The chocolate blood agar was subsequently cooled to 50
o
c before addition 
of 500 μl chloramphenicol (15 μg/ml) and poured into sterile petri dishes 
(Sterilin) 
6. The paltes were stored at 4
o
c until use 




Brain Heart Infusion Broth with glycerol 
For a 300 ml preparation: 
Brain Heart Infusion (Oxoid)                                                        11.4 g 
Yeast Extract (Oxoid)                                                                       1.2 g 
Glycerol                                                                                             60 ml 
Distilled water                                                                                 210 ml 
Horse serum (Gibco)                                                                         30 ml 
 
1. The brain heart infusion, yeast extract, glycerol and distilled water were 
mixed. 
2. The mixture was then autoclaved at 121oC for 20 min.  
3. The medium was cooled before 30 ml of horse serum was added. 
 
APPENDIX  4 
0.01 M Tris-EDTA (TE) buffer 
For a 1 litre prepration: 
Tris-base (Merck)                                                                      1.211 g 
EDTA (Sigma-Aldrich)                                                             0.372 g 
Distilled water                                                                           1000 ml (qsp) 
Adjust to pH 8.0 using HCL 
 
 




Reaction mixture for PCR amplification                                   
For a 50 µl reaction mixture:            
50ng genomic DNA (working stock of 10 ng/µl)                            5 µl 
50 pmol primer (forward and reverse)                                              5 µl each 
1 unit Taq DNA polymerase (Finnzymes)                                     0.5 µl 
200 µM each of dATP, dGTP, dCTP, dTTP (Promega)                    1 µl each 
10 X incubation buffer (Finnzymes)                                                  5 µl 
(10mM Tris-HCl, 50mM KCL, 2mM MgCl2, 0.01% gelatine) 
Sterile distilled water                                                                      25.5 µl 
 
APPENDIX 6 
6 X DNA loading buffer 
For a 100 ml prepration: 
Bromophenol blue (Bio- Rad)                                             0.2 g 
Xylene cyanol (Sigma- Aldrich)                                         0.2 g   
Glycerol (QRec)                                                                    60 ml  
EDTA (Sigma- Aldrich)                                                        1.861 g   








Tris-Acetate-EDTA (TAE) Buffer 
For a litre of 1 litre 50 X TAE buffer preparation: 
Tris-base (Merck)                                                                     242.28 g 
Glacial acetic acid (Schedelco)                                                 57.1  ml 
EDTA (Sigma-Aldrich)                                                                37.22 g 
Distilled water                                                                              1000 ml (qsp) 
 
For a litre of 1 x TAE buffer preparation: 
To 20 ml of 50 x TAE buffer, add 980 ml of distilled water.  
 
APPENDIX 8 
Growth medium for AGS cells 
For a 1 litre preparation: 
Nutrient Mixture F-12 ham Kaighn’s Modification               11.3 g 
NaHCO3 (Sigma- Aldrich)                                                          1.17 g 
Fetal calf serum (Hyclone)                                                          100 ml 
Nanopure water                                                                             1000 ml (qsp)         
The medium was filtered through a 0.22 μm filter (Corning) and stored at 4oC   








Growth medium for THP-1 monocytes. 
For a 1 litre preparation: 
DMEM (Hyclone)                                                                      890 ml 
L- glutamine (200 mM) (Gibco)                                               10 ml 
Fetal calf serum (Hyclone)                                                        100 ml 
1. Fetal calf serum was filtered through a 0.22 μm filter (Millipore) and added 
to DMEM 





Phosphate buffered saline (PBS) 
For 1 litre of 10 X PBS stock preparation:  
NaCl (Sigma-Aldrich)                                                                         80 g 
KH2PO4 (Merck)                                                                                2.4 g 
Na2HPO4.2H20 (Merck)                                                                 14.4 g 
KCl (Merck)                                                                                           2 g 
Distilled water                                                                              1000 ml (qsp) 
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APPENDIX  11 
Reverse Transcription  
RNA Template                                                                                       5 μl 
Random primer (Hexamer)                                                                 1.5 μl 
Incubate 70oC for 10 min, chill on ice.  
dH20                                                                                                  11.5 μl 
5 X RT Buffer                                                                                        4 μl 
dNTPs                                                                                                     1 μl 
Rnasin                                                                                                     1 μl 
Incubate 25
o
C for 5 min  
AMV RT                                                                                               1 μl 
Incubate 25
o
C for 10 min, 37 
0
C for 1 h 
Incubate 75
o














Quantifast SYBR Green q-PCR 
2 x RT-fast master mix                                                                      10 μl 
Forward primers                                                          optimized concentration 
Reverse primers                                                           optimized concentration 
Fast RT mix                                                                                      0.15 μl 
RNA                                                                                                  150 ng 
RNase- free water                                                                              20 μl (qsp)  
 
APPENDIX 13 
Cell Lysis buffer 
For a 100 ml preparation: 
Tris base (pH 7.5) (Merck)                                                               0.606 g 
NaCl (Sigma-Aldrich)                                                                       0.584 g 
Glycerol (QRec)                                                                                     10 ml 
Triton- X 100 (Bio-Rad)                                                                           1 ml 
Protease inhibitor (Roche)                                                                   10 tablets 









Polyacrylamide gel reagents 
Resolving gel buffer (1.5 M Tris-HCL, pH 8.8) 
Tris-base (Merck)                                                                    90.86 g 
Distilled water                                                                            500 ml (qsp) 
Stacking gel buffer (0.5 M Tris-HCl, pH 6.8) 
Tris-base (Merck)                                                                       30.29 g 
Distilled water      500 ml (qsp) 
10% Ammonium persulphate (APS) 
Ammonium persulphate (Bio-Rad)                                                0.5 g 
Distilled water                                                                                      5 ml (qsp) 
 
The resolving and stacking gels were prepared as follows 
Resolving gel (12%) 
For 1 gel (8.5 cm by 7.5 cm) 
Resolving gel buffer                                                                            2.5 ml 
40% acrylamide (Bio-Rad)                                                                 3.0 ml 
10% SDS (Merck)                                                                              100 µl 
TEMED (MP Biochemicals)                                                                  5 µl 
10% APS (Bio-Rad)                                                                              50 µl 
Distilled water                                                                                    4.35 ml 
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Stacking gel (4%) 
For 1 gel (8.5 cm by 7.5 cm) 
Stacking gel buffer                                                                            1.26 ml 
40% acrylamide (Bio-Rad)                                                                 0.5 ml 
10% SDS (Merck)                                                                                 50 µl 
TEMED (MP Biochemicals)                                                                  5 µl 
10% APS (Bio-Rad)                                                                              25 µl 
Distilled water                                                                                    3.18 ml 
  
APPENDIX 15 
5 X Reducing Loading Buffer 
For a 10 ml preparation: 
SDS (Merck)                                                                                      1 g 
1 M Tris (pH 6.8) (Merck)            1.563 ml 
β-mercaptoethanol (Sigma-Aldrich)                                       1.25 ml 
Glycerol (QRec)                                                                          2.5 ml 
Bromophenol blue (Bio-Rad)                                                    2.5 mg 
Distilled water                                                                               10 ml (qsp) 
 
The solution was kept at 4
o
C until use. 
 
 




SDS-PAGE Running Buffer 
For 1 litre of 10 X SDS-PAGE running buffer: 
Tris-base (Merck)                                                                             30.3 g 
Glycine (Fisher Scientific)                                                          150.14 g 
SDS (Merck)                                                                                        10 g 
Distilled water                                                                            1000 ml (qsp) 
 
APPENDIX 17 
Western blot transfer buffer (pH 9.2) 
For a litre of 1 X transfer buffer 
Tris-base (Merck)                                                                                3 g 
Glycine (Fisher Scientific)                                                            14.4 g 
Methanol (Schedelco)                                                                   200 ml 
Distilled water                                                                             1000 ml (qsp) 
 
APPENDIX 18 
2 % BSA-PBS (0.1%) 
For a 100 ml preparation: 
BSA (Merck)                                                                                  2 g 
1 X PBS                                                                                     100 ml                                                                                
 




PBS-Tween buffer (0.1%) 
For a 1 litre preparation: 
Tween 20 (Merck)                                                                                  1 ml 
1 X PBS                                                                                            1000 ml 
 
APPENDIX 20 
Incubation buffer (0.5 % BSA-PBS) 
For a 100 ml preparation: 
BSA (Merck)                                                                                0.5 g 
1 X PBS                                                                                     100 ml                                                                                
 
APPENDIX 21 A 
LB (Luria-Bertani) broth 
For a 1 litre preparation: 
Bacto-tryptone (Oxoid)                                                                      10 g 
Bacto-yeast extract (Oxoid)                                                                 5 g 
NaCl (Merck)                                                                                       10 g 
Distilled water                                                                               1000 ml (qsp) 
1.The solution was adjusted to pH 7.2 with 5 M NaOH. 
2. The mixture was then autoclaved at 121
o
C for 20 min. 
3. The broth was kept at 4
o
C until use. 
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APPENDIX 21 B 
LB (Luria-Bertani) Agar  
For a 1 litre preparation: 
Bacto-agar (Gibco)                                                                         15 g 
LB broth                                                                                       1000 ml (qsp) 
1. The mixture was then autoclaved at 121
o
C for 20 min. 
2. The solution was then cooled to 50
o
C and poured into sterile petri dishes. 
3. The plates were stored at 4
o




For a 200 ml preparation: 
CaCl2.6H2O (Merck)                                                                      54 g 
Distilled water                                                                             200 ml 
1. The solution was sterilized by filtering through a 0.22 µm filter (Satorius, 
Minisart). 
2. It was then kept as 10 ml aliquots at – 20oC until use.  
3. When using, dilute with 100 ml of distilled water, filter through 0.45 µm 









Ampicillin Stock (50 mg/ml) 
For a 10 ml preparation:  
Ampicillin -sodium salt (Sigma)                                                           500 mg 
Distilled water                                                                                            10 ml 
1. The solution was sterilized by filtering through a 0.22 µm filter (Satorius, 
Minisart) 
2. The solution was stored as aliquots of 500 µl at -20
o
C until use.  
 
LB (Luria-Bertani) + Ampicillin (50 µg/ml) Agar plate 
For a 1 litre preparation: 
Bacto- agar (Gibco)                                                                          15 g 
LB medium                                                                                    100 ml (qsp) 
 
1.The mixture was then autoclaved at 121
o
C for 20 min. 
2. It was then cooled to 50
 o
C and 500 µl of ampicillin (50mg/ml) was added. 
3. The LB+Amp plates were stored at 4
 o











Cytosolic and nuclear protein extraction buffers 
A) Buffer A 
HEPES (Sigma-Aldrich)                                                                        240 mg 
KCl (Merck)                                                                                             70 mg 
EDTA (Sigma-Aldrich)                                                                           3.7 mg 
MgCl2 (Merck)                                                                                          31 mg 
Tween 20 (Sigma-Aldrich)                                                                       0.2 ml 
DTT (Bio-Rad)                                                                                     15.42 mg     
PMSF (Merck)                                                                                         8.71 mg 
Distilled water                                                                                100 ml (qsp)   
 
B) Buffer B 
HEPES (Sigma-Aldrich)                                                                        480 mg 
NaCl(Sigma-Aldrich)                                                                              2.3 g 
EDTA (Sigma-Aldrich)                                                                            3.7 mg 
MgCl2 (Merck)                                                                                          31 mg 
Glycerol (QRec)                                                                                        25 ml 
DTT (Bio-Rad)                                                                                     15.42 mg     
PMSF (Merck)                                                                                         8.71 mg 
Distilled water                                                                                100 ml (qsp)   
 





Coating buffer (0.1 M Sodium carbonate, pH 9.5) 
NaHC03 (Sigma-Aldrich)                                                        7.13 g 
Na2CO3 (Merck)                                                                      1.59 g 
Distilled water                                                                           1000 ml (qsp) 
 
APPENDIX 26 
PBS-Tween buffer (0.05%) 
For a 1 litre preparation: 
Tween 20 (Merck)                                                                                 0.5 ml 
1 X PBS                                                                                            1000 ml 
 
APPENDIX 27 
MTT stock solution 
Thiazolyl blue tetrazolium bromide (MTT, Sigma)                        25 mg 
PBS                                5 ml (qsp) 
The solution was filtered and stored in the dark at 4ºC. 
MTT working solution 
MTT working solution was prepared by diluting 1 ml of MTT stock solution 
in 9 ml of the respective cell culture medium (e.g. RPMI 1640 or DMEM). 
 
 




For AGS cells, 
Horse radish peroxidase conjugated streptavidin      1μl 
Phosphate Buffer Saline         1ml 
Bovine Serum Albumin         0.005g 
 
APPENDIX 29 
O-phenylenediamine dichloride (OPD) 
Preparation of OPD Buffer (1 litre), 
a) Citric Acid (BDH)     5.25 g/250ml  
b) Sodium hydrogen phosphate (Merck 6580)  17.8 g/500ml 
Add b) to a) and adjust to pH 5.3. 
Add distilled water to one litre. 
Final pH obtained was pH 5.4. Filter sterilise. 
Working OPD used, 
OPD (Sigma, P-1526)  1 mg 
OPD buffer   1 ml 










2M Sulphuric Acid, for a 250 ml preparation, 
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Galectin 3 (Gal-3) is upregulated in gastric epithelial cells as a host response 
to H. pylori infection. However, the significance of Gal-3 expression in H. 
pylori-infected cells is not well established. We analysed Gal-3 intracellular 
expression, localization and its effects in H. pylori infection. The 
predominantly nuclear confined Gal-3 was shown to be upregulated and 
exported out to the cytoplasm in H. pylori-infected AGS cells. The nuclear 
export was channelled through CRM-1 (exportin-1) protein. Interestingly, 
knockdown of Gal-3 expression led to reduced NFκB promoter activity and 
IL-8 secretion, suggesting its proinflammatory roles. Furthermore, Gal-3 was 
found to be pro-proliferative and anti-apoptotic in nature, as its knockdown 
caused a reduction in cell proliferation, and an increase in apoptosis 
respectively. Taken together, our data suggest the expression and upregulation 
of Gal-3 as a critical endogenous event in H. pylori infection which would 
interfere with various intracellular events, thereby leading to prolonged cell 




Helicobacter pylori infects the human gastric mucosa and plays an important 
role in the pathogenesis of chronic gastritis and peptic ulcer disease (Graham 
et al, 1994; Blaser, 1998). Studies have reported a strong association between 
H. pylori infection and the development of gastric adenocarcinoma and 
mucosa associated gastric lymphoma (Parsonnet et al., 1991; Uemara et al., 
2001). Although considered as a class I carcinogen (IARC, 1994), the 
consequences of H. pylori persistence in gastroduodenal diseases including 
gastric cancer, are determined by interaction of environmental, host, genetic 
and microbial factors (Peek and Blaser 2002; Chang et al., 2006). 
 
H. pylori infection is associated with a concomitant increase in various 
survival responses including an enhanced inflammation and proliferation of 
                                                                                                             
 
 
the gastric epithelium. Development of a chronic inflammation is a hallmark 
event in H. pylori pathogenesis and is initiated by a number of inflammatory 
mediators including cytokines and chemokines (Bodger and Crabtree, 1998). 
The infection is marked by NFκB activation, resulting in an active pro-
inflammatory response through the secretion of IL-8 (Maeda et al., 2000; 
Meyer et al., 2000). The role of H. pylori cytotoxin-associated gene A (CagA) 
protein in inflammation is best established (Odenbreit et al., 2000) as it 
translocates into the host cell through a type IV secretion system (Guruge et 
al., 1998; Backert and Selbach, 2008), triggering a cascade of events leading 
to enhnaced IL-8 secretion (Menheniott et al, 2012). Another characteristic 
feature in H. pylori-induced gastric malignancies arises from its effect in cell 
proliferation. Increased proliferation of epithelial cells could well be an 
important biomarker for increased risk of gastrointestinal adenocarcinoma 
(Lipkin, 1988). H. pylori infection of the gastric mucosa has been associated 
with an increase in gastric epithelial cell proliferation (Peek et al., 1999); 
(Schneider et al., 2011). A failure to regulate proliferation together with 
suppression of apoptosis are the minimal requirements for a cell to become 
cancerous (Green and Evan, 2002; Hipfner and Cohen, 2004). The infection 
induces an upregulation of certain key cell cycle regulators (e.g Cyclin D1, C-
myc etc) (Yang et al., 2004). Studies by Fan et al has shown a shown a role of 
H. pylori in contributing to enhanced proliferation of gastric epithelial cells. 
Hence, inflammation and proliferation acts as major risk factors in H. pylori 
infection promoting cancer development through sustained cell proliferation in 
an environment rich in inflammatory cells.  
 
Recently, there is a growing amount of literature suggesting the role of lectins 
in microbial infections. Among these Galectins, which are a major group of 
mammalian lectins that exhibits regulatory roles in various intracellular 
processes (Yang et al., 2008) and acts as inflammatory mediators in infections 
(Almkvist and Karlsson, 2004). Galectin 3 (Gal-3), a 31-KD β galectoside 
binding lectin, is one of the most studied galectin, is found upregulated during 
inflammation and infection (Vray et al., 2004; Bernardes et al., 2006). 
Increased expression of Gal-3 was reported in Trypanosoma cruzi and 
                                                                                                             
 
 
Streptococcus pneumoniae infections (Silva-Monteiro et al., 2007b; Farnworth 
et al., 2008). Previous studies have demonstrated a critical role of Gal-3 in cell 
cycle regulation and inflammation, both in-vitro (Yoshii et al., 2002; 
Henderson and Sethi, 2009) and in-vivo (Nieminen et al., 2008; Fermino et al., 
2011) 
 
Gal-3 would potentially play a role in gastric malignancies, as it is widely 
expressed in gastric epithelial cells. An increase in Gal-3 expression is linked 
to increased malignancy gastric adenocarcinomas and in a number of tumors 
(Baldus et al., 2000; Miyazaki et al., 2002). Intriguingly, Gal-3 plays a role in 
infection induced gastric abnormalities also, as it is upregulated and rapidly 
secreted as a host response to H. pylori infection (Fowler et al., 2006).  
Although the protein reportedly has various intracellular roles in various 
cancers, no prior work has been done however, to identify its functional 
significance in H. pylori induced gastric infections. Given its diverse 
functions, it is possible that Gal-3 could play a regulatory role in H. pylori 
infection by interfering with various associated host response events. The 
current study aims to identify the intracellular dynamics of Gal-3 and its 
significance H. pylori-infected gastric epithelial cells. Taken together, by 
identifying the expression, localization, as well as its effects in inflammation 
and proliferation, we define the diverse intracellular roles of Gal 3 in 
prolonging cell survival, which however could lead to chronic persistence of 
infection, a characteristic in H. pylori-associated gastric diseases. 
 
Experimental procedures. 
H. pylori strains 
H. pylori 26695 wild type (WT) and isogenic mutant strain of cagA (ΔcagA) 
expressing a chloramphenicol resistance gene cassette, constructed with the 
use of a modified multistep polymerase chain reaction (PCR) approach (Gong 
et al., 2010)  were used. Bacteria were cultured on chocolate blood agar 
(Oxoid) supplemented with 5% horse blood (Thermoscientific). Plates were 





c under micro aerobic conditions (10% CO2, 7.5% O2, 82.5% 
N2). 
Cell culture and H. pylori co-culture 
AGS gastric cancer epithelial cells (CRL-1739; American Type Culture 
Collection, Manassas, VA) were cultured at 37°C under 5% CO2 in Ham’s 
F12K medium supplemented with 10% fetal calf serum (Gibco-BRL, 
Rockville, MD). Cells were cultured in 10% serum- supplemented (Serum+) 
or serum- free (serum-) conditions. H. pylori cells were harvested and washed 
in PBS (7.4), pelletted and resuspended in PBS for co-culture experiments at a 
multiplicity of infection of 100:1 
Western blot analysis of whole cell extracts 
After incubation with H. pylori in serum free F12K, cells were washed with 
PBS to remove bacteria and then lysed with lysis buffer (50Mm Tris, 100mM 
Nacl, 10% glycerol, 1% triton X, protease inhibitor cock tail (Roche, 1/10ml)). 
The protein concentration was quantified by Bradford assay and equal 
amounts were loaded on to 10% SDS running gels. The cell lysates were then 
subjected to PAGE and proteins were electro transferred to PVDF membrane 
(Biorad, USA). The membrane was blocked with 2% BSA (Merk) and 
incubated for 2 h at room temperature or overnight at 4
0
C in PBS containing 
0.2% BSA containing one of the following antibodies: a) Gal-3 rat-MAb 
(SantaCruz Biotechnology) 1:1000 dilution; (b) CagA mouse-Ab (SantaCruz 
Biotechnology) 1: 1000 dilution; (c) cyclin D1 mouse-Ab (SantaCruz 
Biotechnology), 1:200 dilution; (d) β- actin rabbit-Ab (Cell Signalling), 1: 
3000; (e) β- tubulin mouse-Ab (1:2000); (f) Lamin rabbit-Ab (Cell Signalling), 
1: 2000. For detection of the proteins (15-20µG), an ECL detection assay 
(Pierce western blot detection substrate, Thermo scientific) was performed 
according to the manufacturer’s instructions. 
Sub cellular fractionation- Extraction of cytosolic and nuclear proteins 
The extraction was carried out using the ‘proteoJET cytoplasmic and nuclear 
protein extraction kit (Fermentas). The cells were grown on 60mm dishes to 
                                                                                                             
 
 
sub confluency, and was serum starved prior to infection. Cells infected with 
H. pylori strains in serum free F12K were harvested, washed and lysed with 
the lysis buffer containing protease inhibitor and DTT. After 10 min of 
incubation, the cells were centrifuged at 500 xg and the cytosolic extract was 
isolated. Afterwards, the nuclei were washed, followed by lysis with the nuclei 
lysis reagent. The lysed sample was then centrifuged at 20,000 xg and the 
nuclear extract was isolated. The whole procedure was done in ice or at 4
0
c. 
The samples were then analysed by western blotting as described before.  
Immunofluorescence staining 
AGS cell grown on coverslips were serum starved for 12h upon reaching sub 
confluency, followed by co-culturing with H. pylori for various time intervals. 
The cells were washed in PBS and then fixed at room temperature for 30 min 
with 3.7% paraformaldehyde (Merck). After washing with PBS, the cells were 
blocked for 30 mins with 2% BSA, followed by permiabilization with 0.1% 
triton x- 100 for 10 min. The cells were then stained for an h with anti-Gal-3 
MAb (1:100) for 1 h, washed extensively in PBS and stained with anti Gal-3 
secondary antibody conjugated to FITC (1:100). After washing, the cell nuclei 
were stained with Hoechst (2μg/ml; Molecular Probes) and the cover slips 
were then mounted on glass slides using Floursave
TM
 reagent (Calbiochem). 
Optical sections of the immunostained cells were photographed using a laser 
microscope (Olympus Fluoview 1000).  
Transmission electron microscopy and immune gold labelling 
AGS cells were cultured to sub-confluency in 75cm
2
 tissue culture flasks in 
complete F12 K medium. The growth medium was removed 12h prior to 
infection and cells were washed twice with PBS and fresh serum- free F12K 
was added. Cells were infected with H. pylori for 24 h. Following incubation, 
cells were washed twice with PBS and fixed using glutaraldehyde. Fixed cells 
were then cut into thin sections (700-100nm). The cut sections were then 
blocked in 5% BSA-PBS and then conjugated with a rat-anti Gal-3 MAb (1:50 
dilution), followed by incubation with 20nm gold- protein A conjugate (1:20, 
Ted Pella) as the secondary antibody. The sections were stained with uranyl 
                                                                                                             
 
 
acetate and led citrate and then viewed under an electron microscope (Philips 
208S). 
cagA transfection in AGS cells. 
H. pylori cagA cloned in Psp65SRα (mammalian expression vector) was 
kindly provided by Dr. M. Hatakeyama of the Hokkaido University, Japan. 
The cells were grown for 24 h on 60mm culture dishes and the F12K media 
was replaced with Opti-MEM I reduced serum medium (Invitrogen), before 
transfection.  An aliquot of 30µg of the cagA cDNA plasmid was mixed with 
Lipofectamin 2000 transfection reagent (Invitrogen) at a ratio of 1:1 in Opti-
MEM. Following 36 h after transfection, the cells were harvested, lysed and 
the expression of cagA was detected using immune blot analysis.  
IL-8 ELISA. 
Clarified culture supernatants from 24 h infections with H. pylori strains were 
diluted 1:2 to 1:10, as needed. Supernatants were analyzed for IL-8 protein 
with a Quantikine human IL-8 ELISA kit (R&D Systems, Minneapolis, 





Luciferase Reporter Gene Assay  
 
AGS cells were transfected with various plasmids with the use of X-treme 
gene DNA transfection reagent (Roche). pMetLuc2-control vector was used as 
a positive control. The level of NF-kB activation in AGS cells under different 
treatments was evaluated with Ready-To-Glow secreted luciferase reporter 
system (Clontech, Mountain View, CA).  
siRNA mediated knockdown of Gal-3 in AGS cells 
For siRNA transfection, the cells were grown in 6 well plates for 24 h to sub 
confluency. Gal-3 siRNA (Santa Cruz Biotechnology) was used for a transient 
knockdown as per manufacturer’s instruction. Briefly, the siRNA duplex 
                                                                                                             
 
 
(1µg) were diluted in transfection medium (Santa Cruz Biotechnology) and 
then mixed with the siRNA transfection reagent (Santa Cruz Biotechnology). 
The transfection mixture was then added on to the cells and and incubated for 
24-48 h for subsequent experiments. To determine the transfection efficiency, 
cells were harvested, lysed and Gal-3 protein expression was detected using 
immunoblot analysis. 
Cell Viability analysis- MTT assay 
Cell proliferation in Gal-3 depleted (siRNA mediated) AGS cells was 
measured by MTT assay. AGS cells were grown to sub confluency in 24- well 
plates in F12K supplemented with 10% fetal calf serum (Gibco). For Gal-3 
depletion, the cells were transfected with Gal-3 siRNA’s (Santacruz) as 
described previously. Transfected cells were co-cultured with H. pylori. The 
cell culrure media was replaced with 250µl of diluted 3-(4, 5- 
dimethylthiazolyl-2)-2, 5- diphenyltetraolium bromide (MTT) solution at 
specific time intervals and was incubated for 2 hrs. After removal of the MTT 
solution, 250µl of DMSO were added to each well to dissolve the formazan 
crystals. The absorbance at 540 nm was determined using a microplate 
spectrophotometer (Bio-Tek Instruments, Inc, Winooski, VT, USA). Triplicate 
wells were assayed for each condition and standard deviation (S.D) was 
determined. 
Cell apoptosis analysis using Flow cytometry 
Apoptosis was detected by Annexin V- FITC (fluorescein isothiocyanate) kit 
(BD Pharmigen) according to manufacturer’s recommendations. Briefly, cells 
were grown to sub confluency in 25cm2 flasks in F12K supplemented with 
10% fetal calf serum. Prior to infection the medium was replaced with serum 
free F12 K and then co-cultured with H. pylori. After 24 h of incubation, cells 
were harvested, and washed thrice with cold PBS and then resuspended in 1x 
binding buffer. An aliquot of 100µl of the resuspended cell volume (1X 105 
cells) were transferred into a microfuge tube, mixed with equal volumes of 
(5µl) of Annexin V- FITC and Propidium Iodide (PI) respectively. The cells 
were gently vortexed and incubated for 15 min at 37
o
c in the dark, before 
                                                                                                             
 
 
addition of 400µl of 1X binding buffer in each tube. The cells samples were 
then analysed using a flow cytometer within one h.  
 
RESULTS 
Gal-3 expression is upregulated in H. pylori infected AGS cells. 
To investigate the expression of Gal-3 in H. pylori-infected cells, AGS cells 
were infected with WT and ΔcagA strains of H. pylori. The level of 
expression was detected by immunoblotting (Fig 1A). Gal-3 showed a 
significant increase in expression in cells infected with WT H. pylori. This 
increase in Gal-3 expression was delayed in ΔcagA infected cells, hence 
suggesting the role of CagA in initiating Gal-3 upregulation. However, the 
Gal-3 upregulation was found to be independent of cagA as the infection 
progresses with no significant variation in the expression levels at later time 
intervals (≈8h onwards). The results were further confirmed my flow 
cytometric analysis of H. pylori-infected cells (Fig1B). Cells infected with WT 
strains showed a significant upregulation, 24 h-post infection. The cells 
infected with the ΔcagA strains also showed an increase in expression as 
compared with the basal level seen in uninfected cells.  
 
CagA would act as an initiator of Gal-3 up regulation. 
The translocation of CagA into the host cells is reported to initiate a string of 
signal transduction cascade, leading to a global transcriptional response in H. 
pylori-infected cells (Langdon et al, 2005). Previous studies have shown a 
CagA dependent upregulation in Gal-3 mRNA levels (Fowler et al, 2006). In 
our study, cagA seemed to have an effect in Gal-3 protein expression, only at 
the onset of infection. The role of CagA in Gal-3 expression was further 
investigated by the transfection of a cagA-expression vector (pSP65SRα) into 
AGS cells. Cells transfected with pSP65SRα-cagA showed detectable levels 
of CagA protein and gene expression (2A & 2B). Transfection of cagA caused 
                                                                                                             
 
 
an increase in Gal-3 protein expression as compared to the basal level of 
expression seen in uninfected cells (2C). Similarly, cells infected with  WT H. 
pylori also caused a significant increase in Gal-3 expression as compared with 
the uninfected cells. The results confirm the role of cagA as a initiator of Gal-
3 up regulation in H. pylori infected cells.   
 
H. pylori infection induces nuclear export of Gal-3 
The sub cellular localization of Gal-3 was detected in AGS cells. Gal-3 was 
found to be expressed predominantly in the nucleus of AGS cells. Western 
blot analysis of the nuclear and cytoplasmic fractions confirmed the nuclear 
export of Gal-3 (Fig. 3A) in cells infected with H. pylori strains. Gal-3 was 
retained in the nucleus of uninfected cells, however in cells infected with WT 
H. pylori, an active export of Gal-3 was observed from the nucleus to the 
cytoplasm. The Gal-3 nuclear export was delayed in cells infected with ΔcagA 
strains, as it showed significantly reduced levels of cytoplasmic Gal-3 till 6h 
of infection. The intracellular Gal-3 expression was also detected by 
immunofluorescence microscopy (3B), where Gal-3 was seen localised in the 
cytoplasm of H. pylori infected cells. Uninfected cells showed a basal level of 
Gal-3 expression, and was seen restricted mostly in the nucleus. The results 
were further confirmed by transmission electron microscopy (Fig 3C). 
Immunogold labelled Gal-3 was shown to be expressed predominantly in H. 
pylori infected cells, where as the expression was mostly contained in the 
nucleus of uninfected cells. The study reveals the intracellular dynamics of 
Gal-3, being transported from the nucleus to the cytoplasm as a host response 
to H. pylori infection.  
 
Gal-3 nuclear export is mediated through the CRM1 exportin protein. 
The mechanism of Gal-3 nuclear export was identified using a well 
characterized nuclear export inhibitor, Leptomycin B (LMB). LMB binds to 
and inhibits the interaction of exportin1 (CRM1) with the leucine rich NES’s. 
                                                                                                             
 
 
The presence of a leucine rich NES between residues 241-246 of Gal-3 was 
previously reported (Li et al, 2006). Addition of LMB (10nm/ml) resulted in 
the retention of Gal-3 within the nucleus, causing an inhibition of Gal-3 
nuclear export (4A). Western blot anlaysis of the untreated cells infected with 
WT H. pylori showed a significant decrease in the nuclear Gal-3 expression 
upon reaching 24h of infection while comparing with the expression at 12h 
infection (4B). Interestingly, LMB treated cells showed nuclear retention of 
Gal-3 expression till 24h of infection. The result confirms that the nuclear 
export of Gal-3 in H. pylori-infected cells is mediated through the CRM1 
protein.  
 
Knockdown of Gal-3 expression causes a decrease in NFκB activation and 
IL-8 secretion.  
Activation of NFκB is strongly associated with the induction of IL-8 secretion, 
thus contributing to a pro–inflammatory response. H. pylori has been shown to 
activate NFκB and to increase IL-8 production (Torok et al, 2005; Gong et al, 
2010). We detected the NFκB promoter activity in H. pylori-infected cells by a 
luciferase reporter assay (5A). High levels of NFκB activity was observed in 
cell infected with the WT H. pylori. Cells infected with ΔcagA showed a 
reduction in the NFκB activity, hence signifying the importance of cagA in IL-
8 secretion.  The role of Gal-3 in H. pylori directed inflammatory pathway was 
investigated using Gal-3 knockdown cells. Gal-3 depletion caused a 
significant reduction in the NFκB promoter activity in cells infected with both 
WT and ΔcagA strains of H. pylori.  
Earlier reports showed that IL-8 is responsible for the inflammation-associated 
mucosal injury in H pylori–associated gastroduodenal diseases (Crabtree et al, 
1994). As described previously, our studies also showed a significant increase 
in IL-8 secretion in cells infected with WT H. pylori (5B). The IL-8 levels 
were lowered in cells infected with the ΔcagA strains. Interestingly, Gal-3 
depletion caused a significant reduction in the IL-8 levels, suggesting its role 
in mediating the pro-inflammatory response in H. pylori infected cells. The 
                                                                                                             
 
 
reduction of IL-8 levels in Gal-3 depleted cells was more significant upon 
infection with the wt strain than with the ΔcagA.  
 
Gal-3 knockdown accelerated proliferation arrest and apoptosis in H. 
pylori-infected cells. 
To investigate the possibility that the observed effects of Gal-3 on IL-8 
secretion would contribute to an enhanced cell survival, we performed MTT 
assays to monitor the cellular viability and proliferation. Cells transfected with 
Gal-3 siRNA showed a significant reduction in the viability upon infection 
with WT H. pylori (6A). The results were more significant at 48h of infection 
with H. pylori, as the transfected cells showed a 50% drop in the overall 
percentage of cell viability as compared with non-transfected cells. To 
determine if the reduction in cell viability levels associated with Gal-3 
knockdown would reflect a similar effect in the apoptosis, we investigated the 
amount of apoptosis in AGS cells infected with WT and ΔcagA strains of H. 
pylori. As shown in Fig. 6C. Uninfected cells didn’t show any apoptosis as 
indicated in the flow cytometry data. However, H. pylori infection induced 
apoptosis in AGS cells as recorded as 14% and 13% upon infection with the 
WT and ΔcagA strains of H. pylori respectively. Gal-3 knockdown caused a 
significant increase in the percentage of cells undergoing apoptosis. Gal-3 
depleted cells infected with WT and ΔcagA strains recorded 24% and 22% of 




                                                                                                             
 
 
     
 
                                      
 
 
Fig. 1.  Analysis of Gal-3 expression in human gastric cells infected with 
H. pylori. AGS cells were infected with WT and ΔcagA strains of H. pylori 
for up to 24 hrs. (A) Serum starved cell lysates were resolved by SDS-PAGE 
and Gal-3 detected on Western blots with anti Gal-3 MAb. β- actin serve as 
loading control (B) The 24 hr post-infected cells were fixed, permeabilised 
and stained with anti-Gal-3 MAb conjugated to FITC and Gal-3 expression 
was detected by Flow cytometry. The data are representative of three separate 
experiments.   
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Fig. 2. Analysis of cagA transfection and its role in Gal-3 expression. AGS 
cells were transfected with pSP65SRα containing full-length cagA (pSP65Srα-
cagA) and the CagA protein expression was compared against non transfected 
cells which were infected with WT H. pylori. (A) Protein expression 
confirmed by Western blotting with polyclonal anti-CagA antibody (B) The 
plasmid was extracted from the tranfected cells, amplified by PCR and CagA 
protein expression was visualised by electrophoresis. (C). Gal-3 expression 
was detected in cells either infected with WT H. pylori or transfected with the 
cagA expression vector. The cell lysates were subjected to western blot 
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Fig. 3. Detection of Gal-3 sub cellular expression. Serum starved AGS cells 
were infected with H. pylori WT and ΔcagA strains for 24 hrs. Uninfected 
cells serve as experimental control. (A) Immunofluorescent analysis of Gal-3 
nuclear and cytoplasmic expression; Gal-3 is stained green with anti-Gal-3 
MAb conjugated to FITC while the cell nucleus fluoresces blue as stained by 
DAPI. Panels a-c, signals Gal-3 expression; panels a’-c’ shows merged images 
of Gal-3 fluorescence and nuclear florescence. (B) The cytoplasmic and 
nuclear extracts of the infected cells were subjected to western blot analysis 
using anti Gal-3 MAb. β- tubulin and lamin serve as loading controls for the  
cytoplasmic and nuclear fractions, respectively. (C) Immunogold labelling for 
Gal-3 (10 nm gold particles) using ultrathin sections of uninfected (I) and H. 




                                                                                                             
 
 
                 
 
Fig. 4. Effect of Leptomycin B (LMB) treatment on Gal-3 nuclear export. 
AGS cells pre-incubated with LMB (10ng/ml) were infected with WT H. 
pylori for 24 hrs. Uninfected cells serve as control. (A) Immunofluorescent 
analysis of Gal-3 in AGS cells; Gal-3 is stained green with antiGal-3MAb 
conjugated to FITC while the cell nucleus fluoresces blue as stained by DAPI. 
(a) Untreated non-infected cells (b) Untreated infected cells, (c) LMB treated 
infected cells. (B)  Western blot analysis of Gal-3 nuclear expression in LMB 
treated cells; nuclear fractions were extracted from H. pylori-infected cells (12 
& 24 hrs) and immuno-blotted with anti Gal-3 MAb. Lamin and β tubulin 
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Fig. 5. NFkb activation and IL-8 secretion in Gal-3 knockdown AGS cells. 
WT and ΔcagA strains of H. pylori were co-cultured with Gal-3 siRNA 
transfected (+) and non-transfected (-) AGS cells. (A) Total cell lysates were 
prepared  after Gal-3 siRNA transfection and subjected to western blotting of 
Gal-3. β- actin serve as control. (B) The level of NFκB activation was 
evaluated with Ready-To-Glow secreted luciferase reporter system (Clontech, 
Mountain View, CA). (C) Culture supernatants from 24 hrs post-infected cells 
were analyzed for IL-8 secretion using BD optEIA human IL-8 ELISA kit 
(BD biosciences, CA). The data from three independent experiments were 
pooled and analyzed to assess statistical significance. * p value  < 0.05 was 
considered significant. 
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Fig. 6. Effect of Gal-3 knockdown in cell proliferation and apoptosis. WT 
and ΔcagA strains of H. pylori were co-cultured with  Gal-3 siRNA 
transfected (+) and non-transfected (-) AGS cells. Uninfected cells serve as 
control. (A) The cell proliferation was detected using MTT assay at 24 hrs 
post-H. pylori infection. Data was normalized to uninfected AGS, which serve 
as reference standard (B) H. pylori induced apoptosis, as measured by flow 
cytometry using annexin-V  PI assay at 24hrs post infection. The bar graph 
illustrates the percentage of apoptotic cells as indicated by flow cytometric 
analysis. Data are presented as the mean values with standard errors from two 
independent experiments with three replications. * p value < 0.05 was 
considered significant.  
 
Discussion 
The consequence of H. pylori infection ranges widely from asymptomatic 
colonisation to severe gastric malignancies. The interactions between various 
host and microbial proteins results in a chronic infection, where enhanced 
inflammation and proliferation were reported as a major risk factors (Blaser et 
al, 2005; Robinson et al, 2007). Gal-3 is a multi functional lectin and changes 
in its expression are commonly seen in cancers and in microbial infections 
(Yang et al; 2008). Intracellulary, it exists as a component of heterogeneous 
nuclear ribonuclear protein (hnRNP), a factor in pre-mRNA splicing and has 
been found to regulate cell cycle control. Extracellular Gal-3 is often 
associated with the activation of various immune effector cells including 
monocytes, macrophages, neutrophils and lymphocytes. The cellular 
localization of Gal-3 correlates well with its biological roles and strongly 
depends on various factors such as cell type, proliferation status and culture 
condition and (Haudek et al, 2010).  Gal-3 is widely expressed in gastric 
epithelial cells and its expression is upregulated rapidly as a host response to 
H. pylori infection. The current study elucidates the previously undescribed 
intracellular dynamics, expression as well as functional roles of Gal-3 in 
modulating crucial host survival responses in H. pylori infection.  
 
                                                                                                             
 
 
Consistent with the previous findings (Fowler et al., 2006), we have noticed an 
upregulation of intracellular Gal-3 expression in H. pylori-infected gastric 
epithelial cells. In order to study the infection induced changes in its 
intracellular dynamics, Gal-3 sub cellular localization was identified. Gal-3 
was found to be predominantly nuclear localized in AGS cells. Nuclear 
expression of Gal-3 is generally associated with transcriptional regulation, 
mRNA splicing and apoptosis (Lu et al, 2011). Interestingly, H. pylori 
infection triggered an upregulation of Gal-3 and was accompanied by its 
export from the nucleus to the cytoplasm. Nuclear export of Gal-3 was 
previously reported in other cell lines and cancers, however the infection 
induced changes in Gal-3 intracellular dynamics was never been explored 
before. Gal-3 export in H. pylori-infected cells was found to be mediated 
through the CRM-1 protein. CRM 1 is an export receptor for protein with 
leucine-rich nuclear export signals (Fornerod et al, 1997). The presence of a 
leucine rich NES (nuclear export signal) between residues 241-246 of Gal-3 
and a CRM-1 mediated nuclear export of Gal-3 was previously reported in 
various cells(Li et al, 2006). LMB, a cytotoxin that is shown to bind to CRM-1 
is a well characterized inhibitor of CRM-1 mediated nuclear export. The study 
further confirms the uniqueness of Gal-3 nuclear export mechanism across cell 
lines, as LMB treatment resulted in its nuclear retention by inhibiting the 
infection induced changes in sub cellular expression. Previously, CagA was 
identified as a potent inducer of Gal-3 expression, as its translocation into the 
host cells contributed to an early up regulation of Gal-3 expression. Cells 
transfected with CagA expression vector induced significant amounts of Gal-3 
expression, suggesting CagA as a potentiator of early Gal-3. However, the 
whole process of Gal-3 induction and changes in its sub cellular localization 
appeared to be independent of CagA expression during later time intervals of 
infection.  
 
Inflammation and proliferation has long been associated to enhance the risk of 
gastric malignancies in H. pylori infection. Through the luciferase reporter 
assay, we identified a prominent role of Gal-3 in contributing to the NFκB 
promoter activation, a downstream effect of which was observed in the 
                                                                                                             
 
 
extracellular secretion of IL-8. While comparing with the normal AGS cells, 
Gal-3 knockdown cells, infected with H. pylori showed a significant reduction 
in the activation of NFκB promoter activity and IL-8 secretion. This suggests a 
potential role of Gal-3 in mediating the pro–inflammatory response in H. 
pylori infected cells through an NFκB dependent enhancement of IL-8 
secretion. Another mechanism by which H. pylori may augment the risk for 
carcinogenesis is by altering cellular turnover (Cover et al; 2003). Mucosal 
hyper proliferation was demonstrated in H. pylori infected gastric tissue, 
although in vitro studies showed no significant difference in proliferation. Our 
study identifies a regulatory role of  Gal-3 in H. pylori-infected cells as its 
expression presented the cells with pro-proliferative and anti-apoptotic 
properties. Depletion of Gal-3 caused a significant reduction in the 
proliferation of H. pylori infected cells. The pro- proliferative effect of Gal-3 
was concomitant with prolonged survival, as Gal-3 expression showed a 
negative regulatory effect on H. pylori-induced apoptosis. Cells expressing 
Gal-3 showed a prolonged persistence to infection than Gal-3 depleted cells, 
hence suggesting its anti-apoptotic properties.  
 
The study presented here highlights the role of Gal-3 in enhancing the 
inflammatory and proliferative responses in H. pylori-infected cells. Thus Gal-
3 upregulation could account for an enhanced host response in H. pylori 
infected cells that aim to ensure the cell survival concomitant with the 
clearance of infecting microorganism through an enhanced inflammatory 
response. However, the resultant effect of Gal-3 in mediating these cellular 
responses may inadvertently favour the chronic persistence of infected cells, as 
the cell garner a survival advantage. Previous studies which identified the 
inflammatory roles of Gal 3 in bacterial infections were based on the direct 
interaction of Gal-3 with the galectoside-containing glycoconjugates on 
pathogens (Mandrell et al., 1994; Fowler et al., 2006; Li et al., 2008). Our 
study identifies a previously undescribed intracellular pro–inflammatory role 
of Gal-3 in H. pylori-infected cells where its expression may lead to chronic 
cell injury through a sustained inflammation, but in turn could also lead to the 
                                                                                                             
 
 
activation of innate immune response through the recruitment of immune 
effector cells to the site of infection 
 
The current study demonstrates experimental evidence that Gal-3 plays a key 
role in enhancing the inflammatory and proliferative responses in H. pylori 
infected cells. However, more work has to be done to unwind the underlying 
molecular mechanism by which Gal-3 mediates these multiple cellular 
responses in H. pylori infection. The protein appears to have versatile 
functions in infections and beyond, and a detailed understanding of would 
provide valuable information into their potential use in therapeutic 
interventions and would ideally have clinical implications in the treatment of 
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Expression of Galectin-3 (Gal-3) in host response to 
Helicobacter pylori infection. 
 
Introduction 
H. pylori Cytotoxin associated gene A (CagA) protein was reported to 
upregulate the expression of intracellular Gal-3, a 31 kDa ß-galactoside lectin. 
However, the functional characteristics and significance of Gal-3 expression in 
H. pylori-infected host cells remains unidentified. The present study aimed to 
determine the CagA-mediated expression of Gal-3 in response to H. pylori 
infection. The role of Gal-3 in H. pylori induced inflammation and apoptosis 
were also investigated.  
 
Methods. 
AGS cells were infected with H. pylori 26695 WT and ΔcagA strains. The 
subcellular expression and localization were examined using 
immunofluoresence microscopy and immunoblot analysis, respectively. Gal-3 
was transiently knocked down in AGS cells using targeted siRNA and the 
resultant effects in inflammation and apoptosis were analysed using IL-8 and 
flowcytometric assays, respectively.  
 
Results and conclusion. 
In AGS cells, Gal-3 is predominantly found to be nuclear confined. 
Interestingly, in  H. pylori-infected cells, there was an up regulation of  Gal-3 
in the nucleus which was exported into the cell cytoplasm and then onto the 
cell membrane. However, this process was delayed and reduced in the absence 
of CagA suggesting its role in the induction of Gal-3 expression. Furthermore, 
knockdown of Gal-3 expression contributed to an increase in apoptosis and 
reduced IL-8 response in H. pylori-infected AGS cells. Taken together, our 
data suggest that Gal-3 is an important host factor that may interfere with H. 
pylori-associated pathological events. 
 
 
 
